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Abstract 
Proteins and RNA are known to be enzymes in nature. These biopolymers have complex 
secondary and tertiary structures that can enable substrate binding and catalysis. DNA is 
primarily double-stranded and is not known to be catalytic in nature. However, given the 
similarities in chemical structure between DNA and RNA, it is reasonable to think that single-
stranded DNA can also form complex structures. In fact, artificial DNA enzymes have been 
identified in laboratories by in vitro selection. The identification of new enzymes favors the use 
of nucleic acids over proteins for several reasons. First, nucleic acids can be amplified by natural 
enzymes whereas proteins cannot be amplified in any way. Second, the number of possible 
sequences is smaller for nucleic acids (4n, where n is the length of the biopolymer) than for 
proteins (20n). Therefore, selection experiments for identifying nucleic acid enzymes will cover a 
larger fraction of total sequence space. Furthermore, of the sequence space that is covered, a 
large portion of nucleic acid sequences can fold into secondary or tertiary structures, whereas 
most random sequences of proteins often will not fold and thus will aggregate. Between the two 
nucleic acid polymers, DNA offers additional advantages over RNA because DNA can be 
directly amplified by polymerases whereas RNA requires an extra reverse transcription step. 
DNA is also cheaper and more stable compared to RNA. 
An approach to site-specifically modify peptide and protein side chains will be valuable 
to study natural post-translation modification of proteins. That approach will also be useful for 
artificial modification of proteins to generate homogeneous protein conjugates. The idea of using 
DNA enzymes for site-specific protein modification is very attractive. With a suitable in vitro 
selection strategy, peptide-sequence-selective DNA enzymes can be identified to modify peptide 
and protein side chains. 
The formation of covalent linkages between protein side chains and nucleic acids plays 
an essential role in many biological processes. Deoxyribozymes have been previously identified 
to join tyrosine-containing peptides to RNA by reaction of the tyrosine (Tyr) hydroxyl group 
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with the -phosphate of a 5′-triphosphorylated RNA oligonucleotide (5′-pppRNA). The selection 
approach for identifying those DNA enzymes required the peptide substrate to be either 
embedded in or tethered to a DNA oligonucleotide. Consequently, the resulting deoxyribozymes 
either cannot function with untethered peptide substrates, or require high peptide concentration 
for catalysis. In Chapter 2, a new in vitro selection approach for DNA-catalyzed peptide nucleic 
acid conjugation is described. This new selection approach uses untethered, free peptide 
substrates containing an azido group at the N-terminus. Capture of the catalytically active 
sequences by Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) with a 3'-alkyne-modified 
DNA oligonucleotide provides a substantial mass difference to allow PAGE separation of the 
catalytically active DNA. Selection experiments led to several deoxyribozymes that catalyze 
peptide-RNA conjugation of untethered peptides. Separate selection experiments were performed 
using a 5′-phosphorimidazolated DNA oligonucleotide (5′-ImpDNA) as the conjugation partner. 
Imp is a more generalizable electrophile relative to ppp because Imp can be easily placed at 
either terminus (5′ or 3′) of both RNA and DNA. The selection experiments resulted in numerous 
DNA enzymes that catalyze peptide-DNA conjugation. In addition, imposition of selection 
pressure via reduced peptide concentration led to a deoxyribozyme with a preparatively useful 
peptide Km value. 
A key challenge for DNA-catalyzed peptide and protein modification is to achieve 
catalysis using low peptide and protein concentrations that enable practical utility. For 
deoxyribozymes that require high peptide concentration for catalysis, recruiting strategies were 
sought to direct DNA enzymes to their substrates. Chapter 3 describes the development of 
recruiting strategies for DNA-catalyzed reactions. The use of a histidine tag successfully 
recruited a peptide–RNA-conjugating deoxyribozyme to its peptide substrate and enhanced the 
conjugation yield and rate at low peptide concentrations. The histidine recruiting strategy also 
allowed a Tyr kinase deoxyribozyme to achieve, for the first time, DNA-catalyzed Tyr 
phosphorylation of a discrete, untethered peptide substrate. However, the recruiting effect was 
not observed for protein substrates, likely because the tested deoxyribozymes either cannot 
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access the target peptide segments or cannot function when these segments are presented in a 
structured protein context. 
Chapter 4 describes the efforts toward DNA-catalyzed lysine (Lys) methylation. Lys 
methylation is an important protein post-translational modification. Developing DNA enzymes 
to site-specifically methylate Lys side chains on protein surfaces is valuable for biochemical 
studies. SAM analogs with terminal alkyne-containing chains were used in selection experiments 
as the alkyl donors. The terminal alkyne enables CuAAC reaction with a 5′-azido-modified DNA 
to capture the catalytically active DNA sequences. An initial set of selection experiments did not 
lead to deoxyribozymes. Further efforts have focused on incorporating modified nucleotides with 
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Chapter 1: Introduction to Engineered Enzymes and Protein Modification   
1.1 Enzymatic Catalysis 
Enzymes are macromolecules that catalyze biochemical reactions by adopting three-
dimensional structures to bind specifically to substrates and catalyze their transformations. 
During enzymatic catalysis, the activation energy of a reaction is reduced due to destabilization 
of the ground state or stabilization of the transition state by the formation of an enzyme-substrate 
complex.1 The ability to achieve high reaction rate enhancements is one of the reason why 
enzymes are so important in nature. In addition, enzymes are highly specific for their substrates. 
The complex tertiary structures of enzymes can interact with their substrates in many ways and 
at multiple sites, thereby enabling specific substrate recognition.2 Natural enzymes are 
biopolymers composed of small-molecule building blocks, and by the chemical structures of 
those building blocks, natural enzymes can be categorized into protein enzymes and RNA 
enzymes.  
1.1.1 Protein Enzymes 
Most enzymes in nature are protein enzymes, which are made of amino acids connected 
by amide bonds. The wide variety of functional groups on the amino acid side chains contribute 
to the diverse three-dimensional structures and functions of proteins (Figure 1.1). Specific amino 
acid sequences form secondary structures such as -helices and -sheets, which cooperatively 
form tertiary structures. Quaternary structures can be formed in large protein complexes by the 
assembly of several protein subunits. 
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Figure 1.1. Structures of the protein backbone and amino acid side chains. Proteins are made of 
amino acids connected by amide bonds. Here the proline side chain is drawn within the protein 
backbone.  
Protein enzymes catalyze reactions in their active sites. The amino acid side chains in the 
active sites can engage substrates and facilitate catalysis in many ways. For example, in acid-
base catalysis, the functional groups can act as proton donors or acceptors for the substrates.3 In 
some cases such as serine or cysteine proteases, the functional groups can form covalent 
intermediates with the substrates.4 Other molecules can facilitate catalysis as well. For example, 
by coordination, metal ions can stabilize transition states or reduce the pKa of hydroxyl groups 
and water molecules.4,5  
1.1.2 RNA Enzymes (Ribozymes) 
RNA enzymes (ribozymes) are made of ribonucleotides connected by phosphodiester 
bonds. The functional groups on the four ribonucleotide building blocks are much less diverse 
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compared to proteins (Figure 1.2). Nevertheless, ribozymes can still fold into complex tertiary 
structures and catalyze reactions that are involved in many essential biological processes.6  
 
Figure 1.2. Structures of the RNA backbone and nucleobases. RNAs are made of 
ribonucleotides connected by phosphodiester bonds.  
The first two examples of ribozymes are the group I intron and RNase P, which are 
identified independently in the early 1980s.7,8 The Tetrahymena thermophila group I intron 
catalyzes self-cleavage during RNA splicing using the 3′-hydroxyl group of an exogenous 
guanosine cofactor or a guanosine residue as the nucleophile.7,9 RNase P is an RNA-protein 
complex that catalyzes site-specific RNA hydrolysis, i.e., using a water molecule as the 
nucleophile for RNA cleavage.8 Another example of catalytic RNA in an RNA-protein complex 
is the ribosome, which catalyzes the peptidyl transfer reaction during protein translation.10-12   
Due to the limited diversity of functional groups present in ribonucleotides compared to 
amino acids, metal ions are very important in RNA catalysis. Crystal structures of the group I 
intron ribozymes showed that metal ions help deprotonate the 3′-hydroxyl, position the two 
substrates, and stabilize the developing negative charge on the leaving oxygen atom (Figure 
1.3A).6,13,14 In the case of RNase P, the nucleophile of the hydrolysis reaction is a metal-bound 
water molecule.15-17 However, not all ribozymes require metal ions for catalysis. Divalent metal 
ions stabilize the active structure of the hammerhead ribozyme but are not essential for the RNA 
transesterification reaction.18-20 In the case of the hairpin ribozyme, the RNA transesterification 
4 
reaction has a metal-independent mechanism.21,22 Other than metal ions, nucleobases can also 
participate in RNA catalysis. The hepatitis delta virus (HDV) ribozyme uses a protonated 
cytosine nucleobase as a general acid, donating a proton to the leaving 5′-oxygen atom during the 
transesterification reaction (Figure 1.3B).23,24    
 
Figure 1.3. Reaction mechanisms catalyzed by ribozymes. (A) Mechanism of RNA 
transesterification by the Tetrahymena thermophila group I intron. The image depicts the RNA 
cleavage by the 3′-hydroxyl group of an exogenous guanosine. The MA metal ion coordinates the 
3′-oxygen atom of U−1, stabilizing the developing negative charge on the leaving 3′-oxygen; the 
MB metal ion coordinates the 3′-oxygen atom of the exogenous G to aid deprotonation of the 
hydroxyl group; and the MC metal ion assists in positioning the substrates as well as stabilizes 
the trigonal bipyramidal transition state. (B) Mechanism of RNA transesterification by the HDV 
ribozyme. The protonated N3 atom of the C75 nucleobase is a general acid that donates a proton 
to the 5′-oxygen of the leaving ribonucleotide. Figure reprinted with permission from ref 6.  
1.2 Development of Engineered Enzymes 
Inspired by natural enzymes, engineered enzymes have been created in laboratories for 
industrial, academic, and therapeutic applications.25-27 Natural enzymes today are the result of 
billions of years of evolutionary pressure. Their catalytic efficiencies and substrate specificities 
are tailored to their biological roles.28  Engineered protein enzymes have been developed by 
directed evolution or rational design from known proteins to meet specific needs. Artificial 
enzymes made of natural or synthetic genetic biopolymers have been identified by in vitro 
selection from completely random sequence pools to catalyze the desired reactions. This section 
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will briefly discuss methods for protein enzyme engineering and focus on the development of 
artificial nucleic acid enzymes.  
1.2.1 Methods for Protein Enzyme Engineering 
1.2.1.1 Directed Evolution 
Directed evolution is the most commonly used method for protein enzyme engineering to 
derive modified enzymes for desired applications.29-33 The accelerated evolution methodology 
allows enzymes to evolve through laboratory selection pressures for improved catalytic 
properties and new functions. A known protein enzyme with a similar catalytic activity to that of 
the desired modified enzyme is required as a starting point. Genetic diversification techniques 
are used to generate a library of gene mutants to explore a small fraction of the gene sequence 
space. Screening or selection is performed to identify the mutants with the desired catalytic 
property. The whole process is iterated until the new catalytic activity of evolved enzymes is 
satisfactory (Figure 1.4). 
 
Figure 1.4. General diagram of the directed evolution of protein enzymes. Gene diversification 
is performed to generate a library of genetic variants from a parent gene. Translation is 
performed to express the protein mutants, which are screened or selected. The process is iterated 
until proteins with the desired activity are identified. Figure reprinted with permission from ref. 
33. 
6 
Genetic diversification techniques can be categorized into random mutagenesis, focused 
mutagenesis, and homologous recombination. Random mutations can be introduced into genes 
by chemical reagents such as alkylating34 or deaminating compounds,35 both of which cause 
DNA damage and lead to errors during DNA replication. However, these chemical mutagenesis 
approaches are biased and therefore not commonly used for library generation. Error-prone PCR 
is performed under conditions that reduce the base-pairing fidelity of DNA polymerases, thereby 
increasing the rate of generating point mutations during PCR.36-38 Focused mutagenesis requires 
substantial structural information about catalysis or substrate binding of the parent enzymes. 
Mutation focusing on specific regions of a protein allows the exploration of more possible 
variants within those regions.39 However, focused mutagenesis often excludes mutation of 
residues away from the active site, even though mutating those residues may be beneficial. 
Homologous recombination such as DNA shuffling initiated by gene fragmentation40 or 
staggered-extension process41 has also been used to further increase the diversity of the genetic 
library.  
Screening or selection is required to identify individual mutants with the desired 
activity.33 Various methods have been used to screen variants, albeit all with limited throughput. 
Traditional methods such as chromatography, mass spectrometry, and colorimetric assays have 
screening throughput of 102–104 variants in a reasonable time. Methods such as fluorescence-
activated cell sorting (FACS) can screen larger libraries of ~108 variants. Unlike screening 
methods, selection strategies do not require the separate examination of every variant. For 
example, selection strategies can be developed by linking the desired protein function with the 
survival of an organism, such as E. coli or S. cerevisiae.42,43 Organisms that contain the active 
mutant proteins can survive and replicate, leading to the enrichment of the corresponding gene 
variants. These strategies allow the analysis of libraries consisting of 108–1010 variants, 
depending on the transformation efficiency.33 
Traditional directed evolution methods require time- and labor-intensive steps to generate 
gene libraries and perform screening or selection experiments. In contrast, phage-assisted 
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continuous evolution (PACE) is a powerful evolution technique that enables multiple rounds of 
evolution without manual intervention.44,45 The desired protein function is linked with the 
phage’s ability to infect host cells. Because the evolution cycle is based on phage replication, 
PACE enables many rounds of evolution in a very short time period. In addition, the library size 
for PACE is 108–1012, limited by the phage titer.33 
Directed evolution has made a significant impact on protein engineering. Many 
engineered protein enzymes have been developed for enhanced thermostability,46 catalytic 
activity,47 and for new reactions.26 However, there are still some disadvantages for directed 
evolution. The requirement of a parent enzyme as the starting point may limit the reaction scope 
of the evolved enzymes. In addition, directed evolution for changing substrate selectivity often 
leads to relaxed selectivity rather than a shift in selectivity.48  
1.2.1.2 De Novo Design 
 De novo design of proteins 49 has been pursued to develop new enzymes without a 
known protein enzyme as the starting point. This process starts from first determining a 
mechanism for the desired reaction (Figure 1.5). An active-site motif is constructed containing 
amino acid side chains required for the proposed reaction mechanism. This “theozyme” is 
combined computationally with a variety of protein scaffolds and evaluated experimentally for 
catalytic activity. Designing enzymes from scratch with optimal stability and catalytic activity is 
very challenging. Therefore, directed evolution is often performed to improve these properties of 
the designed enzymes. Several successful examples of designed enzymes have been reported for 
reactions such as Kemp elimination,50 the retro-aldol reaction,51 the Diels-Alder reaction,52 and 
ester hydrolysis.53 However, designing enzymes entirely from scratch is extremely difficult. A 
study of designing retro aldolase showed that after directed evolution of the computationally 
designed enzyme, the originally engineered active site was abandoned while a new active site 
was created with better catalytic activity than the originally designed enzyme.54 This result 
further highlights the challenges in de novo protein design. 
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Figure 1.5. Steps for de novo design of protein enzymes. (a) The mechanism of the desired 
reaction is determined. (b) The theozyme is designed computationally. (c) A set of active-site 
configurations is determined. (d) The active-site configurations are mapped into various protein 
scaffolds to determine the compatible active sites and the corresponding scaffolds. (e) The 
chosen structures are further optimized by varying the amino acids around the active sites. 
Directed evolution is usually performed after the initial enzyme is designed to improve its 
properties. Figure reprinted with permission from ref. 49.   
1.2.1.3 mRNA Display 
Identifying enzymes from a completely random sequence pool does not need a known 
enzyme to start. Neither does it require knowledge about the structure or reaction mechanism. 
Screening methods are not feasible for this approach because the throughput is simply not high 
enough. In vitro selection has a much higher throughput than screening because in vitro selection 
allows a large number of sequences to go through iterated rounds of sequence enrichment and 
amplification. Unfortunately, in vitro selection of proteins cannot be performed. The main reason 
is that protein sequences cannot be amplified in any way. In addition, the sequence space 
comprised by the 20 natural amino acids for a reasonable length of a protein is tremendously 
large. Covering a substantial fraction of that sequence space is extremely difficult. Furthermore, 
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specific sequences are required for protein folding. Therefore, of the limited sequence space that 
is sampled, most of the sequences are unfolded and thus aggregated.  
Despite the limitations mentioned above, methods similar to in vitro selection for protein 
enzymes have been developed. mRNA display is a commonly used method that creates a 
covalent linkage between the translated proteins and the encoding mRNA (Figure 1.6).55,56 
Functional proteins are separated, and the corresponding mRNA sequences are amplified via 
reverse transcription and PCR. The process is iterated until the catalytic activity is observed. 
New protein enzymes have been identified using mRNA display from a partially randomized 
protein scaffold.57 However, no protein enzymes have been identified from a completely random 
sequence library.  
 
Figure 1.6. mRNA display as a selection strategy to identify protein enzymes for bond formation 
reactions. A library of DNA sequences is transcribed and the mRNA is linked to puromycin, 
which forms a covalent linkage with the translated protein. The mRNA is reverse-transcribed 
into cDNA with a primer containing substrate A. Substrate B bearing an anchor group is added 
during the selection step. Any protein that catalyzes bond formation between A and B links its 
corresponding cDNA to the anchor group, and the separated cDNA is PCR-amplified. Figure 
reprinted with permission from ref. 57.  
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1.2.2 In Vitro Selection for Artificial Nucleic Acid Enzymes 
Unlike protein enzymes, nucleic acid enzymes can be identified from completely random 
sequence pools. RNA can be reverse-transcribed to cDNA, which can be amplified by PCR 
during in vitro selection. DNA is similar to RNA in its chemical structure and can be directly 
amplified by PCR. Although in nature DNA is non-catalytic and primarily double-stranded, 
artificial single-stranded DNA enzymes have been identified via in vitro selection.58,59 The 
identification of artificial nucleic acid enzymes for a desired reaction does not require a known 
enzyme as a starting point nor extensive knowledge about the reaction mechanism. In vitro 
selection for nucleic acid enzymes covers a much larger fraction of the sequence space relative to 
proteins, given that nucleic acids have four monomers while proteins have twenty. Moreover, of 
the sequence space that is sampled, a large portion of nucleic acid sequences are capable of 
folding into complex secondary and tertiary structures, whereas most random protein sequences 
are unlikely to fold and thus will aggregate. Based on these advantages, nucleic acids are strong 
candidates for developing entirely new enzymes from scratch. 
A general in vitro selection procedure for nucleic acid enzymes starts with a large 
population of random sequences (~1014 molecules; Figure 1.7). Catalytically active sequences 
are enriched through a selection step followed by a separation method to isolate the catalytically 
active sequences. Some inactive sequences will also survive due to artifacts of the separation 
strategy or the catalyzed reaction. The enriched sequences are amplified to generate more copies 
of each sequence for the subsequent selection round. For RNA enzymes, the amplification step 
includes reverse transcription of the RNA sequences and PCR of the cDNA. For DNA enzymes, 
the amplification step is simply PCR. This selection process is iterated until catalytic activity is 
observed. Finally, the pool is cloned and sequenced to identify individual nucleic acid enzymes.  
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Figure 1.7. General diagram of in vitro selection. An initial pool contains ~1014 sequences. The 
catalytically active sequences (red dots) are enriched and amplified through selection and 
amplification steps, respectively. For RNA, the amplification step includes reverse transcription 
and PCR.  
Artificial ribozymes have been identified for various reactions involving RNA 
oligonucleotides.60-63 In addition, artificial ribozymes have also been identified to catalyze the 
Diels-Alder reaction,64,65 the aldol reaction,66 and an amino acid acyl transfer reaction,67,68 
demonstrating that the reaction scope is not limited to oligonucleotide substrates. However, 
detailed structural and mechanistic information is limited because only a few crystal structures of 
artificial ribozymes have been obtained.69-71 Similar to artificial ribozymes, artificial DNA 
enzymes have been identified for a wide variety of reactions. 
The identification of xeno nucleic acid (XNA) enzymes from in vitro selection was also 
reported.72 These synthetic genetic polymers are made of nucleotides that have the same 
nucleobases as DNA but different sugar rings (Figure 1.8). The XNAs used in the selection 
experiments included arabino nucleic acids (ANA), 2′-fluoroarabino nucleic acids (FANA), 
hexitol nucleic acids (HNA), and cyclohexene nucleic acids (CeNA). Amplification of these 
XNAs is enabled by engineered DNA polymerases.73 The XNA enzymes demonstrated the 
ability to catalyze RNA cleavage by transesterification, RNA ligation, and XNA ligation. As the 
methodologies advance for synthesis and replication of more chemically divergent genetic 
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polymers, in vitro selection is likely to lead to a wide range of artificial enzymes with expanded 
physiochemical properties. 
 
Figure 1.8. Structures of xeno nucleic acids (XNAs).  
1.2.3 DNA Enzymes (Deoxyribozymes) 
DNA lacks the 2′-hydroxyl group of RNA and the nucleobase thymine is present in place 
of uracil (Figure 1.9). In vitro selection for DNA enzymes does not require reverse transcription 
during the amplification step. In addition, DNA is chemically more stable than RNA and thus the 
synthesis of DNA is easier. Similar to RNA, single-stranded DNA can fold into complex 
secondary and tertiary structures and has been identified in laboratories for binding74 and 
catalysis.59 The first deoxyribozyme was identified in 1994.58 This DNA enzyme catalyzes the 
cleavage of a single ribonucleotide embedded in a DNA substrate. Since then, numerous 
deoxyribozymes have been identified for a wide variety of reactions involving oligonucleotide 
substrates and non-oligonucleotide substrates.59     
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Figure 1.9. Structures of the DNA backbone and nucleobases. DNAs are made of 2′-
deoxyribonucleotides connected by phosphodiester bonds.  
Obtaining crystal structures of DNA enzymes is extremely challenging.75 Therefore, 
complete understanding of structures and reaction mechanisms of deoxyribozymes is limited. 
Nevertheless, the first high resolution-resolution crystal structure of a DNA enzyme was reported 
in 2016.76 The crystal structure of the 9DB1 deoxyribozyme, which catalyzes RNA ligation, 
provided some mechanistic insight into DNA-catalyzed reactions (Figure 1.10). For example, 
divalent metal ions are important for the catalytic activity of DNA enzymes, and the 9DB1 
deoxyribozyme requires either Mg2+ or Mn2+ for catalysis. However, the crystal structure 
revealed no metal ions at the active site, but instead, an oxygen atom of an internucleotide 
phosphodiester linkage was found closely in contact with the newly formed phosphodiester 
linkage (Figure 1.10C). Even though 9DB1 still requires metal ions for catalysis, the crystal 




Figure 1.10. The 9DB1 deoxyribozyme. (A) The RNA ligation reaction catalyzed by 9DB1. (B) 
The post-ligation crystal structure of 9DB1. The color codes match the image in panel A. (C) 
The zoom-in structure of the active site. The internucleotide phosphodiester oxygen between 
dC12 and dA13 interacts with the phosphorus of the newly formed phosphodiester bond. Panels 
B and C adapted with permission from ref. 76. 
The scope of DNA catalysis has been expanded to reactions of non-oligonucleotide 
substrates. In particular, DNA enzymes have been found to catalyze peptide side chain 
modification reactions. The Tyr1 deoxyribozyme is the first example, catalyzing the conjugation 
of a tyrosine side chain and a 5′-triphosphorylated RNA oligonucleotide (5′-pppRNA; Figure 
1.11).77 A major focus in the Silverman laboratory is to develop DNA enzymes for site-specific 
peptide side chain modification reactions.78  
 
Figure 1.11. Nucleopeptide linkage formation catalyzed by the Tyr1 deoxyribozyme, which 
catalyzes the conjugation of a tyrosine residue (red) and a 5′-pppRNA (blue). The tyrosine amino 
acid is embedded in a DNA substrate (grey and purple). The substrates are Watson-Crick base-
paired to the fixed-sequence binding arms (brown and gold). The catalytic regions are depicted 
in green and pink.  
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Modified nucleotides containing protein-like functional groups have been incorporated 
into deoxyribozymes to improve the scope of DNA catalysis. Modified nucleotides with a 
primary amino, imidazoyl, or guanidinium group have been incorporated into RNA-cleaving 
DNA enzymes to reduce the metal ion requirements (Figure 1.12A), which is important for 
biological applications.79-81 In addition, modified nucleotides have been used in selection 
experiments to identify DNA enzymes for new catalytic functions. Deoxyribozymes with natural 
nucleotides have been identified for the hydrolysis of esters and aromatic amides (anilides).82 
However, efforts toward DNA-catalyzed hydrolysis of aliphatic amides using natural nucleotides 
were unsuccessful. Incorporation of either primary amino-, carboxyl-, or hydroxyl-modified 
nucleotides led to deoxyribozymes that catalyze aliphatic amide bond hydrolysis (Figure 
1.12B).83  
 
Figure 1.12. DNA enzymes with modified nucleotides. (A) Incorporation of both amino- and 
imidazoyl-modified nucleotides led to M2+-independent DNA enzymes for RNA cleavage via 
transesterification. (B) Incorporation of either amino-, carboxyl-, or hydroxyl-modified 
nucleotides led to deoxyribozymes for amide bond hydrolysis. Panels A and B reprinted with 
permission from ref. 79 and 83.  
1.3 Peptide and Protein Side Chain Modification 
Many natural proteins are modified by enzymes after translation to further expand their 
diversity. Post-translational modifications (PTMs) play crucial roles in cellular processes such as 
signaling, regulation, trafficking, and differentiation.84 Laboratory approaches for site-specific 
introduction of PTMs into peptides and proteins can enable detailed understanding of the roles of 
the individual modification sites. In addition, protein side chains can be modified for purposes 
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such as labeling,85,86 immobilization,87 drug conjugation,88,89 or increasing circulation half-life.90 
A wide range of approaches for protein modification is available today, and the appropriate 
strategy can be chosen based on specific needs.91,92  
1.3.1 Traditional Methods for Protein Modification 
Most chemical approaches for protein modification have been developed to target 
nucleophilic side chains such as those of lysine (Lys) and cysteine (Cys) (Figure 1.13). One of 
the most well-known reaction for modifying amines is amide bond formation with an activated 
acid (e.g., an NHS ester). Other reactions such as urea/thiourea formation and reductive 
amination are also common. Disulfide formation, S-alkylation, and the Michael addition reaction 
have been utilized for Cys modification. Chemoselective modification of tyrosine (Tyr) residues 
has been developed. For example, diazonium salts bearing electron-withdrawing para-
substituents can react with a Tyr residue at the ortho position of the phenol ring.93-95 For all the 
reactions mentioned above, bifunctional molecules that contain the reactive groups for side chain 
modification and a bioorthogonal group for subsequent conjugation can be used.96,97 However, 
these modification reactions simply rely on the chemical reactivity and the surface accessibility 
of the amino acid side chains. Therefore, site specificity generally cannot be achieved using these 
traditional modification methods. 
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Figure 1.13. Chemical modification reactions of Lys, Cys, and Tyr residues. Modification 
reactions for Lys or N-terminal amino group: (1) Amide formation with an NHS ester, (2) 
Urea/thiourea formation with an isocyanate/isothiocyanate, (3) Reductive amination with an 
aldehyde and NaCNBH3. Modification reactions for the Cys thiol group: (1) Disulfide exchange, 
(2) Alkylation with -halocarbonyls, (3) Michael addition with a maleimide. Modification 
reaction for the Tyr hydroxyl group with diazonium salts containing electron-withdrawing para-
substituents. Figure adapted with permission from ref. 92.  
1.3.2 Methods for Site-Specific Protein Modification 
Methods for site-specific protein modification are required to achieve homogeneous 
conjugation or to study natural PTMs. Semisynthesis has been used to introduce site-specific 
PTMs into proteins (Figure 1.14A).98 A peptide fragment containing the modified amino acid is 
prepared via solid-phase synthesis. This peptide fragment is connected to the remainder of the 
protein by native chemical ligation (NCL), which requires a C-terminal thioester and an N-
terminal cysteine at the ligation site. A protein with a C-terminal thioester can be prepared via 
intein-based expression.99 If the PTM is in the middle of a protein, sequential NCL can be 
performed to ligate three polypeptide fragments (Figure 1.14B).100 Despite many successes, 
challenges for this approach lie in the synthesis of lengthy peptide fragments as well as the 
stability of materials, such as thioesters and some of the modified amino acid monomers.  
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Figure 1.14. Semisynthesis for incorporating site-specific PTMs into proteins. (A) General 
diagram for the semisynthesis approach. (B) Sequential NCL to introduce an acetylated Lys 
residue into the middle of a protein. In the first NCL step, the acetyllysine-containing fragment 
has an N-terminal thiazolidine group, which is later treated with methoxylamine to unmask the 
N-terminal Cys for the second NCL step. Figure adapted with permission from ref. 98.  
Unnatural amino acid incorporation has also been used for site-specific protein 
modification.101-103 A modified tRNA and its corresponding aminoacyl-tRNA synthetase are 
developed to exclusively recognize the unnatural amino acid. The rarely used amber stop codon 
is suppressed by the modified tRNA containing the unnatural amino acid, which can be site-
specifically incorporated into a protein based on the location of the amber stop codon in the 
modified DNA gene (Figure 1.15A). Using this approach, an azido- or alkynyl-modified amino 
acid has been site-specifically introduced into proteins for subsequent bioconjugation 
reactions.102 In addition, amino acids with natural PTMs such as phosphoserines104 and 
acetyllysines105 can be incorporated using the amber codon suppression strategy. Evolving a 
tRNA synthetase to selectively use methyllysine over lysine is challenging due to their high 
structural similarity. Nevertheless, a two-step approach was reported to incorporate a 
methyllysine into the histone H3 protein.106 First, an N-tert-butyloxycarbonyl-N-methyllysine 
was incorporated into the protein using the evolved pyrrolysyl-tRNA synthetase/tRNACUA pair 
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(Figure 1.15B). The tert-butyloxycarbonyl group was then removed under mild conditions, 
revealing a methyllysine. Using the amber stop codon suppression method to site-specifically 
insert artificial groups or natural PTMs is powerful. However, challenges for this strategy 
include the development of orthogonal tRNA synthetases, expression of full-length modified 
proteins, and incorporation of more than one modification in proteins.  
 
Figure 1.15. Incorporation of unnatural amino acids. (A) General diagram for the amber stop 
codon suppression method. (B) A two-step approach to site-specifically incorporate methyllysine 
into proteins using the amber stop codon suppression method. Panel A and B reprinted and 
adapted with permission from ref. 103 and ref. 106, respectively. 
Several methods have been developed targeting Cys residues for site-specific protein 
modification.107-109 Cys is one of the least abundant amino acids present in proteins. In addition, 
Cys residues are often buried in proteins or are in disulfide form.110,111 Therefore, introducing a 
single Cys into a protein by site-directed mutagenesis provides a unique handle for site-specific 
modification. For traditional Cys modification reactions (except for disulfide formation), cross-
reactivity with other nucleophilic amino acids can occur. Converting Cys to a dehydroalanine 
(Dha) via various methods changes the nucleophilic thiol group into an electrophile and therefore 
prevents cross-reactivity.112,113 Subsequent Michael addition reaction with a thiol-modified 
molecule leads to site-specific modification of a protein (Figure 1.16A). Thioether analogs of 
natural PTMs can be generated using this approach.114,115 However, the sulfur atom of a thioether 
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analog leads to different bond length and degrees of freedom from a native amino acid.116 In 
addition, the sulfur atom may affect the pKa of the side chain functional group.
117 A radical-
based reaction of Dha was reported to introduce natural PTMs or other synthetic moieties into 
proteins (Figure 1.16B).118 Alkyl radicals are generated from the corresponding alkyl halides. An 
alkyl radical reacts with Dha, forming a C–C single bond and a stabilized C radical, which can 
be quenched by NaBH4. Modified products of both approaches using Dha have a mixture of 
stereocenters at the  carbon (Figure 1.16C). Furthermore, site specificity cannot be achieved for 
proteins containing other surface-exposed Cys residues.  
 
Figure 1.16. Converting Cys to Dha followed by thiol addition or alkylation for site-specific 
protein modification. (A) Elimination of Cys to Dha by O-mesitylsulfonylhydroxylamine (MSH) 
followed by Michael addition reaction with thiol-modified group. (B) Radical-based approach to 
form C-Csingle bond from Dha and alkyl halide. The image depicts the generation of a 
trimethyllysine at Lys9 of the histone H3 protein. (C) Modification methods based on reactions 
with Dha result in products that have a mixture of C stereocenters. Panels A and B reprinted 
with permission from ref. 113 and 118. 
The above-described strategies for protein modification described above have all been 
used to incorporate artificial groups into proteins for various purposes. The site-specific 
modification methods have been employed especially for studying the biological roles of natural 
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PTMs. Each method has its own advantages and limitations. An alternative approach to site-
specifically introduce modified residues into proteins will provide an additional tool for protein 
bioconjugation as well as the study of natural PTMs.  
1.3.3 DNA Enzymes for Site-Specific Peptide and Protein Modification 
Artificial DNA enzymes are identified by in vitro selection from completely random 
sequence pools. The idea of using DNA enzymes for site-specific protein modification is very 
attractive. DNA enzymes are capable of catalyzing various modification reactions of peptide side 
chains.78 In addition, peptide-sequence-selective deoxyribozymes were identified for some 
modification reactions.119,120 
DNA enzymes have been identified for Tyr side chain modification reactions, including 
peptide-nucleic acid conjugation,77,121 adenylylation,120 phosphorylation,119,122 and 
dephosphorylation.123 The first two modification reactions involve the nucleophilic attack of a 
Tyr hydroxyl group on the -phosphorus of a 5′-triphosphoryl donor (Figure 1.17A). 
Deoxyribozymes for peptide-nucleic acid conjugation use a 5′-triphosphorylated RNA 
oligonucleotide (5′-pppRNA) as the substrate, while unrelated deoxyribozymes for Tyr 
adenylylation use ATP as the substrate. 2′-azido-dATP was also used by Tyr-adenylylating 
deoxyribozymes to attach an azido group onto a peptide. Subsequent Cu(I)-catalyzed azide-
alkyne cycloaddition (CuAAC) reaction with an alkyne-modified poly(ethylene glycol) or an 
alkyne-modified fluorescein led to peptide PEGylation or labeling (Figure 1.17B).120 The DNA-
catalyzed Tyr phosphorylation reaction (Tyr kinase activity) is similar to peptide-nucleic acid 
conjugation and adenylylayion, but instead, a Tyr hydroxyl group attacks the -phosphorus of a 
5′-triphosphoryl donor (Figure 1.17A).122 Peptide-sequence-selective DNA enzymes were 
identified for both Tyr adenylylation and phosphorylation, demonstrating the capability of 
achieving site-specific peptide side chain modification. DNA enzymes for dephosphorylation 
(phosphatase activity) catalyze the hydrolysis of a Tyr phosphomonoester as well as a Ser 
phosphomonoester (Figure 1.17A). The study also demonstrated the dephosphorylation of a 
22 
pTyr-containing peptide when the peptide was connected to the C-terminus of a 91-mer 
protein.123 
 
Figure 1.17. DNA-catalyzed Tyr side chain modification. (A) Reactions of DNA-catalyzed Tyr 
side chain modification: peptide-nucleic acid conjugation (where X = RNA), Tyr adenylylation 
(where X = A), Tyr phosphorylation (where X = RNA or N), and pTyr dephosphorylation. (B) A 
two-step peptide modification by DNA-catalyzed azido-adenylylation and the subsequent 
CuAAC reaction. Panel B adapted with permission from ref. 120. 
DNA-catalyzed Ser side chain modification reactions include peptide-nucleic acid 
conjugation,121,124 phosphorylation,122 and dephosphorylation.123 One type of DNA-catalyzed 
pSer dephosphorylation reaction is the formation of Dha by elimination of the phosphate (pSer 
lyase activity; Figure 1.18).125 A pSer lyase deoxyribozyme was used to synthesize a thioether 
analog of the compstatin cyclic peptide from a precursor containing a pSer and a homocysteine 
(Hcy). DNA-catalyzed Lys side chain modification was also achieved, with a sole example of 
peptide-DNA conjugation using a DNA-anchored Lys-containing peptide and a 5′-
phosphorimidazolidated DNA oligonucleotide.126  
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Figure 1.18. Synthesis of compstatin thioether analog by DNA-catalyzed formation of Dha and 
an uncatalyzed base treatment. Figure reprinted with permission from ref. 125. 
Using DNA enzymes to modify protein side chains will be useful because of its potential 
for site specificity. With a suitable in vitro selection strategy, deoxyribozymes can be identified 
for a desired modification reaction with specific requirements, such as peptide sequence 
selectivity. In vitro selection strategies for many peptide modification reactions require the 
peptide substrate to be covalently anchored to the DNA sequence pool during selection. 
Consequently, deoxyribozymes for some of these modification reactions currently do not work 
with a discrete, unanchored peptide substrate. Nevertheless, DNA enzymes that function with 
unanchored peptide substrates have been identified.120,121,123,125 Challenges for this strategy 
include achieving unanchored peptide and protein activity and improving catalytic parameters 
(kcat and Km).  
1.4 Thesis Research Focus 
The research described in this thesis is focused on the identification and development of 
deoxyribozymes for covalent modification of peptide and protein side chains. The work has 
focused on two specific modification reactions: peptide-nucleic acid conjugation and Lys 
methylation. DNA-catalyzed peptide-nucleic acid conjugation was achieved previously. 
24 
However, to enable practical utility, DNA enzymes are required to function sufficiently well 
with discrete, unanchored peptide substrates at low peptide concentrations. Chapter 2 describes a 
new in vitro selection approach for peptide-nucleic acid conjugation using unanchored peptide 
substrates. Selection experiments with this approach imposed a more stringent selection pressure 
than the previous approaches and led to deoxyribozymes that are catalytically active with 
unanchored peptides and have better peptide Km values. Chapter 3 focuses on post-selection 
development of deoxyribozymes to enhance their catalytic activities. Strategies were sought to 
recruit DNA enzymes to their peptide or protein substrates for improvements in yield, kobs, and 
Km at low peptide concentrations. A recruiting strategy was used to replace the covalent linkage 
between the peptide and the anchor DNA. Chapter 4 discusses the efforts toward identifying 
deoxyribozymes for Lys methylation using analogs of S-adenosyl-L-methionine as alkyl donors. 
Multiple incubation conditions were investigated in selection experiments. In addition, modified 
nucleotides were included in selection experiments to assist catalysis.  
1.5 References 
(1) Miller, B. G.; Wolfenden, R. Catalytic proficiency: the unusual case of OMP 
decarboxylase. Annu. Rev. Biochem. 2002, 71, 847-885. 
(2) Srere, P. A. Why are enzymes so big? Trends Biochem. Sci. 1984, 9, 387-390. 
(3) Jencks, W. P. General acid-base catalysis of complex reactions in water. Chem. Rev. 1972, 
72, 705-718. 
(4) Erez, E.; Fass, D.; Bibi, E. How intramembrane proteases bury hydrolytic reactions in the 
membrane. Nature 2009, 459, 371-378. 
(5) Vallee, B. L.; Williams, R. J. Metalloenzymes: the entatic nature of their active sites. Proc. 
Natl. Acad. Sci. U. S. A. 1968, 59, 498-505. 
(6) Doudna, J. A.; Cech, T. R. The chemical repertoire of natural ribozymes. Nature 2002, 
418, 222-228. 
25 
(7) Cech, T. R.; Zaug, A. J.; Grabowski, P. J. In vitro splicing of the ribosomal RNA precursor 
of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening 
sequence. Cell 1981, 27, 487-496. 
(8) Guerrier-Takada, C.; Gardiner, K.; Marsh, T.; Pace, N.; Altman, S. The RNA moiety of 
ribonuclease P is the catalytic subunit of the enzyme. Cell 1983, 35, 849-857. 
(9) Kruger, K.; Grabowski, P. J.; Zaug, A. J.; Sands, J.; Gottschling, D. E.; Cech, T. R. Self-
splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening 
sequence of Tetrahymena. Cell 1982, 31, 147-157. 
(10) Ban, N.; Nissen, P.; Hansen, J.; Moore, P. B.; Steitz, T. A. The complete atomic structure 
of the large ribosomal subunit at 2.4 A resolution. Science 2000, 289, 905-920. 
(11) Nissen, P.; Hansen, J.; Ban, N.; Moore, P. B.; Steitz, T. A. The structural basis of ribosome 
activity in peptide bond synthesis. Science 2000, 289, 920-930. 
(12) Hiller, D. A.; Singh, V.; Zhong, M.; Strobel, S. A. A two-step chemical mechanism for 
ribosome-catalysed peptide bond formation. Nature 2011, 476, 236-239. 
(13) Shan, S.; Kravchuk, A. V.; Piccirilli, J. A.; Herschlag, D. Defining the catalytic metal ion 
interactions in the Tetrahymena ribozyme reaction. Biochemistry 2001, 40, 5161-5171. 
(14) Stahley, M. R.; Strobel, S. A. RNA splicing: group I intron crystal structures reveal the 
basis of splice site selection and metal ion catalysis. Curr. Opin. Struct. Biol. 2006, 16, 
319-326. 
(15) Warnecke, J. M.; Held, R.; Busch, S.; Hartmann, R. K. Role of metal ions in the hydrolysis 
reaction catalyzed by RNase P RNA from Bacillus subtilis. J. Mol. Biol. 1999, 290, 433-
445. 
(16) Warnecke, J. M.; Sontheimer, E. J.; Piccirilli, J. A.; Hartmann, R. K. Active site constraints 
in the hydrolysis reaction catalyzed by bacterial RNase P: analysis of precursor tRNAs 
with a single 3'-S-phosphorothiolate internucleotide linkage. Nucleic Acids Res. 2000, 28, 
720-727. 
(17) Mondragon, A. Structural studies of RNase P. Annu. Rev. Biophys. 2013, 42, 537-557. 
26 
(18) O'Rear, J. L.; Wang, S.; Feig, A. L.; Beigelman, L.; Uhlenbeck, O. C.; Herschlag, D. 
Comparison of the hammerhead cleavage reactions stimulated by monovalent and divalent 
cations. RNA 2001, 7, 537-545. 
(19) Curtis, E. A.; Bartel, D. P. The hammerhead cleavage reaction in monovalent cations. RNA 
2001, 7, 546-552. 
(20) Scott, W. G.; Horan, L. H.; Martick, M. The hammerhead ribozyme: structure, catalysis, 
and gene regulation. Prog. Mol. Biol. Transl. Sci. 2013, 120, 1-23. 
(21) Nesbitt, S.; Hegg, L. A.; Fedor, M. J. An unusual pH-independent and metal-ion-
independent mechanism for hairpin ribozyme catalysis. Chem. Biol. 1997, 4, 619-630. 
(22) Rupert, P. B.; Ferre-D'Amare, A. R. Crystal structure of a hairpin ribozyme-inhibitor 
complex with implications for catalysis. Nature 2001, 410, 780-786. 
(23) Ferre-D'Amare, A. R.; Zhou, K.; Doudna, J. A. Crystal structure of a hepatitis delta virus 
ribozyme. Nature 1998, 395, 567-574. 
(24) Chen, J. H.; Yajima, R.; Chadalavada, D. M.; Chase, E.; Bevilacqua, P. C.; Golden, B. L. A 
1.9 Å crystal structure of the HDV ribozyme precleavage suggests both Lewis acid and 
general acid mechanisms contribute to phosphodiester cleavage. Biochemistry 2010, 49, 
6508-6518. 
(25) Kirk, O.; Borchert, T. V.; Fuglsang, C. C. Industrial enzyme applications. Curr. Opin. 
Biotechnol. 2002, 13, 345-351. 
(26) Hult, K.; Berglund, P. Engineered enzymes for improved organic synthesis. Curr. Opin. 
Biotechnol. 2003, 14, 395-400. 
(27) Cherry, J. R.; Fidantsef, A. L. Directed evolution of industrial enzymes: an update. Curr. 
Opin. Biotechnol. 2003, 14, 438-443. 
(28) Bar-Even, A.; Noor, E.; Savir, Y.; Liebermeister, W.; Davidi, D.; Tawfik, D. S.; Milo, R. 
The moderately efficient enzyme: evolutionary and physicochemical trends shaping 
enzyme parameters. Biochemistry 2011, 50, 4402-4410. 
27 
(29) Arnold, F. H.; Volkov, A. A. Directed evolution of biocatalysts. Curr. Opin. Chem. Biol. 
1999, 3, 54-59. 
(30) Bloom, J. D.; Arnold, F. H. In the light of directed evolution: pathways of adaptive protein 
evolution. Proc. Natl. Acad. Sci. U. S. A. 2009, 106 Suppl 1, 9995-10000. 
(31) Renata, H.; Wang, Z. J.; Arnold, F. H. Expanding the enzyme universe: accessing non-
natural reactions by mechanism-guided directed evolution. Angew. Chem. Int. Ed. 2015, 
54, 3351-3367. 
(32) Currin, A.; Swainston, N.; Day, P. J.; Kell, D. B. Synthetic biology for the directed 
evolution of protein biocatalysts: navigating sequence space intelligently. Chem. Soc. Rev. 
2015, 44, 1172-1239. 
(33) Packer, M. S.; Liu, D. R. Methods for the directed evolution of proteins. Nat. Rev. Genet. 
2015, 16, 379-394. 
(34) Lai, Y. P.; Huang, J.; Wang, L. F.; Li, J.; Wu, Z. R. A new approach to random 
mutagenesis in vitro. Biotechnol. Bioeng. 2004, 86, 622-627. 
(35) Myers, R. M.; Lerman, L. S.; Maniatis, T. A general method for saturation mutagenesis of 
cloned DNA fragments. Science 1985, 229, 242-247. 
(36) McCullum, E. O.; Williams, B. A.; Zhang, J.; Chaput, J. C. Random mutagenesis by error-
prone PCR. Methods Mol. Biol. 2010, 634, 103-109. 
(37) Zaccolo, M.; Williams, D. M.; Brown, D. M.; Gherardi, E. An approach to random 
mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J. 
Mol. Biol. 1996, 255, 589-603. 
(38) Eckert, K. A.; Kunkel, T. A. High fidelity DNA synthesis by the Thermus aquaticus DNA 
polymerase. Nucleic Acids Res. 1990, 18, 3739-3744. 
(39) Wells, J. A.; Vasser, M.; Powers, D. B. Cassette mutagenesis: an efficient method for 
generation of multiple mutations at defined sites. Gene 1985, 34, 315-323. 
(40) Stemmer, W. P. Rapid evolution of a protein in vitro by DNA shuffling. Nature 1994, 370, 
389-391. 
28 
(41) Zhao, H.; Giver, L.; Shao, Z.; Affholter, J. A.; Arnold, F. H. Molecular evolution by 
staggered extension process (StEP) in vitro recombination. Nat. Biotechnol. 1998, 16, 258-
261. 
(42) Gaj, T.; Mercer, A. C.; Gersbach, C. A.; Gordley, R. M.; Barbas, C. F. Structure-guided 
reprogramming of serine recombinase DNA sequence specificity. Proc. Natl. Acad. Sci. U. 
S. A. 2011, 108, 498-503. 
(43) Young, E. M.; Tong, A.; Bui, H.; Spofford, C.; Alper, H. S. Rewiring yeast sugar 
transporter preference through modifying a conserved protein motif. Proc. Natl. Acad. Sci. 
U. S. A. 2014, 111, 131-136. 
(44) Esvelt, K. M.; Carlson, J. C.; Liu, D. R. A system for the continuous directed evolution of 
biomolecules. Nature 2011, 472, 499-503. 
(45) Dickinson, B. C.; Packer, M. S.; Badran, A. H.; Liu, D. R. A system for the continuous 
directed evolution of proteases rapidly reveals drug-resistance mutations. Nat. Commun. 
2014, 5, 5352. 
(46) Besenmatter, W.; Kast, P.; Hilvert, D. Relative tolerance of mesostable and thermostable 
protein homologs to extensive mutation. Proteins 2007, 66, 500-506. 
(47) Choi, Y. H.; Kim, J. H.; Park, J. H.; Lee, N.; Kim, D. H.; Jang, K. S.; Park, I. H.; Kim, B. 
G. Protein engineering of alpha2,3/2,6-sialyltransferase to improve the yield and 
productivity of in vitro sialyllactose synthesis. Glycobiology 2014, 24, 159-169. 
(48) Yoo, T. H.; Pogson, M.; Iverson, B. L.; Georgiou, G. Directed evolution of highly selective 
proteases by using a novel FACS-based screen that capitalizes on the p53 regulator 
MDM2. ChemBioChem 2012, 13, 649-653. 
(49) Nanda, V. Do-it-yourself enzymes. Nat. Chem. Biol. 2008, 4, 273-275. 
(50) Rothlisberger, D.; Khersonsky, O.; Wollacott, A. M.; Jiang, L.; DeChancie, J.; Betker, J.; 
Gallaher, J. L.; Althoff, E. A.; Zanghellini, A.; Dym, O.; Albeck, S.; Houk, K. N.; Tawfik, 
D. S.; Baker, D. Kemp elimination catalysts by computational enzyme design. Nature 
2008, 453, 190-195. 
29 
(51) Jiang, L.; Althoff, E. A.; Clemente, F. R.; Doyle, L.; Rothlisberger, D.; Zanghellini, A.; 
Gallaher, J. L.; Betker, J. L.; Tanaka, F.; Barbas, C. F., 3rd; Hilvert, D.; Houk, K. N.; 
Stoddard, B. L.; Baker, D. De novo computational design of retro-aldol enzymes. Science 
2008, 319, 1387-1391. 
(52) Siegel, J. B.; Zanghellini, A.; Lovick, H. M.; Kiss, G.; Lambert, A. R.; St Clair, J. L.; 
Gallaher, J. L.; Hilvert, D.; Gelb, M. H.; Stoddard, B. L.; Houk, K. N.; Michael, F. E.; 
Baker, D. Computational design of an enzyme catalyst for a stereoselective bimolecular 
Diels-Alder reaction. Science 2010, 329, 309-313. 
(53) Richter, F.; Blomberg, R.; Khare, S. D.; Kiss, G.; Kuzin, A. P.; Smith, A. J.; Gallaher, J.; 
Pianowski, Z.; Helgeson, R. C.; Grjasnow, A.; Xiao, R.; Seetharaman, J.; Su, M.; 
Vorobiev, S.; Lew, S.; Forouhar, F.; Kornhaber, G. J.; Hunt, J. F.; Montelione, G. T.; Tong, 
L.; Houk, K. N.; Hilvert, D.; Baker, D. Computational design of catalytic dyads and 
oxyanion holes for ester hydrolysis. J. Am. Chem. Soc. 2012, 134, 16197-16206. 
(54) Giger, L.; Caner, S.; Obexer, R.; Kast, P.; Baker, D.; Ban, N.; Hilvert, D. Evolution of a 
designed retro-aldolase leads to complete active site remodeling. Nat. Chem. Biol. 2013, 9, 
494-498. 
(55) Keefe, A. D.; Szostak, J. W. Functional proteins from a random-sequence library. Nature 
2001, 410, 715-718. 
(56) Roberts, R. W.; Szostak, J. W. RNA-peptide fusions for the in vitro selection of peptides 
and proteins. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 12297-12302. 
(57) Seelig, B.; Szostak, J. W. Selection and evolution of enzymes from a partially randomized 
non-catalytic scaffold. Nature 2007, 448, 828-831. 
(58) Breaker, R. R.; Joyce, G. F. A DNA enzyme that cleaves RNA. Chem. Biol. 1994, 1, 223-
229. 
(59) Silverman, S. K. Catalytic DNA: Scope, Applications, and Biochemistry of 
Deoxyribozymes. Trends Biochem. Sci. 2016, 41, 595-609. 
30 
(60) Pan, T.; Uhlenbeck, O. C. A small metalloribozyme with a two-step mechanism. Nature 
1992, 358, 560-563. 
(61) Ekland, E. H.; Szostak, J. W.; Bartel, D. P. Structurally complex and highly active RNA 
ligases derived from random RNA sequences. Science 1995, 269, 364-370. 
(62) Johnston, W. K.; Unrau, P. J.; Lawrence, M. S.; Glasner, M. E.; Bartel, D. P. RNA-
catalyzed RNA polymerization: accurate and general RNA-templated primer extension. 
Science 2001, 292, 1319-1325. 
(63) Lorsch, J. R.; Szostak, J. W. In vitro evolution of new ribozymes with polynucleotide 
kinase activity. Nature 1994, 371, 31-36. 
(64) Seelig, B.; Jaschke, A. A small catalytic RNA motif with Diels-Alderase activity. Chem. 
Biol. 1999, 6, 167-176. 
(65) Seelig, B.; Keiper, S.; Stuhlmann, F.; Jaschke, A. Enantioselective Ribozyme Catalysis of a 
Bimolecular Cycloaddition Reaction. Angew. Chem. Int. Ed. 2000, 39, 4576-4579. 
(66) Fusz, S.; Eisenfuhr, A.; Srivatsan, S. G.; Heckel, A.; Famulok, M. A ribozyme for the aldol 
reaction. Chem. Biol. 2005, 12, 941-950. 
(67) Jenne, A.; Famulok, M. A novel ribozyme with ester transferase activity. Chem. Biol. 1998, 
5, 23-34. 
(68) Morimoto, J.; Hayashi, Y.; Iwasaki, K.; Suga, H. Flexizymes: their evolutionary history 
and the origin of catalytic function. Acc. Chem. Res. 2011, 44, 1359-1368. 
(69) Wedekind, J. E.; McKay, D. B. Crystal structure of a lead-dependent ribozyme revealing 
metal binding sites relevant to catalysis. Nat. Struct. Biol. 1999, 6, 261-268. 
(70) Serganov, A.; Keiper, S.; Malinina, L.; Tereshko, V.; Skripkin, E.; Hobartner, C.; 
Polonskaia, A.; Phan, A. T.; Wombacher, R.; Micura, R.; Dauter, Z.; Jaschke, A.; Patel, D. 
J. Structural basis for Diels-Alder ribozyme-catalyzed carbon-carbon bond formation. Nat. 
Struct. Mol. Biol. 2005, 12, 218-224. 
(71) Shechner, D. M.; Bartel, D. P. The structural basis of RNA-catalyzed RNA polymerization. 
Nat. Struct. Mol. Biol. 2011, 18, 1036-1042. 
31 
(72) Taylor, A. I.; Pinheiro, V. B.; Smola, M. J.; Morgunov, A. S.; Peak-Chew, S.; Cozens, C.; 
Weeks, K. M.; Herdewijn, P.; Holliger, P. Catalysts from synthetic genetic polymers. 
Nature 2015, 518, 427-430. 
(73) Pinheiro, V. B.; Taylor, A. I.; Cozens, C.; Abramov, M.; Renders, M.; Zhang, S.; Chaput, 
J. C.; Wengel, J.; Peak-Chew, S. Y.; McLaughlin, S. H.; Herdewijn, P.; Holliger, P. 
Synthetic genetic polymers capable of heredity and evolution. Science 2012, 336, 341-344. 
(74) Bock, L. C.; Griffin, L. C.; Latham, J. A.; Vermaas, E. H.; Toole, J. J. Selection of single-
stranded DNA molecules that bind and inhibit human thrombin. Nature 1992, 355, 564-
566. 
(75) Nowakowski, J.; Shim, P. J.; Prasad, G. S.; Stout, C. D.; Joyce, G. F. Crystal structure of 
an 82-nucleotide RNA-DNA complex formed by the 10-23 DNA enzyme. Nat. Struct. Biol. 
1999, 6, 151-156. 
(76) Ponce-Salvatierra, A.; Wawrzyniak-Turek, K.; Steuerwald, U.; Höbartner, C.; Pena, V. 
Crystal structure of a DNA catalyst. Nature 2016, 529, 231-234. 
(77) Pradeepkumar, P. I.; Hobartner, C.; Baum, D. A.; Silverman, S. K. DNA-catalyzed 
formation of nucleopeptide linkages. Angew. Chem. Int. Ed. 2008, 47, 1753-1757. 
(78) Silverman, S. K. Pursuing DNA catalysts for protein modification. Acc. Chem. Res. 2015, 
48, 1369-1379. 
(79) Lermer, L.; Roupioz, Y.; Ting, R.; Perrin, D. M. Toward an RNaseA Mimic:  A DNAzyme 
with Imidazoles and Cationic Amines. J. Am. Chem. Soc. 2002, 124, 9960-9961. 
(80) Hollenstein, M.; Hipolito, C. J.; Lam, C. H.; Perrin, D. M. A DNAzyme with three protein-
like functional groups: enhancing catalytic efficiency of M2+-independent RNA cleavage. 
ChemBioChem 2009, 10, 1988-1992. 
(81) Hollenstein, M. Expanding the catalytic repertoire of DNAzymes by modified nucleosides. 
Chimia 2011, 65, 770-775. 
32 
(82) Brandsen, B. M.; Hesser, A. R.; Castner, M. A.; Chandra, M.; Silverman, S. K. DNA-
catalyzed hydrolysis of esters and aromatic amides. J. Am. Chem. Soc. 2013, 135, 16014-
16017. 
(83) Zhou, C.; Avins, J. L.; Klauser, P. C.; Brandsen, B. M.; Lee, Y.; Silverman, S. K. DNA-
Catalyzed Amide Hydrolysis. J. Am. Chem. Soc. 2016, 138, 2106-2109. 
(84) Walsh, C. T.; Garneau-Tsodikova, S.; Gatto, G. J., Jr. Protein posttranslational 
modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. 2005, 44, 
7342-7372. 
(85) Spicer, C. D.; Davis, B. G. Selective chemical protein modification. Nat. Commun. 2014, 5, 
4740. 
(86) Asano, S.; Patterson, J. T.; Gaj, T.; Barbas, C. F., 3rd Site-selective labeling of a lysine 
residue in human serum albumin. Angew. Chem. Int. Ed. 2014, 53, 11783-11786. 
(87) Steen Redeker, E.; Ta, D. T.; Cortens, D.; Billen, B.; Guedens, W.; Adriaensens, P. Protein 
engineering for directed immobilization. Bioconjug. Chem. 2013, 24, 1761-1777. 
(88) Junutula, J. R.; Raab, H.; Clark, S.; Bhakta, S.; Leipold, D. D.; Weir, S.; Chen, Y.; 
Simpson, M.; Tsai, S. P.; Dennis, M. S.; Lu, Y.; Meng, Y. G.; Ng, C.; Yang, J.; Lee, C. C.; 
Duenas, E.; Gorrell, J.; Katta, V.; Kim, A.; McDorman, K.; Flagella, K.; Venook, R.; Ross, 
S.; Spencer, S. D.; Lee Wong, W.; Lowman, H. B.; Vandlen, R.; Sliwkowski, M. X.; 
Scheller, R. H.; Polakis, P.; Mallet, W. Site-specific conjugation of a cytotoxic drug to an 
antibody improves the therapeutic index. Nat. Biotechnol. 2008, 26, 925-932. 
(89) Chudasama, V.; Maruani, A.; Caddick, S. Recent advances in the construction of antibody-
drug conjugates. Nat. Chem. 2016, 8, 114-119. 
(90) Pasut, G.; Veronese, F. M. State of the art in PEGylation: the great versatility achieved 
after forty years of research. J. Control. Release 2012, 161, 461-472. 
(91) Stephanopoulos, N.; Francis, M. B. Choosing an effective protein bioconjugation strategy. 
Nat. Chem. Biol. 2011, 7, 876-884. 
33 
(92) Boutureira, O.; Bernardes, G. J. Advances in chemical protein modification. Chem. Rev. 
2015, 115, 2174-2195. 
(93) Hooker, J. M.; Kovacs, E. W.; Francis, M. B. Interior surface modification of 
bacteriophage MS2. J. Am. Chem. Soc. 2004, 126, 3718-3719. 
(94) Schlick, T. L.; Ding, Z.; Kovacs, E. W.; Francis, M. B. Dual-surface modification of the 
tobacco mosaic virus. J. Am. Chem. Soc. 2005, 127, 3718-3723. 
(95) Gavrilyuk, J.; Ban, H.; Nagano, M.; Hakamata, W.; Barbas, C. F., 3rd Formylbenzene 
diazonium hexafluorophosphate reagent for tyrosine-selective modification of proteins and 
the introduction of a bioorthogonal aldehyde. Bioconjug. Chem. 2012, 23, 2321-2328. 
(96) Zhang, J.; Ma, D.; Du, D.; Xi, Z.; Yi, L. An efficient reagent for covalent introduction of 
alkynes into proteins. Org. Biomol. Chem. 2014, 12, 9528-9531. 
(97) Bauer, D. M.; Ahmed, I.; Vigovskaya, A.; Fruk, L. Clickable tyrosine binding bifunctional 
linkers for preparation of DNA-protein conjugates. Bioconjug. Chem. 2013, 24, 1094-1101. 
(98) Siman, P.; Brik, A. Chemical and semisynthesis of posttranslationally modified proteins. 
Org. Biomol. Chem. 2012, 10, 5684-5697. 
(99) Muir, T. W.; Sondhi, D.; Cole, P. A. Expressed protein ligation: A general method for 
protein engineering. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 6705-6710. 
(100) Shimko, J. C.; North, J. A.; Bruns, A. N.; Poirier, M. G.; Ottesen, J. J. Preparation of fully 
synthetic histone H3 reveals that acetyl-lysine 56 facilitates protein binding within 
nucleosomes. J. Mol. Biol. 2011, 408, 187-204. 
(101) Wang, L.; Brock, A.; Herberich, B.; Schultz, P. G. Expanding the genetic code of 
Escherichia coli. Science 2001, 292, 498-500. 
(102) Liu, W.; Brock, A.; Chen, S.; Chen, S.; Schultz, P. G. Genetic incorporation of unnatural 
amino acids into proteins in mammalian cells. Nat Meth 2007, 4, 239-244. 
(103) Wals, K.; Ovaa, H. Unnatural amino acid incorporation in E. coli: current and future 
applications in the design of therapeutic proteins. Frontiers in Chemistry 2014, 2, 15. 
34 
(104) Rogerson, D. T.; Sachdeva, A.; Wang, K.; Haq, T.; Kazlauskaite, A.; Hancock, S. M.; 
Huguenin-Dezot, N.; Muqit, M. M.; Fry, A. M.; Bayliss, R.; Chin, J. W. Efficient genetic 
encoding of phosphoserine and its nonhydrolyzable analog. Nat. Chem. Biol. 2015, 11, 
496-503. 
(105) Neumann, H.; Peak-Chew, S. Y.; Chin, J. W. Genetically encoding N(epsilon)-acetyllysine 
in recombinant proteins. Nat. Chem. Biol. 2008, 4, 232-234. 
(106) Nguyen, D. P.; Garcia Alai, M. M.; Kapadnis, P. B.; Neumann, H.; Chin, J. W. Genetically 
encoding N(epsilon)-methyl-L-lysine in recombinant histones. J. Am. Chem. Soc. 2009, 
131, 14194-14195. 
(107) Chalker, J. M.; Bernardes, G. J.; Lin, Y. A.; Davis, B. G. Chemical modification of 
proteins at cysteine: opportunities in chemistry and biology. Chem. Asian J. 2009, 4, 630-
640. 
(108) Gianneschi, N. C.; Ghadiri, M. R. Design of molecular logic devices based on a 
programmable DNA-regulated semisynthetic enzyme. Angew. Chem. Int. Ed. 2007, 46, 
3955-3958. 
(109) Krall, N.; da Cruz, F. P.; Boutureira, O.; Bernardes, G. J. Site-selective protein-
modification chemistry for basic biology and drug development. Nat. Chem. 2016, 8, 103-
113. 
(110) Miseta, A.; Csutora, P. Relationship between the occurrence of cysteine in proteins and the 
complexity of organisms. Mol. Biol. Evol. 2000, 17, 1232-1239. 
(111) Marino, S. M.; Gladyshev, V. N. Cysteine function governs its conservation and 
degeneration and restricts its utilization on protein surfaces. J. Mol. Biol. 2010, 404, 902-
916. 
(112) Chalker, J. M.; Gunnoo, S. B.; Boutureira, O.; Gerstberger, S. C.; Fernandez-Gonzalez, M.; 
Bernardes, G. J. L.; Griffin, L.; Hailu, H.; Schofield, C. J.; Davis, B. G. Methods for 
converting cysteine to dehydroalanine on peptides and proteins. Chem. Sci. 2011, 2, 1666-
1676. 
35 
(113) Chalker, J. M.; Bernardes, G. J.; Davis, B. G. A "tag-and-modify" approach to site-
selective protein modification. Acc. Chem. Res. 2011, 44, 730-741. 
(114) van Kasteren, S. I.; Kramer, H. B.; Jensen, H. H.; Campbell, S. J.; Kirkpatrick, J.; Oldham, 
N. J.; Anthony, D. C.; Davis, B. G. Expanding the diversity of chemical protein 
modification allows post-translational mimicry. Nature 2007, 446, 1105-1109. 
(115) Guo, J.; Wang, J.; Lee, J. S.; Schultz, P. G. Site-specific incorporation of methyl- and 
acetyl-lysine analogues into recombinant proteins. Angew. Chem. Int. Ed. 2008, 47, 6399-
6401. 
(116) Gellman, S. H. On the role of methionine residues in the sequence-independent recognition 
of nonpolar protein surfaces. Biochemistry 1991, 30, 6633-6636. 
(117) Gloss, L. M.; Kirsch, J. F. Decreasing the basicity of the active site base, Lys-258, of 
Escherichia coli aspartate aminotransferase by replacement with gamma-thialysine. 
Biochemistry 1995, 34, 3990-3998. 
(118) Wright, T. H.; Bower, B. J.; Chalker, J. M.; Bernardes, G. J.; Wiewiora, R.; Ng, W. L.; Raj, 
R.; Faulkner, S.; Vallee, M. R.; Phanumartwiwath, A.; Coleman, O. D.; Thezenas, M. L.; 
Khan, M.; Galan, S. R.; Lercher, L.; Schombs, M. W.; Gerstberger, S.; Palm-Espling, M. 
E.; Baldwin, A. J.; Kessler, B. M.; Claridge, T. D.; Mohammed, S.; Davis, B. G. 
Posttranslational mutagenesis: A chemical strategy for exploring protein side-chain 
diversity. Science 2016, 354. 
(119) Walsh, S. M.; Konecki, S. N.; Silverman, S. K. Identification of Sequence-Selective 
Tyrosine Kinase Deoxyribozymes. J. Mol. Evol. 2015, 81, 218-224. 
(120) Wang, P.; Silverman, S. K. DNA-Catalyzed Introduction of Azide at Tyrosine for Peptide 
Modification. Angew. Chem. Int. Ed. 2016, 55, 10052-10056. 
(121) Wong, O.; Pradeepkumar, P. I.; Silverman, S. K. DNA-catalyzed covalent modification of 
amino acid side chains in tethered and free peptide substrates. Biochemistry 2011, 50, 
4741-4749. 
36 
(122) Walsh, S. M.; Sachdeva, A.; Silverman, S. K. DNA catalysts with tyrosine kinase activity. 
J. Am. Chem. Soc. 2013, 135, 14928-14931. 
(123) Chandrasekar, J.; Silverman, S. K. Catalytic DNA with phosphatase activity. Proc. Natl. 
Acad. Sci. U. S. A. 2013, 110, 5315-5320. 
(124) Sachdeva, A.; Silverman, S. K. DNA-catalyzed serine side chain reactivity and selectivity. 
Chem. Commun. 2010, 46, 2215-2217. 
(125) Chandrasekar, J.; Wylder, A. C.; Silverman, S. K. Phosphoserine Lyase Deoxyribozymes: 
DNA-Catalyzed Formation of Dehydroalanine Residues in Peptides. J. Am. Chem. Soc. 
2015, 137, 9575-9578. 
(126) Brandsen, B. M.; Velez, T. E.; Sachdeva, A.; Ibrahim, N. A.; Silverman, S. K. DNA-
catalyzed lysine side chain modification. Angew. Chem. Int. Ed. 2014, 53, 9045-9050. 
 
37 
Chapter 2: DNA Enzymes for Peptide-Nucleic Acid Conjugation† 
2.1 Introduction 
The Tyr1 deoxyribozyme catalyzes the formation of a nucleopeptide linkage by reaction 
of a tyrosine (Tyr) hydroxyl group with the -phosphate of a 5′-triphosphorylated RNA 
oligonucleotide (5′-pppRNA; Figure 2.1).1 DNA-catalyzed conjugation of a less reactive serine 
(Ser) hydroxyl group to a RNA oligonucleotide in a similar manner was also achieved.2 The 
formation of covalent linkages between protein side chains and nucleic acids plays an essential 
role in many biological processes including topoisomerization,3,4 DNA recombination,5 viral 
propagation,6-10 and activity of tumor suppressor proteins.11  
 
Figure 2.1. DNA-catalyzed Peptide-nucleic acid conjugation reactions. The conjugation reaction 
involves the nucleophilic attack of a Tyr or Ser hydroxyl group on the -phosphate of 5′-
pppRNA. 
                                                            
† This research has been published:  
Chu, C.; Wong, O.; Silverman, S. K. A Generalizable DNA-Catalyzed Approach to Peptide- 
Nucleic Acid Conjugation. ChemBioChem 2014, 15, 1905–1910.  
University of Illinois graduate student Adrienne (On Yi) Wong performed selection experiments 
using DNA-anchored peptide substrates and identified 15MZ36 deoxyribozyme that catalyzed 
the conjugation of a discrete, free peptide to a RNA oligonucleotide.18 She also identified 
deoxyribozymes for reductive amination.22  
University of Illinois graduate student Benjamin M. Brandsen performed selection experiments 
to identify DNA enzymes for lysine side chain modification using a 5′-phosphorimidazolated 
DNA (5′-ImpDNA) substrate.42 
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Approaches to conjugate proteins or peptides to nucleic acids in vitro are valuable for 
biochemical research to generate biologically relevant protein-nucleic acid conjugates or 
nucleopeptides. Such approaches may also contribute to the development of new artificial 
protein bioconjugation methods. However, current synthetic strategies for site-specific 
conjugation of peptide side chains to nucleic generally require detailed and sophisticated 
strategies that involve extensive use of protecting groups.12-16 The use of DNA enzymes provides 
an alternative approach to create these conjugates in one step without any protecting groups on 
either the peptide or the nucleic acid substrate. In addition, DNA enzymes as large biomolecules 
are capable of achieving sequence selectivity, for example, DNA enzymes are capable of 
distinguishing two Tyr residues in different sequence contexts.  
2.1.1 DNA-Catalyzed Peptide-Nucleic Acid Conjugation of Free Peptide Substrates 
Initial in vitro selection attempts to identify deoxyribozymes for peptide-nucleic acid 
conjugation employed a three-helix-junction architecture to juxtapose the amino acid side chain 
and 5′-pppRNA for catalysis (Figure 2.2A).1,2,17 Although the design was sufficient to address 
the fundamental question of whether DNA is capable of catalyzing this conjugation reaction, the 
highly preorganized arrangement obviated the need for the catalytic DNA to spatially position its 
substrates. The drawback notably prevented the applicability of this preorganized strategy to a 
discrete, free peptide substrate. A design with a less restricted architecture is required for further 




Figure 2.2. Two selection approaches for DNA-catalyzed peptide-nucleic acid conjugation. (A) 
2D (left) and 3D (right) schematic depiction of the selection design using a three-helix-junction 
architecture. The P4 strand that is formed by four base pairs juxtaposes the nucleophile (Tyr) to 
the electrophile (5′-pppRNA). (B) Selection design using DNA-anchored peptide substrates. The 
CYA peptide substrate is tethered to the DNA anchor via a disulfide linkage between the N-
terminal cysteine of the peptide and the 3′-thiol modification on the DNA anchor 
oligonucleotide. Image on the right of panel A adapted with permission from ref. 17. 
2.1.1.1 Selection Approach using DNA-Anchored Peptide Substrates 
To present the substrates to the DNA pool in a non-preorganized fashion, selection 
experiments were performed by Adrienne (On Yi) Wong using DNA-anchored peptide 
substrates.18 The peptides are covalently tethered via a disulfide linkage to a DNA anchor that is 
Watson-Crick base-paired to the fixed-sequence binding arm of the DNA pool (Figure 2.2B). 
The DNA anchor provides substantial binding energy but still challenges the DNA sequences to 
spatially arrange the substrates for catalysis, especially when the tether is lengthy. The DNA-
anchored peptide substrate, like the DNA-peptide-DNA substrate used in the previous three-
helix-junction architecture, provides sufficient gain in mass for the catalytic active DNA 
sequences after selection step and thereby enables a straightforward PAGE-shift separation 
strategy.  
The selection experiment using a DNA-anchored CYA tripeptide substrate showed that 
even though the peptide substrate was covalently tethered to the DNA anchor during selection, 
the tether itself was not required for catalysis. The identified deoxyribozymes are reproducibly 
active with a free (unanchored) peptide substrate, albeit with quite low rate and yield. 
Furthermore, using a longer tether during the selection led to deoxyribozymes that have much 
improved catalytic activities with a free peptide substrate. Although selection experiments using 
DNA-anchored CSA tripeptide substrate showed no activity, a subsequent adjustment to begin 
40 
selection with a DNA-tethered aliphatic hydroxyl group and later switch to a DNA-anchored 
CSA substrate led to deoxyribozymes with Ser activity, albeit still no activity with a free CSA 
peptide substrate. Interestingly, one of the identified deoxyribozyme in this selection experiment, 
15MZ36, exhibited the best catalytic activity with both the DNA-anchored and free CYA 
substrate among all DNA enzymes found in this study. The use of DNA-anchored peptide 
substrates has since been the selection strategy for most DNA-catalyzed peptide side chain 
modification reactions. Deoxyribozymes with free peptide activity have been identified for Tyr 
dephosphorylation,19 adenylylation,20 and the formation of dehydroalanine from phosphoserine.21 
Despite the achievement of DNA-catalyzed modification of unanchored peptides, a major 
practical limitation for this approach is that the deoxyribozymes are not required to interact with 
the peptide moiety sufficiently well during the selection, given the Watson-Crick binding energy 
provided separately by the DNA anchor. Consequently, the identified DNA enzymes often 
require high (~mM) peptide concentration for catalysis. In particular, the 15MZ36 
deoxyribozyme has an apparent peptide Km value of 1.8 ± 0.5 mM.  
2.1.1.2 Previous Effort of Using Unanchored Peptides in Selection Experiments  
A straightforward solution to address the limitation of using DNA-anchored peptides is to 
use an entirely free (unanchored) peptide substrate in the selection experiments. This strategy is 
not feasible for many peptide modification reactions because for those cases the peptide is 
required to be covalently linked to the DNA pool. Fortunately for peptide-nucleic acid 
conjugation, 5′-pppRNA as the other conjugation partner can be ligated (linked) to the DNA 
pool, allowing the peptide substrate to be presented unanchored. The use of a free peptide 
substrate inherently requires the deoxyribozymes to interact more tightly with the peptide 
moiety. Furthermore, selection pressure for DNA enzymes to function at low peptide 
concentrations can be imposed by reducing the peptide concentration during selection rounds.  
The immediate difficulty for this approach is that the mere addition of a free peptide 
substrate to the RNA strand, which is already connected to the deoxyribozyme, does not provide 
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sufficient gel shift for our separation procedure. An initial effort to overcome this difficulty 
utilized an unanchored peptide with a free N-terminal amino group. In each round the DNA pool 
is presented with the unanchored peptide during the key selection step, in which the catalytically 
active DNA sequences can join the peptide to the RNA strand. The catalytically active DNA 
sequences now become covalently linked to the N-terminal amino group on the peptide, due to 
the presence of the remote RNA-DNA junction. In a subsequent capture step where the DNA 
pool is presented with a 3′-dialdehyde DNA oligonucleotide, reductive amination with the N-
terminal amino group on the peptide increases the mass of only the active DNA sequences by the 
size of the dialdehyde DNA oligonucleotide, thereby enables PAGE-shift separation of these 
active sequences (Figure 2.3). However, this strategy unexpectedly led to deoxyribozymes that 
catalyze peptide-independent reductive amination of the 3′-dialdehyde DNA oligonucleotide 
with the 5′-terminal guanosine nucleobase of the RNA oligonucleotide.22 Therefore, an 
alternative capture strategy to distinguish the peptide substrate from the rest of the 
oligonucleotide molecule is required. A click reaction that is bioorthogonal was chosen for our 
new capture strategy.  
 
Figure 2.3. Selection approach with an N-terminal amino peptide substrate and reductive 
amination capture step. The intended capture step unexpectedly became the selection step, which 
resulted in deoxyribozymes that recognize the N2-amine of the 5′-terminal G as the nucleophile 
for reductive amination with the 3′-dialdehyde DNA oligonucleotide. Figure adapted with 
permission from ref. 17. 
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2.2 Results and Discussion 
2.2.1 Development of Click Chemistry for Capture Step 
Our previous attempt to use the N-terminal amine of the free peptide substrate for the 
subsequent capture of the catalytic active DNA sequences. However, other amino groups on the 
oligonucleotide molecule (such as the N2-amine of the guanosine nucleobase) could also be used 
for reductive amination with the 3′-dialdehyde DNA oligonucleotide. In light of that study, we 
sought an alternative capture reaction involving functional groups that are orthogonal to the ones 
presented in our selection experiments. Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) is 
one of the well-known click reaction that has been widely applied in bioconjugation reactions.23-
27 In addition, such a reaction has been used in the context of DNA-templated conjugation 
reactions.28,29 Therefore, CuAAC is an ideal candidate for our capture strategy.  
2.2.1.1 In Vitro Selection Strategy Using CuAAC Capture Reaction 
A new selection approach was designed to incorporate CuAAC as the capture reaction. A 
Tyr-or Ser-containing peptide substrate bearing an azido (N3) group at the N-terminus was 
presented during the key selection step. Catalytically active DNA sequences that join the azido-
peptide to the RNA strand during the selection step can be linked to the azido-peptide, due to the 
presence of the remote RNA-DNA junction. In a subsequent capture step where the DNA pool is 
provided with a 3′-alkyne-modified DNA oligonucleotide, a DNA splint oligonucleotide and 
Cu+, DNA-templated CuAAC reaction can sufficiently increase the mass of only the catalytically 
active DNA sequences and enable PAGE-shift separation from the other inactive sequences 
(Figure 2.4).  
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Figure 2.4. Selection approach using azido-peptide substrates and DNA-templated CuAAC 
capture. The peptide includes a N-terminal C6-tethered azido group. 5′-pppRNA is ligated to the 
DNA pool prior to the selection step. After the DNA-catalyzed selection step, active DNA 
sequences are captured by DNA-splinted CuAAC reaction with a 3′-alkyne DNA (alternating 
long and short), leading to a substantial PAGE shift that enables separation. Figure adapted with 
permission from ref. 33. 
The concept of introducing an additional capture step to the selection experiment was 
also applied in many other DNA-catalyzed peptide side chain modification reactions.19-21,30 In 
some of those cases, the length of the capture DNA oligonucleotide was alternated to prevent 
aberrantly migrating DNA sequences from surviving the capture step in consecutive selection 
rounds. Therefore, two alkyne-modified capture DNA oligonucleotides in different lengths were 
used in our new selection approach for DNA-catalyzed peptide-nucleic acid conjugation.  
2.2.1.2 Optimization of CuAAC Capture Reaction 
A N3-AYA–RNA conjugate was first synthesized by 15MZ36 deoxyribozyme. This 
peptide-RNA conjugate was further ligated to a 5′-32P-radiolabeled DNA pool as the capture 
standard used in assays for the optimization of CuAAC capture conditions. The CuAAC reagents 
are three essential components for the reaction: sodium ascorbate, CuSO4, and THPTA (tris(3-
hydroxypropyltriazolylmethyl)amine). Sodium ascorbate reduces Cu2+ to Cu+ in situ to enable 
the catalyzed formation of the triazole moiety. THPTA is a water-soluble Cu(I)-binding ligand 
used to prevent Cu(I)-mediated degradation of biomolecules such as nucleic acids25,28. The ratio 
of the three components was evaluated to achieve the optimal efficiency of CuAAC capture. 
When an initial concentration of 2.8 mM THPTA, 4 mM sodium ascorbate and 0.4 mM CuSO4 
(7:10:1 ratio) was tested at 37 °C incubation, severe degradation of the oligonucleotide sample 
was observed (42% loss after 30 min; Figure 2.5). By retaining the concentration of CuSO4 and 
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varying the ratio of THPTA and sodium ascorbate relative to CuSO4, an optimal combination of 
2.8 mM THPTA, 0.8 mM sodium ascorbate and 0.4 mM CuSO4 (7:2:1 ratio) was obtained, 
leading to 75% yield after 30 min and merely 10% loss of sample (In three of the four cases in 
the figure, the full yield was observed in just 30 s).  
 
Figure 2.5. Optimization of CuAAC reaction conditions. The reaction was performed using the 
capture standard in 50 mM HEPES, pH 7.5, 2.5 µM DNA splint, 5 µM alkyne-DNA, 150 mM 
NaCl, appropriate ratios of THPTA, sodium ascorbate and CuSO4 ([CuSO4] was set at 0.4 mM). 
The sample was incubated at 37 °C and portions of the sample were quenched at 30 s, 30 min, 
1 h, and 2 h. S = starting material; P = product. Sample loss calculations were based on the initial 
total counts (S + P) of the 30 s timepoint.     
CuAAC reaction was then evaluated in a practical selection scenario. The internally-32P-
radiolabeled capture standard was first incubated with the azido-peptide substrate and divalent 
metal ions (Mg2+, Mn2+ and Zn2+) at 37 °C for 14 h. Ethanol precipitation was performed to 
remove the metal ions before initiating CuAAC capture reaction. The evaluation showed that 
capture was compatible with the selection conditions with a slight compromise in yield. In 
addition, no capture product was observed in a negative control using a 5′-pppRNA-DNA pool 
conjugate (Figure 2.6). 
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Figure 2.6. CuAAC capture under selection conditions. CuAAC reaction was performed using a 
32P-radiolabeled pppRNA-DNA pool conjugate (negative control) and a 32P-radiolabeled N3-
peptide–RNA-DNA pool conjugate (capture standard). The oligonucleotide conjugates were first 
incubated in 70 mM HEPES, pH 7.5, 0.25 µM unradiolabeled pppRNA-DNA pool conjugate, 
1 mM N3-AYA, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl at 37 °C for 
14 h followed by ethanol precipitation. CuAAC reaction was initiated in 50 mM HEPES, pH 7.5, 
2.5 µM DNA splint, 5 µM alkyne-DNA, 2.8 mM THPTA, 0.8 mM sodium ascorbate, 0.4 mM 
CuSO4 at 37 °C. Portions of the sample were quenched at appropriate times. No capture product 
was observed in the negative control, whereas the N3-peptide conjugate showed 50% yield at 
30 min. S = starting material; P = product. Radiolabeled samples were prepared by ligation of the 
RNA oligonucleotides (pppRNA or N3-peptide–RNA) to a 5′-
32P-radiolabeled DNA pool. 
2.2.2 Identification and Characterization of Deoxyribozymes for Peptide-RNA Conjugation 
New in vitro selection experiments were designed for peptide–RNA-conjugating 
deoxyribozymes. Selection experiments began with ligation of the 5′-pppRNA substrate to the 
initially random DNA pool (Figure 2.7). The ligation product was separated by PAGE. Selection 
step was performed by incubating the ligation product with an azido-peptide substrate and 
divalent metal ions at pH 7.5 to enable catalysis. Subsequently, the sample was precipitated with 
75% ethanol to remove the divalent metal ions. CuAAC capture step was performed in which the 
sample was incubated with the DNA splint, 3′-alkyne capture DNA, and CuAAC reagents. 
PAGE was used to separate the catalytically active DNA sequences that are now added with the 
mass of the capture DNA. Finally, PCR was performed using primers that bind to the fixed-
sequence regions of the DNA pool to amplify the surviving DNA sequences. This process was 
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iterated, each round enriching the opulation of catalytic active DNA sequences until they 
dominated the population.  
 
Figure 2.7. In vitro selection procedure for peptide–RNA-conjugating deoxyribozymes using 
unanchored peptide substrates and CuAAC capture step. First, the 5′-pppRNA substrate was 
ligated to the initially random DNA pool. Next, the ligation product was incubated with the 
azido-peptide substrate (depicted here with N3-AYA). A helper DNA oligonucleotide was 
initially presented during the selection step to sequester the binding arm at the 3′-end of the DNA 
pool. However, this strategy was omitted in later sets of selection experiments. CuAAC capture 
was performed to add mass to the conjugation product connected to the catalytically active DNA 
sequences. The surviving DNA sequences were PCR-amplified. PAGE purification was 
performed between each step except not between the selection and capture step, where ethanol 
precipitation was performed instead. The selection process was repeated until the catalytically 
active DNA sequence dominated the population. 
Selection experiments XG-XM was designed using 5′-pppRNA and the azido-peptide 
substrates (Figure 2.8). Peptide substrates included Tyr-containing peptides AYA, GPYSGN and 
Ser-containing peptide ASA as a proof of concept. GPYSGN was derived from the N-terminal 
sequence of the human rhinovirus 14 genome-linked protein that is naturally joined at the Tyr to 
the 5′-end of viral ssRNA.31,32 XG selection was a reselection of 15MZ36 deoxyribozyme by 
partially randomizing (25% per nucleotide) the sequence of the DNA enzyme. Selection 
conditions were 50 mM HEPES (or 70 mM if Zn2+ is used), pH 7.5, 1 mM azido-peptide, one of 
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40 mM Mg2+/20 mM Mn2+, 40 mM Mg2+/20 mM Mn2+/1 mM Zn2+ or 1 mM Zn2+ alone (all in 
chloride salts), and 150 mM NaCl at 37 °C for 14 h. Zn2+ was included because previous studies 
has shown that it can be a crucial catalytic cofactor for DNA enzymes.19,30 A helper DNA 
oligonucleotide was used in all six selection experiments to bind and sequester the constant-
sequence region of the DNA pool.   
 
Figure 2.8. In vitro selection design for XG-XM (selection experiments are given alphanumeric 
codes in the following pattern: A–Z, AA–ZZ, AA1–ZZ1, etc.). All selections were incubated at 
37 °C for 14 h. A helper DNA oligonucleotide was used in all selection experiments. XG 
selection was a reselection using a partially randomized pool from 15MZ36 deoxyribozyme 
(25% per nucleotide). Zn2+ was included in XJ-XL selections with it being the only divalent 
metal ion in XK selection. A Ser-containing peptide was used in XL selection for DNA-
catalyzed free Ser activity. A biologically relevant Tyr-containing peptide sequence, GPSYGN, 
was used in XM selection. 
Peptide-RNA conjugation activity was observed for all selection experiments using Tyr-
containing peptide substrates (Figure 2.9). However, sequences identified from cloning the active 
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pools of XG and XH selection were identical to (or had very few mutations relative to) the 
15MZ36 deoxyribozyme (Figure 2.10). For selection experiments with N40 random region 
length, each selection experiment only covers ~10-10 of the total sequence space. Therefore, the 
chance of finding the exact sequence of 15MZ36 or its closely related variants in a separate 
selection experiment is extremely low. A more probable explanation is that the selection 
experiments here were contaminated with the sequence of 15MZ36. If a sample of 15MZ36 
(which was synthesized and used in the laboratory) was accidentally introduced into the DNA 
pool anytime during in vitro selection, and 15MZ36 is catalytically active under the selection 
conditions, then the 15MZ36 sequence can be enriched, amplified, and can overwhelm other 
active sequences in the DNA pool. Consequently, the cloning results will reveal only the 
contaminating sequence.  
 
Figure 2.9. Selection progression of XG–XM experiments. “Control” refers to the yield of 
CuAAC standard capture reaction, which was performed in parallel with the selection 
experiments. Arrows mark the cloned rounds. Image on the right reprinted with permission from 
ref. 33.  
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Figure 2.10. Sequences of deoxyribozymes identified from the XG–XK selections. The 
sequences are aligned to the sequence of the 15MZ36 deoxyribozyme. Only the initially random 
(N40) sequences are shown. In each alignment, a dot denotes conservation with the uppermost 
sequence, and a dash denotes a gap. The numbers on the far right are the sequence length and (in 
parenthesis) the number of times the sequence was found during cloning. Sequence alignment of 
XG and XH selection with 15MZ36 deoxyribozyme indicated that the pool activities observed in 
XG and XH selection were due to contamination. XJ and XK selection resulted in one and two 
unique sequences, respectively.  
Because contamination was observed in the XG and XH experiments, it is very likely that 
the early activity of the XM selection was also due to contamination, given that 15MZ36 is 
tolerant of the GPYSGN sequence. Nevertheless, 15MZ36 showed very little activity (~2%) in 
the XJ selection conditions and no activity in the XK selection conditions. Cloning results from 
the XJ and XK selection experiment led to one and two new deoxyribozymes, respectively, for 
peptide-RNA conjugation.33 
The newly identified deoxyribozymes were characterized in single-turnover assays using 
a 3′-32P-radiolabeled 5′-pppRNA substrate. The conjugation product formed a slower-migrating 
band in PAGE that shifted higher than the band of the 5′-pppRNA due to the attachment of the 
peptide substrate. 8XJ105 deoxyribozyme requires both Mn2+ and Zn2+ for optimal activity (even 
higher yield in the additional presence of Mg2+), whereas either Mg2+/Zn2+ or Zn2+ alone allows 
trace activity (Figure 2.11A). In addition, the yield for 8XJ105 was optimal at 0.4–1 mM Zn2+. 
8XJ105 had 45% yield using 1 mM N3-AYA, with kobs of 0.41 h
–1 and apparent Km of >1 mM 
peptide (Figure 2.11B). The XK deoxyribozymes that require only Zn2+ had optimal yields of 
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~15% at 1 mM peptide, 1 mM Zn2+ in 14 h (Figure 2.12). Due to their poor yields, these DNA 
enzymes were not further characterized. 
 
Figure 2.11. Characterization of the 8XJ105 deoxyribozyme. (A) Metal ion dependence of 
8XJ105. Incubation conditions: 50 mM (– Zn2+) or 70 mM (+ Zn2+) HEPES, pH 7.5, 1 mM N3-
AYA, divalent metal ions as indicated, and 150 mM NaCl at 37 °C for 14 h. For [Zn2+] 
dependence assays, reactions at 14 h had already reached their maximal yield. Therefore, these 
data do not allow precise determination of the apparent Kd values. Different symbols correspond 
to different data sets. (B) Kinetic plots to determine kobs and peptide Km values. Incubation 
conditions: 70 mM HEPES, pH 7.5, 1–5000 µM N3-AYA, 40 mM MgCl2, 20 mM MnCl2, 1 mM 
ZnCl2, and 150 mM NaCl at 37 °C. PAGE image represents kinetic assays at timepoints of 30 s, 
2 h, 24 h. S = substrate; P = product. kobs values of 8XJ105 at 1 mM and 100 µM peptide are 0.41 
and 0.10 h–1, respectively. For the determination of apparent peptide Km value (plot on the right), 
the initial kobs values were determined from initial-rate kinetics (linear fits to yield versus time 
from 0–2 h). Therefore, these kobs values do not match precisely the analogous kobs values 
obtained by fitting the full reaction curves as shown in the full kinetic plot. The apparent Km 
value was obtained by fitting to kobs = kmax•([peptide]
n/(Km
n+[peptide]n), where n is the Hill 
coefficient. Peptide apparent Km of 8XJ105 is 1230 ± 140 µM (N = 1); The fit value only reflects 
the lower limit of the actual Km value because the data points have not turned over yet. Figure 
adapted with permission from ref. 33. 
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Figure 2.12. [Zn2+] dependence of the 10XK22 and 10XK35 deoxyribozymes. Incubation 
conditions: 70 mM HEPES, pH 7.5, 1 mM N3-AYA, 0–3 mM ZnCl2, and 150 mM NaCl at 37 °C 
for 14 h. Different symbols correspond to different data sets.  
In independent selection experiments performed by other lab members, contamination 
was also observed in reselection attempts for other DNA-catalyzed reactions because the 
reselection conditions were always identical or similar to the parent selection conditions. We 
tried to prevent contamination by using a DNA pool that has different sequences at the fixed-
sequence regions. The DNA pool used in our selection experiments consists of two fixed-
sequence regions flanking the random region (Figure 2.13). The 5′-terminal fixed-sequence 
region is an 18 nt long binding arm that binds to the 5′-pppRNA substrate. The reverse 
complement of this region (synthesized during PCR) is also where the forward primer binds to 
amplify the surviving DNA sequences. On the other hand, the 3′-terminal fixed-sequence region 
has a binding arm (16 nt long) adjacent to the random region and a separate primer binding 
region (15 nt long). We systematically designed multiple sets of binding arm sequences by 
retaining the first three nucleotides next to the random region on both arms and varied the rest of 
the binding arm sequence. Such a design should prevent substrate ligation and PCR amplification 
of DNA sequences with the “wrong” binding arm pair. 
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Figure 2.13. Design of DNA pools with different binding arm sequences to avoid contamination. 
The typical DNA pool used in our selection experiments is constructed with a random region and 
two fixed-sequence regions on both termini. The 5′-terminal region is the substrate binding arm; 
the same sequence is also used for primer binding during PCR. The 3′-terminal region is 
composed of a substrate binding arm and a primer binding region. The new DNA pools have 
three conserved nucleotides immediately next to the random region on both binding arms. Each 
DNA pool has a different sequence in the rest of the binding arm (marked by asterisk).  
A second set of in vitro selection experiments, EJ1-EM1, was designed with each 
experiment using a DNA pool with a different set of binding arm sequences. the EJ1, EK1 and 
EL1 selections had the same selection conditions as the XG, XH, and XL selections, respectively 
(Figure 2.14). The EM1 selection was analogous to the XM selection (both using the N3-
GPYSGN peptide substrate) but included Zn2+. The helper DNA oligonucleotide was omitted in 
this new set of selection experiments.  
 
Figure 2.14. In vitro selection design for EJ1-EM1. Each selection experiment used a DNA pool 
with different binding arm sequences. All selections were incubated at 37 °C for 14 h. The helper 
DNA oligonucleotide was omitted. Zn2+ was included in EL1 and EM1 selections. A biologically 
relevant Tyr-containing peptide sequence, GPSYGN, was used in the EM1 selection. 
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The EM1 selection led to 16% capture yield after 11 rounds using 1 mM N3-GPYSGN. 
Cloning from that round revealed a single deoxyribozyme sequence, 11EM103 (Figure 2.15A). 
Because the population at round 11 had already converged on one single DNA sequence, further 
imposition of selection pressure by reducing the peptide concentration even to 10 µM after round 
11 led only to the same sequence after cloning. Assays of 11EM103 using GPFSGN and 
GPYAGN instead of GPYSGN showed equivalent yield for GPYAGN but no reaction for 
GPFSGN (Figure 2.15B), indicating that the conjugation site with the RNA strand is at Tyr (a 
more reactive nucleophile) rather than the adjacent Ser. No activity was observed for EL1 
selection experiment using a Ser-containing peptide substrate. Therefore, covalent modification 
of free serine side chain remains a challenge for DNA enzymes.  
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Figure 2.15. Selection outcome of the EM1 selection experiment. (A) Selection progression of 
EM1 experiment and deoxyribozyme sequence. “Control” refers to the yield of CuAAC standard 
capture reaction, which was performed in parallel with the selection experiments. The arrow 
marks the cloned round. For the sequence of 11EM103, only the initially random N40 sequence is 
shown. The number on the far right is the sequence length and (in parenthesis) the number of 
times the sequence was found during cloning. (B) Assays of 11EM103 with variants of the 
GPYSGN peptide to establish the site of nucleopeptide junction. Incubation conditions: 70 mM 
HEPES, pH 7.5, 1 mM peptide substrate, 40 mM MgCl2, 20 mM MnCl2, 0.4 mM ZnCl2, and 
150 mM NaCl at 37 °C (t = 30 s, 2 h, 24 h). Figure adapted with permission from ref. 33. 
The 11EM103 deoxyribozyme requires all three of Mg2+, Mn2+, and Zn2+ for optimal 
activity, with slightly lower yield using only Mg2+/Zn2+ or Mn2+/Zn2+ (Figure 2.16A). Although 
identified by selection at 1 mM Zn2+, 11EM103 has a sharp Zn2+ dependence with an optimal 
yield at 0.4 mM. 11EM103 had 60% yield at 1 mM N3-GPYSGN, with kobs of 0.34 h
–1 and 
apparent Km of 168 ± 16 µM peptide (Figure 2.16B). Furthermore, substantial yield was retained 
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by 11EM103 even at only 10 µM peptide (34% yield after 60 h), which is a practically useful 
concentration for preparative synthesis. 
 
Figure 2.16. Characterization of the 11EM103 deoxyribozyme. (A) Metal ion dependence of 
11EM103. Incubation conditions: 50 mM (– Zn2+) or 70 mM (+ Zn2+) HEPES, pH 7.5, 1 mM 
N3-GPYSGN, divalent metal ions as indicated, and 150 mM NaCl at 37 °C for 14 h. For [Zn
2+] 
dependence assays, reactions at 14 h had already reached their maximal yield. Therefore, these 
data do not allow precise determination of the apparent Kd values. Different symbols correspond 
to different data sets. (B) Kinetic plots to determine kobs and peptide Km values. Incubation 
conditions: 70 mM HEPES, pH 7.5, 1–5000 µM N3-GPYSGN, 40 mM MgCl2, 20 mM MnCl2, 
0.4 mM ZnCl2, and 150 mM NaCl at 37 °C. PAGE image represents kinetic assays at timepoints 
of 30 s, 2 h, 24 h. S = substrate; P = product. kobs values of 11EM103 at 1 mM, 100 µM, and 
10 µM peptide are 0.34, 0.19, and 0.029 h–1, respectively. For the determination of apparent 
peptide Km value (plot on the right), the initial kobs values were determined from initial-rate 
kinetics (linear fits to yield versus time from 0–2 h). The apparent Km value was obtained by 
fitting to kobs = kmax•([peptide]
n/(Km
n+[peptide]n), where n is the Hill coefficient. Open data 
points indicate inhibition at high peptide concentrations and were omitted from the fit. Peptide 
apparent Km of 11EM103 is 168 ± 16 µM (N = 3, error bars are standard deviation). The fit value 
only reflects the lower limit of the actual Km values because the data points have not turned over 
yet. Figure adapted with permission from ref. 33. 
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2.2.3 Preparative-Scale Synthesis of a Peptide-RNA Conjugate 
11EM103 deoxyribozyme was used to demonstrate a larger-scale synthesis of peptide-
RNA conjugates by DNA enzymes, given the strong activity of 11EM103 observed at 10 µM 
peptide. Previous single-turnover assays were performed using a radiolabeled scale (~20 nM) of 
5′-pppRNA oligonucleotide as the limiting reagent and large excess (~mM) of the peptide 
substrate. However, in a practical scenario for the synthesis of large peptide or protein-nucleic 
acid conjugate, one would hope to use the more precious material (usually the peptide or the 
protein) as the limiting reagent. In addition, a feasible concentration for reactions involving 
larger peptide or protein substrates is typically 10–30 µM because a higher concentration usually 
results in aggregation. We sought to use the peptide substrate as the limiting reagent at 10 and 
20 µM peptide in DNA-catalyzed conjugation to 5′-pppRNA. 
The Zn2+ concentration was reoptimized in preparative experiments. Our previous study 
with phosphatase deoxyribozymes showed that higher concentration of Zn2+ is required for 
reactions involving a higher concentration of DNA enzyme to compensate for nonspecific 
chelation of Zn2+ by the increased amount of DNA.19 Under reaction conditions similar to the 
preparative experiment, 0.7 and 1 mM Zn2+ were optimal, respectively, for 10 and 20 µM 
peptide (Figure 2.17A). In the preparative experiment, the N3-GPYSGN peptide, the 11EM103 
deoxyribozyme, and 5′-pppRNA were incubated in 1.0:1.5:2.0 mole ratio in two parallel 
reactions, using 1 nmol peptide substrate at 10 and 20 µM. Both reactions led to substantial yield 
of the peptide-RNA conjugate after PAGE (Figure 2.17B). Based on the peptide as the limiting 
reagent, the yield of peptide-RNA conjugate for 10 and 20 μM peptide was 22% and 33%, 
respectively, limited in part by ~50% gel extraction efficiency. The identity of the conjugation 
product was confirmed by MALDI mass spectrometry.  
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Figure 2.17. Preparative-scale synthesis of a peptide-RNA conjugate using the 11EM103 
deoxyribozyme. (A) Smaller-scale assays to optimize [Zn2+] for the 11EM103 preparative-scale 
experiments. Assay conditions: 10 µL volume of 10 or 20 µM N3-GPYSGN, 15 or 30 µM 
11EM103 deoxyribozyme, 20 or 40 µM 5′-pppRNA (with 20 nM 3′-32P-radiolabeled 5′-
pppRNA), 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 0.4–4 mM ZnCl2, and 150 
mM NaCl at 37 °C. For 0.4, 1.0, and 4.0 mM Zn2+, error bars represent half of range (N = 2). For 
0.7 and 1.5 mM Zn2+, N = 1. The yields were quantified by observing the radiolabeled RNA, and 
thus the maximum observed yield is 50%. The yields shown in the plots are normalized yields. 
First-order curve fits are provided merely to guide the eye. (B) Preparative-scale synthesis of 
peptide-RNA conjugation, catalyzed by 11EM103. Reaction conditions: 100 or 50 μL total 
volume of 10 or 20 μM N3-GPYSGN, 15 or 30 μM 11EM103 deoxyribozyme, 20 or 40 μM 
pppRNA, 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 0.7 mM or 1.0 mM ZnCl2, and 
150 mM NaCl at 37 °C for 60 h. The PAGE image was acquired by UV shadowing. The 22% 
and 33% yield was based on the quantity of the conjugation product recovered from the gel, 
limited by ~50% gel extraction efficiency. Figure adapted with permission from ref. 33. 
2.2.4 A Generalizable Approach to DNA-Catalyzed Peptide-Nucleic Acid Conjugation 
The use of 5′-pppRNA as the electrophile led to the identification of deoxyribozymes for 
peptide-RNA conjugation. However, biologically relevant nucleopeptides include a wider variety 
of junctions not only at peptide–5′-RNA,6,7 but also peptide–5′-DNA3,5,8,9 and DNA-3′–
peptide.4,5 While 5′-pppRNA is readily prepared by in vitro transcription using a double-stranded 
DNA template and a phage RNA polymerase, the sequence must begin with G or A and 
preferably be purine-rich at the 5′-end.34,35 Although several methods for solid-phase synthesis of 
triphosphorylated oligonucleotides have been described,36-39 their implementation is limited only 
to 5′-end incorporation. No known method is reported to our knowledge for the preparation of 3′-
pppRNA or DNA. Therefore, an alternative electrophile is required for RNA and DNA 
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substrates to achieve a generalizable DNA-catalyzed approach to peptide-nucleic acid 
conjugation.  
Phosphorimidazolide (Imp) is approximately 102-fold more reactive than triphosphate 
(ppp) and reacts analogously to ppp in nucleophilic substitution reactions with imidazole as the 
leaving group (Figure 2.18). In addition, either terminus of either RNA or DNA can be activated 
in solution as Imp from a simple 5′- or 3′-phosphate.40,41 We evaluated the use of Imp as an 
alternative electrophile in DNA oligonucleotide substrates for DNA-catalyzed peptide-DNA 
conjugation reaction. 
 
Figure 2.18. Structures of 5′-pppRNA and 5′-ImpDNA, and their reaction with a Tyr nucleophile 
(X = RNA or DNA). The leaving group for nucleophilic attack of a ppp is a pyrophosphate 
group, whereas the leaving group for nucleophilic attack of an Imp is an imidazole group. Figure 
reprinted with permission from ref. 33. 
2.2.5 Identification and Characterization of Deoxyribozymes for Peptide-DNA Conjugation 
Selection experiments were designed for peptide–DNA-conjugating deoxyribozymes 
using 5′-ImpDNA and free azido peptides as substrates. Ligation, selection, CuAAC capture, and 
PCR step were identical to previous azido-peptide–RNA-conjugating selection experiments. 
Before PAGE purification in the ligation step, the ligation product was first phosphorylated at 
the 5′-end of the DNA oligonucleotide substrate (Figure 2.19). After PAGE purification, the 5′-
phosphorylated ligation product was treated with EDC and imidazole to form 5′-ImpDNA. The 
sample was desalted with a spin column prior to the selection step, in which the DNA sequences 
were incubated at pH 7.5 with an azido-peptide substrate and divalent metal ions.  
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Figure 2.19. Diagram of in vitro selection procedure for peptide–DNA-conjugating 
deoxyribozymes using 5′-ImpDNA. The diagram is identical to Figure 2.7 in ligation, selection, 
CuAAC capture, and PCR step. Selection procedure was modified from that of DNA-catalyzed 
peptide-RNA conjugation between ligation and selection step for the formation of Imp. After 
ligation, a phosphate was first added to the 5′-end of DNA substrate followed by PAGE 
purification. The phosphate was converted to an Imp by EDC and imidazole. The sample was 
desalted prior to the selection step. 
The N3-AYA peptide was used in both the EN1 and EP1 selection experiments (Figure 
2.20). The selection conditions for EN1 is 50 mM HEPES, pH 7.5, 1 mM N3-AYA, 40 mM 
MgCl2, 20 mM MnCl2, and 150 mM NaCl at 37 °C for 14 h. Zn
2+ was included in EP1, with 
selection conditions of 70 mM HEPES, pH 7.5, 1 mM N3-AYA, 40 mM MgCl2, 20 mM MnCl2, 
1 mM ZnCl2, and 150 mM NaCl at 37 °C for 14 h. Activity was observed for EN1 selection, and 
cloning at round 13 revealed five unique catalytic DNA sequences (Figure 2.21). 20% pool 
activity was observed for EP1 selection at round 11, after which a selection pressure was 
imposed with a lower concentration of 100 µM peptide for three more rounds. At round 14, the 
DNA pool had 8% capture yield. six and five different DNA sequences were identified after 
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cloning at round 11 and 14, respectively; of the latter five sequences, four were the same as 
found in round 11 and one is a new sequence.  
 
Figure 2.20. In vitro selection design for EN1 and EP1. Each selection experiment used a DNA 
pool with different binding arm sequences. Both selections used N3-AYA as the peptide substrate 
and were incubated at 37 °C for 14 h. Zn2+ was included in EP1 selection.  
 
Figure 2.21. Progression and deoxyribozyme sequences of EN1 and EP1 selection experiments. 
“Control” refers to the yield of CuAAC standard capture reaction, which was performed in 
parallel with the selection experiments. The arrows mark the cloned rounds. For the 
deoxyribozyme sequences, only the initially random N40 sequences are shown. In each 
alignment, a dot denotes conservation, i.e., the same nucleotide as in the uppermost sequence. 
The number on the far right is the sequence length and (in parenthesis) the number of times the 
sequence was found during cloning. Figure reprinted with permission from ref. 33. 
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EN1 deoxyribozymes had ≤10% yield after 20 h (Figure 2.22). Due to their poor catalytic 
activities, these enzymes were not pursued further. 11EP101, 11EP103, 11EP119 and 11EP126 
deoxyribozymes require the 3′-terminal primer binding region for catalysis. That region was 
single-stranded during each selection round and therefore it could adopt a specific structure that 
participated in the catalyzed reaction. For the other three deoxyribozymes (11EP104, 11EP111, 
and 14EP125), that region can be omitted without any loss of rate or yield. All EP1 
deoxyribozymes had yields ranging from 12%–45% (kobs 0.30–0.53 h
–1) after 10 h (Figure 2.22) 
with optimal activities near 0.4 mM Zn2+ (Figure 2.23).  
The EP1 deoxyribozymes had peptide apparent Km values ranging from 93 µM to >1 mM 
peptide (Figure 2.24). Notably, 14EP125 has the lowest apparent Km value (93 µM). Therefore, 
the result showed that the imposition of selection pressure by reducing the peptide concentration 
successfully led to a deoxyribozyme with an improved Km value for its peptide substrate. 
 
Figure 2.22. Kinetic plots of EN1 and EP1 deoxyribozymes. kobs values of EN1 deoxyribozymes 
were 0.10–0.19 h–1; kobs values of EP1 deoxyribozymes were 0.30–0.53 h
–1. The PAGE image of 
14EP125 with representative time points (30 s, 2 h, 10 h) is shown. S = substrate; P = product. 
The 5′-ImpDNA partially degrades to 5′-pDNA throughout the reaction, limiting the yield. 
Kinetic plot and gel image on the right adapted with permission from ref. 33. 
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Figure 2.23. [Zn2+] dependence of EP1 deoxyribozymes. Incubation conditions: 70 mM HEPES, 
pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 0–2 mM ZnCl2, and 150 mM NaCl at 37 °C for 14 h. 
These data do not allow precise determination of the apparent Kd values because the reactions 
had already reached their maximal extent in 14 h. The annealing buffer had EDTA to a final 
concentration of 0.05 mM; [Zn2+] in the plots were uncorrected for EDTA chelation. Different 
symbols represent different data sets. Figure adapted with permission from ref. 33. 
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Figure 2.24. Determination of peptide apparent Km values for five representative EP1 
deoxyribozymes. Incubation conditions: 70 mM HEPES, pH 7.5, 1–5000 µM peptide, 40 mM 
MgCl2, 20 mM MnCl2, 0.4 mM ZnCl2, and 150 mM NaCl at 37 °C. The initial kobs values were 
determined from initial-rate kinetics (linear fits to yield versus time from 0–2 h). Apparent Km 
values were obtained by fitting to kobs = kmax•([peptide]
n/(Km
n+[peptide]n), where n is the Hill 
coefficient. Error bars are not shown. Apparent Km values (µM): 11EP101 731 ± 71; 11EP103 
741 ± 196; 11EP111 1340 ± 170; 11EP119 392 ± 149; 14EP125 93 ± 10. The fit values except 
for 14EP125 only reflect the lower limit of the actual Km values because the data points have not 
turned over yet. Apparent Km values (µM) for the other two deoxyribozymes not shown: 
11EP104 1570 ± 280; 11EP126 879 ± 270. Figure reprinted with permission from ref. 33. 
Independent selection experiments were performed by Ben Brandsen using 5′-ImpDNA 
substrates for DNA-catalyzed lysine side chain modification.42 A DNA-anchored peptide with a 
hexaethylene glycol (HEG) tether was used in the selection experiments. The study led to 
deoxyribozymes that catalyze the conjugation of peptide to DNA by reaction of the amino group 
on the lysine side chain with the phosphorus of 5′-ImpDNA oligonucleotide (Figure 2.25). All 
deoxyribozymes were not catalytically active with an unanchored peptide substrate, which is 
unsurprising given that a tethered peptide substrate was used in the selection experiment. 
Nevertheless, the use of Imp electrophile enabled DNA-catalyzed modification of the lysine side 
chain, which has been challenging to achieve by DNA enzymes.  
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Figure 2.25. DNA-catalyzed lysine side chain modification. The selection experiments used 5′-
ImpDNA as the electrophile and a DNA-anchored Lys-containing peptide as the nucleophile.  
The relatively high reactivity of Imp correlates with its instability, both during 
preparation and subsequent incubation. As observed in gel-based assays such as the one in 
Figure 2.22, the 5′-ImpDNA reactant degraded to 5′-pDNA during the reaction. Therefore, the 
stability of Imp was investigated. The assessment indicated that Imp was unstable to several 
treatments, including annealing (heating/cooling) before assays and incubation under the assay 
conditions (Figure 2.26). Immediately after initiation of the reaction, the 5′-ImpDNA in the 
samples was substantially degraded (~50% degradation in the annealed samples and ~35% in the 
nonannealed samples; data obtained by quantifying the bands of 5′-ImpDNA and 5′-pDNA at 
30 s time point). The higher level of degradation in the annealed sample led to a lower reaction 
yield relative to the reaction yield of the nonannealed sample. In addition, the assessment showed 
that reactions with 5′-ImpDNA were suppressed when preincubation was performed prior to the 
initiation of the reactions. The evaluation of Imp stability suggested that 5′-ImpDNA is rather 
unstable; annealing as well as overnight storage should be avoided when handling samples 
containing 5′-ImpDNA.  
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Figure 2.26. Assessment of 5′-Imp stability. PAGE images represent assays with 14EP125 and 
11EP111 with or without the annealing step. The kinetic plots are assays with 14EP125 and 
11EP111, either with or withour anneaing, and with various preincubation of the 5′-ImpDNA. 
Preincubation time is 10 h. All preincubations except in water were performed in 70 mM 
HEPES, pH 7.5, 150 mM NaCl, either with or without 40 mM MgCl2/20 mM MnCl2/1 mM 
ZnCl2, or the 1 mM peptide substrate as indicated. Figure reprinted with permission from ref. 33.   
2.2.6 Evaluation of Peptide Sequence Tolerance of XJ, EM1, EP1 Deoxyribozymes 
A protein-binding nucleic acid aptamer functions by interacting with a specific region on 
the protein based on the protein’s sequence or structure.43,44 A deoxyribozyme as a single-
stranded DNA is likely to recognize its substrate similarly to aptamers and selectively modify 
peptides based on the sequence context. Sequence selectivity is important for site-specific 
protein modification reactions when more than one possible reacting amino acid residue is 
presented. Nevertheless, sequence-general deoxyribozymes can also be useful in various 
applications when site specificity is not a concern or only one reacting amino acid residue is 
presented.  
The approach of using unanchored peptide substrates requires the catalytic DNA 
sequences to interact sufficiently well with the peptide substrates during the selection. Therefore, 
peptide sequence tolerance of the newly identified DNA enzymes was investigated. 8XJ105, 
11EM103 and all seven of the EP1 deoxyribozymes were tested with four other Tyr-containing 
66 
peptides to evaluate their peptide sequence requirement for catalysis. The sequences of these 
heptapeptides were derived from human -thrombin that contains various amino acids including 
multiple ones with potentially nucleophilic side chains (Ser, Thr, Lys, His, Arg, Asp, Glu). 
8XJ105 is highly tolerant of amino acids other than Ala near the reacting Tyr residue, with 20–
52% yield after 16 h with the four thrombin-related peptide substrates and four other available 
peptide substrates (Figure 2.27). 11EP104 is moderately tolerant of changing the nearby amino 
acids, with only one case reaching half of the yield observed with the parent AYA substrate. The 
rest of the DNA enzymes are either much less tolerant or intolerant.  
The sequence-selective 11EM103 deoxyribozyme was identified from the selection 
experiment using a peptide sequence (GPYSGN) with more diverse amino acids (rather than just 
plain alanine). Studies of other DNA-catalyzed peptide modification reactions have also shown 
that using a peptide substrate with a mixed-composition sequence in the selection experiment can 
lead to sequence-selective deoxyribozymes. However, as also shown in those studies, the 
outcome of obtaining selective enzymes is not guaranteed because selectivity is not required for 
DNA sequences to survive the in vitro selection process.20,45 
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Figure 2.27. Peptide sequence tolerance of 8XJ105, 11EM103, and EP1 deoxyribozymes. PAGE 
images represent a sequence-general (8XJ105) and a sequence-selective (11EM103) 
deoxyribozyme. The thrombin-related peptides were N-acetylated. The other four peptides that 
8XJ105 was also tested with have an N-terminal azido group. Assay conditions: 20 nM 3′-32P-
radiolabeled 5′-pppRNA or 5′-ImpDNA, 0.5 μM deoxyribozyme, 1 mM peptide, 70 mM HEPES, 
pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1.0 mM (8XJ105) or 0.4 mM (all other deoxyribozymes) 
ZnCl2, and 150 mM NaCl at 37 °C for 16 h. PAGE images adapted with permission from ref. 33. 
2.3 Summary and Future Directions 
DNA-catalyzed conjugation of a discrete, free Tyr-containing peptide substrate to a RNA 
oligonucleotide had previously been achieved using a DNA-anchored peptide substrate in the 
selection experiments. However, such an approach does not always lead to free peptide activity. 
Furthermore, the imposition of selection pressure for better substrate-binding enzymes in such a 
design is not feasible. A previous effort toward using an unanchored peptide substrate in 
selection experiments led to the unexpected identification of a new DNA-catalyzed reaction. 
Here, a new selection approach was developed using unanchored peptide substrates that have an 
N-terminal azido group for subsequent CuAAC capture. This selection strategy was viable as 
several new DNA enzymes for peptide-nucleic acid conjugation were identified. One 
deoxyribozyme, 11EM103, had substantial activity at low peptide concentration (10 µM) and 
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was used to demonstrate the preparative-scale synthesis of peptide-RNA conjugate using 
practically useful peptide concentrations and amount of materials.  
Imp was evaluated as a more reactive and generalizable electrophile to be used for DNA-
catalyzed peptide-nucleic acid conjugation. An Imp group can be easily placed at either the 5′-
end or 3′-end of either RNA and DNA. The use of 5′-ImpDNA substrates in selection 
experiments resulted in the identification of DNA enzymes for peptide-DNA conjugation. 
Furthermore, the EP1 selection showed that the imposition of selection pressure by reducing the 
peptide concentration led to a deoxyribozyme, 14EP125, that has an apparent Km value of 93 µM 
peptide.  
Assays with peptides of different sequences showed that 8XJ105 is a peptide-sequence-
general deoxyribozyme, which is especially useful for general conjugation of any Tyr-containing 
peptides to RNA oligonucleotides. 8XJ105 was used in various experiments to generate peptide-
RNA conjugates or develop methods for DNA-catalyzed protein modification. By using a 
peptide substrate with a more complex sequence, the selection led to a sequence-specific 
deoxyribozyme, 11EM103. This strategy has also been successful in other selection experiments 
for the identification of sequence-selective DNA enzymes.  
DNA-catalyzed Ser-nucleic acid conjugation with unanchored peptides is still a challenge. 
Future selection experiments will use 5′-ImpDNA as a more reactive electrophile as well as a 
Ser-containing peptide substrate with mixed-composition peptide sequence to enhance the 
interaction between the DNA sequences and the peptide substrate. Future efforts will be focused 
on identifying DNA enzymes for the synthesis of biologically relevant peptide-nucleic acid 
conjugates and developing strategies for deoxyribozymes to function with natively folded protein 
substrates.  
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2.4 Materials and Methods 
2.4.1 Synthesis of 6-Azidohexanoic Acid 
The synthesis of 6-azidohexanoic acid was performed based on the procedure in Jetson 
et al.46 Briefly, a 10 mL mixture of 1.00 g (5.13 mmol) 6-bromohexanoic acid and 1.70 g 
(26.15 mmol) sodium azide in dimethylformamide (DMF) was stirred under argon at room 
temperature for 20 h followed by further stirring at 75 °C for another 3 h. The mixture was 
cooled back to room temperature and diluted with 40 mL dichloromethane. Two washes with 
20 mL of 0.1 M HCl and one wash with 15 mL of brine were performed. The solution was dried 
over Na2SO4 and concentrated on a rotary evaporator to yield 0.65 g (80%) of the product as a 
yellow oil. 1H NMR (500 MHz, CDCl3)  3.26 (t, J = 6.9, 2H), 2.36 (t, J = 7.4, 2H), 1.63 (m, 
4H), 1.42 (m, 2H) ppm. ESI-MS: [M−H]− calcd. 156.2, found 156.4, Δ = +0.13%. 
2.4.2 Substrate Preparation Procedures 
Peptide substrates. Peptides were prepared by solid-phase synthesis at 0.2 mmol scale 
using Fmoc Rink amide MBHA resin as described.19 To introduce the azido group at the N-
terminus, the final coupling reaction was performed for 12 h using 5 equivalents (157 mg, 
1 mmol) of 6-azidohexanoic acid, 5 equivalents (126 mg, 1 mmol) of diisopropyl carbodiimide 
(DIC), and 5 equivalents (135 mg, 1 mmol) of 1-hydroxybenzotriazole (HOBt) in 5 mL of DMF. 
In the step where the peptide was cleaved from the resin, ethanedithiol was omitted because here 
no peptide included cysteine.  
Oligonucleotide substrates. DNA oligonucleotides were obtained from Integrated DNA 
Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument 
using reagents from Glen Research. 5′-pppRNA oligonucleotides were prepared by in vitro 
transcription using synthetic DNA templates and T7 RNA polymerase.47 All oligonucleotides 
were purified by 7 M urea denaturing PAGE with running buffer 1× TBE (89 mM each Tris and 
boric acid and 2 mM EDTA, pH 8.3) as described.48,49 5′-ImpDNA oligonucleotides were 
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prepared freshly by treatment of 5′-pDNA with 100 mM EDC and 100 mM imidazole at room 
temperature for 2 h followed by desalting using a Micro Bio-Spin P-6 column (Bio-Rad).  
Procedure for synthesis of the N3-AYA–RNA conjugate. The N3-AYA peptide was 
conjugated to the 5′-pppRNA oligonucleotide by the 15MZ36 deoxyribozyme. A 25 µL sample 
containing 800 pmol of 5-pppRNA, 900 pmol of 15MZ36 and 1 nmol of the helper DNA 
oligonucleotide was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by 
heating at 95 °C for 1 min and cooling on ice for 5 min. The reaction was initiated by bringing 
the sample to 100 µL total volume containing 50 mM HEPES, pH 7.5, 1 mM N3-AYA, 40 mM 
MgCl2, 20 mM MnCl2, and 150 mM NaCl. The sample was incubated at 37 °C for 48 h, 
precipitated with ethanol, and purified by 20% PAGE. The product was quantified by UV 
absorbance (A260), and a typical yield was ~20%.  
Procedure for 3-32P-radiolabeling of 5-pppRNA and 5-ImpDNA. Radiolabeling of 5ʹ-
pppRNA was achieved starting from the unlabeled 5ʹ-pppRNA using 5-32P-pCp and T4 RNA 
ligase as previously described.18 The 3-32P-radiolabeled 5-ImpDNA oligonucleotides for single-
turnover assays were prepared via a multi-step procedure. The unlabeled DNA oligonucleotide 
was 3-32P-radiolabeled by incubating 20 pmol of oligonucleotide, 20 µCi of -32P-dCTP 
(800 Ci/mmol), and 10 units of terminal deoxytransferase (Fermentas) in 20 µL of 1 TdT 
reaction buffer (200 mM potassium cacodylate, 25 mM Tris, pH 7.2, 0.01% Triton X-100, and 
1 mM CoCl2) at 37 °C for 30 min. The TdT was inactivated by heating at 75 °C for 20 min. The 
3-32P-radiolabeled oligonucleotide was 5-phosphorylated in the same tube by adding 5 units of 
T4 polynucleotide kinase (Fermentas) and ATP to 1 mM in a total volume of 30 µL, followed by 
incubation at 37 °C for 1 h and purification by 20% PAGE. The resulting sample was assumed to 
contain 20 pmol of PAGE-purified 5-phosphorylated 3-32P-radiolabeled oligonucleotide. To 
form 5-Imp, a 5 pmol portion was incubated in a total volume of 25 µL containing 100 mM 1-
ethyl 3-(3-dimethylaminopropyl) carbodiimide (EDC), 100 mM imidazole (pH 6.0 with HCl), 
and 5 pmol of a 5-phosphorylated decoy oligo of unrelated sequence (included to suppress 
nonspecific sticking to the subsequent desalting column) at room temperature for 2 h. A Micro 
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Bio-Spin P-6 desalting column (Bio-Rad) was prepared by centrifuging at 1000 g for 1 min and 
rinsing 4 by adding 500 µL of water followed by centrifuging at 1000 g for 1 min. The 25 µL 
sample was applied to the column and eluted by centrifuging at 1000 g for 4 min. The eluant was 
dried by SpeedVac and redissolved in 25 µL of water. The resulting sample was assumed to 
contain 5 pmol of 3-32P-radiolabeled 5-ImpDNA in 25 µL of water (0.2 µM). 
2.4.3 Oligonucleotide Sequences 
The oligonucleotide sequences used during in vitro selection, cloning, and assay 
procedures are listed in Table 2.1. All sequences are written 5 to 3 and are DNA unless 
indicated explicitly as RNA (the two 5-pppRNA substrates). The 3-alkyne was introduced using 
3-alkyne serinol CPG (Glen Research). In the reverse primer for selection, X denotes the HEG 
spacer to stop Taq polymerase. For the decoy DNA for assays of 8XJ105, the underlined 
nucleotides are complementary to the initially random (N40) region of 8XJ105; the non-
underlined nucleotides are complementary to the flanking sequences of the binding arms. 
Table 2.1. Oligonucleotide sequences. 
oligonucleotide purpose oligonucleotide sequence 
  
3ʹ-alkyne capture DNA for all selection experiments 
3ʹ-alkyne capture DNA (16 nt) GCCGCATCAGACAGCG 
3ʹ-alkyne capture DNA (49 nt) (AAC)11GCCGCATCAGACAGCG 
 
XG–XM selection experiments 
partially random pool for reselection CGAAGTCGCCATCTCTTC-N41-ATAGTGAGTCGTATTAAGCTGATCCTGATGG 
random pool for selection CGAACGAAAGCCTCCTTC-N40-ATACGCATAAAGGTAGAGCTGATCCTGATGG 
XG 5-pppRNA substrate GGAAGAGAUGGCGACGG 
XH–XM 5-pppRNA substrate GGAAGGAGGCUUUCGGG 
XG helper DNA (19 nt) GGATAATACGACTCACTAT 
XG helper DNA (40 nt) (AAC)7GGATAATACGACTCACTAT 
XH–XM helper DNA (19 nt) GGACTACCTTTATGCGTAT 
XH–XM helper DNA (40 nt) (AAC)7GGACTACCTTTATGCGTAT 
XG splint for capture TTCGCCGTCGCCATCTCTTCCCGCTGTCTGATGCGGC 
XH–XM splint for capture TTCGCCCGAAAGCCTCCTTCCCGCTGTCTGATGCGGC 
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Table 2.1 (cont.). 
oligonucleotide purpose oligonucleotide sequence 
  
XG–XM selection experiments (cont.) 
XG forward primer for selection (5-p) CGAAGTCGCCATCTCTTC 
XH–XM forward primer for selection (5-p) CGAACGAAAGCCTCCTTC 
reverse primer for selection (AAC)4XCCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
Decoy DNA for assays of 8XJ105 TTATGCGTATCCATTCCGTACTGAAAGTTTCCGTCTGAGAGACATCTCCCGAAGGAGGCT 
 
EM1 selection experiment 
random pool for selection CGAAATAGATTATCATTC-N40-ATAATTAGTAACCTGAAGCTGATCCTGATGG 
5-pppRNA substrate GGAAUGAUAAUCUAUGG 
splint for capture TTCGCCATAGATTATCATTCCCGCTGTCTGATGCGGC 
forward primer for selection (5-p) CGAAATAGATTATCATTC 
reverse primer for selection (AAC)4XCCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
 
EN1 and EP1 selection experiments 
EN1 random pool for selection CGAACATTGCAACAGTTC-N40-ATATCATCAGTGGCTCAGCTGATCCTGATGG 
EP1 random pool for selection CGAAGTATAAACCTGTTC-N40-ATATTTGTATCCAGGAAGCTGATCCTGATGG 
EN1 5-ImpDNA substrate GGAACTGTTGCAATGGGA 
EP1 5-ImpDNA substrate GGAACAGGTTTATACGGA 
EN1 splint for ligation GAACTGTTGCAATGTTCGTCCCATTGCAACAGTTC 
EP1 splint for ligation GAACAGGTTTATACTTCGTCCGTATAAACCTGTTC 
EN1 splint for capture TTCGTCCCATTGCAACAGTTCCCGCTGTCTGATGCGGC 
EP1 splint for capture TTCGTCCGTATAAACCTGTTCCCGCTGTCTGATGCGGC 
EN1 forward primer for selection (5-p) CGAACATTGCAACAGTTC 
EP1 forward primer for selection (5-p) CGAAGTATAAACCTGTTC 
reverse primer for selection (AAC)4XCCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
  
2.4.4 In Vitro Selection Procedures 
2.4.4.1 Selections with 5-pppRNA Substrates 
Procedure for ligation step in round 1. A 50 µL sample containing 1 nmol of DNA pool, 
1 mM ATP, 1 T4 PNK buffer A, and 10 units of T4 polynucleotide kinase (Fermentas) was 
incubated at 37 °C for 2.5 h. T4 polynucleotide kinase was removed by phenol/chloroform 
extraction followed by ethanol precipitation. The sample was dissolved in 20 µL of 5 mM Tris, 
pH 7.5, 15 mM NaCl, and 0.1 mM EDTA containing 1.2 nmol of 5-pppRNA substrate and 
73 
annealed by heating at 95 °C for 3 min and cooling on ice for 5 min. The ligation reaction was 
initiated by bringing the sample to a final volume of 30 µL containing 50 mM Tris, pH 7.5, 
10 mM DTT, 5 mM MgCl2, 0.05 mM ATP and 20 units of T4 RNA ligase (Fermentas). The 
sample was incubated at 37 °C for 12 h and purified by 8% PAGE. 
Procedure for ligation step in subsequent rounds. A 10 µL sample containing the PCR-
amplified DNA pool (~5–10 pmol) and 100 pmol of 5-pppRNA substrate was annealed in 5 mM 
Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice 
for 5 min. The ligation reaction was initiated by bringing the sample to a final volume of 20 µL 
containing 50 mM Tris, pH 7.5, 10 mM DTT, 5 mM MgCl2, 0.05 mM ATP and 10 units of T4 
RNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h and purified by 8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 
200 pmol of the ligated N40 pool. A 20 µL sample containing 200 pmol of ligated N40 pool was 
annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 
3 min and cooling on ice for 5 min (XG–XM selections additionally included 250 pmol of a 
19 nt helper DNA oligonucleotide). The selection reaction was initiated by bringing the sample 
to 40 µL total volume containing 70 mM HEPES, pH 7.5, 1 mM azido-peptide (added from 
50 mM stock solution in DMF), each of 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2 if included, 
and 150 mM NaCl. The sample was incubated at 37 °C for 14 h followed by ethanol 
precipitation. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 
95 °C for 3 min and cooling on ice for 5 min (XG–XM selections additionally included 50 pmol 
of a 19 nt helper DNA oligonucleotide in odd rounds and a 40 nt helper DNA oligonucleotide in 
even rounds). The selection reaction was initiated by bringing the sample to 20 µL total volume 
containing 70 mM HEPES, pH 7.5, 1 mM or 100 µM or 10 µM azido-peptide (added from a 
stock solution of 50 mM peptide in DMF, 1 mM peptide in 2% aqueous DMF, or 100 µM 
peptide in 0.2% aqueous DMF), each of 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2 if included, 
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and 150 mM NaCl. The sample was incubated at 37 °C for 14 h followed by ethanol 
precipitation. 
Procedure for CuAAC capture step in round 1. The precipitated selection sample was 
brought to 20 µL total volume containing 200 pmol of DNA splint for capture, 300 pmol of 49 nt 
3-alkyne capture oligonucleotide, 50 mM HEPES, pH 7.5, 150 mM NaCl, 2.8 mM tris(3-
hydroxypropyltriazolylmethyl)amine (THPTA), 0.8 mM sodium ascorbate, and 0.4 mM CuSO4. 
The three reagents were added from 28 mM (10), freshly prepared 20 mM (25), and 4 mM 
(10) stock solutions, respectively; the three reagents were mixed together and added at once to 
the other components. The sample was incubated at 37 °C for 1 h and separated by 8% PAGE. 
Procedure for CuAAC capture step in subsequent rounds. The precipitated selection 
sample was brought to 20 µL total volume containing 50 pmol of DNA splint for capture, 
100 pmol of 16 nt (even rounds) or 49 nt (odd rounds) 3-alkyne capture oligonucleotide, 50 mM 
HEPES, pH 7.5, 150 mM NaCl, 2.8 mM tris(3-hydroxypropyltriazolylmethyl)amine (THPTA), 
0.8 mM sodium ascorbate, and 0.4 mM CuSO4. THPTA, sodium ascorbate, and CuSO4 were 
added from 28 mM (10), freshly prepared 20 mM (25), and 4 mM (10) stock solutions, 
respectively; the three reagents were mixed together and added at once to the other components. 
The sample was incubated at 37 °C for 1 h and separated by 8% PAGE. 
Procedure for PCR. In each selection round, two PCR reactions were performed, 10-
cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared containing the 
PAGE-separated capture product, 200 pmol of 5-phosphorylated forward primer, 50 pmol of 
reverse primer, 20 nmol of each dNTP, 10 µL of 10 Taq polymerase buffer (1 = 20 mM Tris-
HCl, pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100), and 1 µL 
of Taq polymerase. This sample was incubated in a PCR thermocycler with the following PCR 
program: 94 °C for 2 min, 10 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. 
Taq polymerase was removed by phenol/chloroform extraction. Second, a 50 µL sample was 
prepared containing 1 µL of the 10-cycle PCR product, 100 pmol of 5-phosphorylated forward 
primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 20 µCi of -32P-dCTP 
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(800 Ci/mmol), 5 µL of 10 Taq polymerase buffer, and 0.5 µL of Taq polymerase. This sample 
was incubated in a PCR thermocycler with the following PCR program: 94 °C for 2 min, 30 
(94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. The sample was separated by 
8% PAGE. 
2.4.4.2 Selections with 5-ImpDNA Substrates 
Procedure for ligation and 5-phosphorylation steps in round 1. A 50 µL sample 
containing 1 nmol of DNA pool, 1 mM ATP, 1 T4 PNK buffer A, and 10 units of T4 
polynucleotide kinase (Fermentas) was incubated at 37 °C for 2.5 h. T4 polynucleotide kinase 
was removed by phenol/chloroform extraction followed by ethanol precipitation. The sample 
was dissolved in 20 µL of 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA containing 
1.2 nmol of DNA splint and 1.5 nmol of DNA substrate and annealed by heating at 95 °C for 
3 min and cooling on ice for 5 min. The ligation reaction was initiated by bringing the sample to 
a final volume of 40 µL containing 1 T4 DNA ligase buffer and 5 units of T4 DNA ligase 
(Fermentas). The sample was incubated at 37 °C for 12 h, and T4 DNA ligase was inactivated by 
heating at 65 °C for 30 min. To avoid adenylylation of the 5-phosphorylated DNA substrate by 
T4 DNA ligase, the 5-phosphate was incorporated onto the DNA substrate (now attached to the 
DNA pool) after the ligation step. The ligation product was 5-phosphorylated in 50 µL volume 
containing 1 mM ATP, 1 T4 PNK buffer A, and 10 units of T4 polynucleotide kinase 
(Fermentas). The sample was incubated at 37 °C for 5 h and purified by 8% PAGE. 
Procedure for ligation and 5-phosphorylation steps in subsequent rounds. A 17 µL 
sample containing the PCR-amplified DNA pool (~5–10 pmol), 50 pmol of DNA splint, and 
100 pmol of DNA substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The ligation reaction was 
initiated by bringing the sample to a final volume of 20 µL containing 1 T4 DNA ligase buffer 
and 1 unit of T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h, and T4 
DNA ligase was inactivated by heating at 65 °C for 30 min. The ligation product was 5-
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phosphorylated in 30 µL volume containing 1 mM ATP, 1 T4 PNK buffer A, and 5 units of T4 
polynucleotide kinase (Fermentas). The sample was incubated at 37 °C for 1 h and purified by 
8% PAGE. 
Procedure for 5-phosphorimidazolide (5-Imp) formation. Immediately prior to 
performing the selection step, a 25 µL sample containing the 5-phosphorylated ligation product, 
100 mM 1-ethyl 3-(3-dimethylaminopropyl) carbodiimide (EDC), and 100 mM imidazole 
(pH 6.0 with HCl) was incubated at room temperature for 2 h. A Micro Bio-Spin P-6 desalting 
column (Bio-Rad) was prepared by centrifuging at 1000 g for 1 min and rinsing 4 by adding 
500 µL of water followed by centrifuging at 1000 g for 1 min. The 25 µL sample was applied to 
the column and eluted by centrifuging at 1000 g for 4 min. For round 1, the eluant was quantified 
by NanoDrop. For subsequent rounds, the eluant was dried by SpeedVac. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the 5-Imp ligated N40 pool. A 20 µL sample containing 200 pmol of 5-Imp ligated N40 
pool was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 
95 °C for 3 min and cooling on ice for 5 min. The selection reaction was initiated by bringing the 
sample to 40 µL total volume containing 50 mM (–Zn2+) or 70 mM (+Zn2+) HEPES, pH 7.5, 
1 mM N3-AYA (added from 50 mM stock solution in DMF), each of 40 mM MgCl2, 20 mM 
MnCl2, 1 mM ZnCl2 if included, and 150 mM NaCl. The sample was incubated at 37 °C for 14 h 
followed by ethanol precipitation. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the 5-Imp 
ligated N40 pool was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by 
heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction was initiated by 
bringing the sample to 20 µL total volume containing 50 mM (–Zn2+) or 70 mM (+Zn2+) HEPES, 
pH 7.5, 1 mM or 100 µM N3-AYA (added from 50 mM peptide in DMF or 1 mM peptide in 2% 
aqueous DMF), each of 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2 if included, and 150 mM 
NaCl. The sample was incubated at 37 °C for 14 h followed by ethanol precipitation. 
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Procedure for CuAAC capture step in round 1. The procedure for the 5-pppRNA 
substrate was used. 
Procedure for CuAAC capture step in subsequent rounds. The procedure for the 5-
pppRNA substrate was used. 
Procedure for PCR. The procedure for the 5-pppRNA substrate was used. 
2.4.5 Cloning and Screening Procedure 
The 10-cycle PCR product from the appropriate selection round was diluted 1000-fold. A 
50 μL sample was prepared containing 1 μL of the diluted 10-cycle PCR product, 25 pmol of 
forward cloning primer, 25 pmol of reverse cloning primer, 10 nmol of each dNTP, 5 μL of 10 
Taq polymerase buffer, and Taq polymerase. This sample was cycled 30 times according to the 
following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 
°C for 5 min. The sample was purified by 2% agarose gel and extracted using a GeneJET Gel 
Extraction Kit (Thermo Fisher). The extracted product was quantified by absorbance (A260) and 
diluted to 4–8 ng/μL. A 1 μL portion of the diluted PCR product was inserted into the pCR2.1-
TOPO vector using a TOPO TA cloning kit (Thermo Fisher). Individual E. coli colonies 
harboring plasmids with inserts were identified by blue-white screening and grown in LB/amp 
media. Miniprep DNA was prepared using a GeneJET Plasmid Miniprep Kit (Thermo Fisher) 
and screened for properly sized inserts by EcoRI digestion and agarose gel analysis. Before 
sequencing, assays of individual deoxyribozyme clones were performed with PAGE-purified 
DNA strands prepared by PCR from the miniprep DNA, using the single-turnover assay 
procedure described below.  
2.4.6 Deoxyribozyme Characterization Procedures 
Procedure for single-turnover assays. A 10 µL sample containing 0.4 pmol of 3-32P-
radiolabeled 5-pppRNA or 5-ImpDNA substrate and 10 pmol of deoxyribozyme was annealed 
in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 1 min and 
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cooling on ice for 5 min (for 8XJ105, 10XK22, and 10XK35, 20 pmol of a helper DNA 
oligonucleotide was included). The peptide-nucleic acid conjugation reaction was initiated by 
bringing the sample to 20 µL total volume containing 50 mM (–Zn2+) or 70 mM (+Zn2+) HEPES, 
pH 7.5, 1–5000 µM azido-peptide, MgCl2/MnCl2/ZnCl2 as appropriate, and 150 mM NaCl. The 
sample was incubated at 37 °C, and 2 µL aliquots were quenched at appropriate times with 5 µL 
of stop solution (80% formamide, 1 TBE [89 mM each Tris and boric acid, 2 mM EDTA, 
pH 8.3], 50 mM EDTA, and 0.025% each bromophenol blue and xylene cyanol). For 8XJ105, 
10 pmol of a decoy oligonucleotide was added to each aliquot before PAGE, to displace the 
deoxyribozyme from the substrate and product. Samples were separated by 20% PAGE and 
quantified with a PhosphorImager. kobs values were obtained by fitting the complete yield versus 
time data directly to first-order kinetics. Alternatively, for initial-rate kinetics as used for all 
apparent Km plots, data for the initial linear portion (up to 1 or 2 h) was fit to a straight line. 
Procedure for preparative-scale experiments of 11EM103. For 10 or 20 µM peptide, a 50 
or 25 µL sample containing 1.5 nmol of 11EM103 and 2 nmol of 5-pppRNA was annealed in 
5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 1 min and 
cooling on ice for 5 min. The reaction was initiated by bringing the sample to 100 or 50 µL total 
volume containing 70 mM HEPES, pH 7.5, 1 nmol of azido-GPYSGN, 40 mM MgCl2, 20 mM 
MnCl2, 0.7 or 1 mM ZnCl2, and 150 mM NaCl. The sample was incubated at 37 °C for 60 h, 
precipitated with ethanol, and purified by 20% PAGE. The product was quantified after gel 
extraction by UV absorbance (A260) and analyzed by mass spectrometry on a Bruker 
UltrafleXtreme MALDI-TOF mass spectrometer with matrix 3-hydroxypicolinic acid in positive 
ion mode. [M+H]+ calcd. 6268.7, found 6272.3 (10 µM peptide) and 6268.2 (20 µM peptide), Δ 
= +0.06% and –0.008%. 
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Chapter 3: Recruiting DNA Enzymes for Peptide and Protein Modification† 
3.1 Introduction 
3.1.1 DNA-Catalyzed Modification Reactions of Protein Substrates 
Deoxyribozymes with the ability to site-specifically modify protein side chains can be 
very useful for biochemical studies. Efforts toward achieving DNA-catalyzed modification 
reactions of natively folded proteins often first aim at a shorter-term goal of identifying DNA 
enzymes that function with discrete, free peptide substrates. This shorter-term goal alone is 
challenging, especially for modification reactions that can only use DNA-anchored peptide 
substrates during in vitro selection. Nevertheless, several deoxyribozymes have been identified 
with free peptide activity for a few modification reactions using the anchored-peptide strategy.1-4 
Moreover, a phosphatase deoxyribozyme, 14WM9, demonstrated the ability to dephosphorylate 
a 91-mer protein that has a phosphotyrosine-containing peptide segment CAAYPAA at the C-
terminus.2 Although this study showed that 14WM9 was capable of recognizing the YP residue 
in the context of a protein with a large surface area rather than merely on a short hexapeptide, the 
reaction site was located at the unstructured end of a protein. Therefore, this result is still very 
different from modifying an amino acid side chain in a protein region with a well-defined 
structure. DNA enzymes with free peptide activity were also identified for DNA-catalyzed 
peptide-nucleic acid conjugation using the unanchored azido-peptide approach mentioned in 
Chapter 2.5 However, those deoxyribozymes were not tested with protein substrates.  
                                                            
† This research has been published:  
Chu, C.; Silverman, S. K. Assessing Histidine Tags for Recruiting Deoxyribozymes to Catalyze 
Peptide and Protein Modification Reactions. Org. Biomol. Chem.  2016, 14, 4697–4703. 
University of Illinois graduate student Shannon M. Walsh performed the selection experiment to 
identify the 6CF134 kinase deoxyribozyme.26  
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Within the scope of obtaining DNA enzymes that function with free peptides, identifying 
peptide-sequence-selective deoxyribozymes is an important aspect.4,6 The intention is that these 
selective DNA enzymes will recognize the corresponding motifs when the sequences used in the 
selection experiments are presented as a part of a protein substrate. Using a specific peptide 
segment rather than plain alanines flanking the reacting residue in selection experiments can be 
effective at obtaining deoxyribozymes with the desired sequence selectivity. 
Challenges associated with DNA-catalyzed modification of protein substrates include the 
accessibility by a deoxyribozyme to the reacting residue on a structured protein, where both are 
large biomolecules, and whether the peptide segment on the protein surface can adopt a 
conformation that allows its DNA-catalyzed modification. If both of these challenges can be 
overcome, then another major practical challenge is to achieve catalysis at low protein 
concentrations. In the previous chapter, the selection approach using an unanchored azido-
peptide substrate led to a DNA enzyme with peptide Km value of ~100 µM. However, that 
approach is not applicable to all DNA-catalyzed reactions. For modification reactions that use a 
DNA-anchored peptide substrate during selection, obtaining deoxyribozymes with poor peptide 
Km values can be a serious concern and limitation.  
3.1.2 Recruiting DNA Enzymes to Their Substrates by Noncovalent Interactions 
We sought to develop a strategy to recruit a deoxyribozyme to its substrate for DNA-
catalyzed peptide or protein modification. The increase of local concentration around the DNA 
enzyme in this manner can compensate the poor interaction of the DNA enzyme with the 
substrate or boost the catalytic activity at low substrate concentrations. Two strategies were 
evaluated for their ability to recruit DNA enzymes: the protein-aptamer binding interaction and 
the histidine-metal-NTA complex formation.  
Protein-binding DNA aptamers are identified via SELEX (systematic evolution of ligands 
by exponential enrichment) and selectively bind to their target proteins.7,8 The selectivity allows 
them to detect their targets in complex samples. Vinkenborg et al. reported the use of DNA 
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aptamers for affinity protein labeling.9 By functionalizing the 5-end of a DNA aptamer with a 
phenyl azide crosslinking group and a biotin group, the DNA aptamer recognized its target 
protein and covalently linked to that protein upon UV irradiation. The biotin group enabled 
affinity enrichment of the aptamer-protein conjugate by streptavidin beads (Figure 3.1A). The 
large surface area of a DNA aptamer can also mask a specific region of the corresponding 
protein surface and prevent that protein’s interaction with other biomolecules. Rohrbach et al. 
created a photocleavable protein cage by modifying a thrombin-binding aptamer with a 
photocleavable tether that had a reactive sulfo-NHS ester at the end.10 Upon binding of the caged 
aptamer to thrombin, the lysine residues on the protein surface reacted with the sulfo-NHS ester 
group and covalently linked the aptamer to the protien. The linkage was cleaved by UV 
irradiation, thereby releasing the aptamer from the protein and exposing the thrombin exosite 
(Figure 3.1B). Both studies utilized the affinity of a DNA aptamer to direct a reactive group to a 
protein surface for non-enzymatic, proximity-driven protein tagging and modification. 
 
Figure 3.1. Aptamer-based approaches to direct a reactive group to the protein target. (A) 
Aptamer-based affinity protein labeling by Vinkenborg et al. The aptamer is modified at the 5-
end with a photocrosslinking group and a biotin for protein tagging.9 (B) A photocleavable cage 
for thrombin developed by Rohrbach et al. The linker has a photosensitive nitrobenzyl group that 
can be cleaved upon UV irradiation. The sulfo-NHS ester group at the end of the tether allows 
the conjugation reaction with the lysine side chain on the protein surface.10 Images reprinted with 
permission from refs. 9 and 10.   
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Hexahistidine (His6) tags are often fused with recombinant proteins for post-expression 
purification by affinity chromatography. The metal-mediated interaction between a His6 tag and 
a nitrilotriacetic acid (NTA) group allows the His6-tagged proteins to bind to the metal ion-NTA 
resin (metal ion = Co2+, Ni2+, Cu2+, Zn2+, etc.) during the purification process.11-13 This 
interaction has also been used to enable site-specific protein modification reactions.14,15 Rosen et 
al. reported the use of a tris(NTA)-modified DNA oligonucleotide as the template to direct a 
NHS-ester-modified DNA oligonucleotide to a specific region on a protein surface.15 Subsequent 
non-enzymatic, DNA-templated reaction with a lysine residue led to site-specific conjugation of 
the DNA strand to the protein (Figure 3.2). 
   
Figure 3.2. The histidine recruiting strategy reported by Rosen et al. for DNA-templated site-
specific conjugation of a DNA oligonucleotide to a His6-tagged or natively metal-binding 
protein.15 The purple groups in the protein crystal structure depict the surface-exposed lysine side 
chains on the protein. Figure reprinted with permission from ref. 15. 
3.2 Results and Discussion 
3.2.1 Evaluation of the 8XJ105 Deoxyribozyme with Protein Substrates 
The selection approach of using an unanchored peptide substrate led to the identification 
of several deoxyribozymes that are catalytically active with free peptide substrates.5 Among 
those DNA enzymes, 8XJ105 is highly tolerant of different amino acids flanking the tyrosine 
(Tyr) residue. Therefore, 8XJ105 was evaluated for its catalytic ability with natively folded 
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protein substrates. bovine -chymotrypsinogen A (25.6 kDa) and Chicken egg white lysozyme 
(14.3 kDa) were selected as the proof-of-concept protein substrates for 8XJ105 because they 
possess multiple surface-exposed Tyr residues.16-19 In single-turnover assays where 0.4 pmol 
(20 nM) of 3-32P-radiolabeled 5′-pppRNA was the limiting reagent and the protein substrate was 
presented in large excess (0.5 or 1 mM), ~25% yield of the protein-RNA conjugation products 
were observed in SDS-PAGE, migrating slower than the radiolabeled 5′-pppRNA substrate 
(Figure 3.3). Further analysis of the product is difficult because only a very small fraction of the 
protein is modified. 
 
Figure 3.3. Assays of the 8XJ105 deoxyribozyme with protein substrates. Assay conditions: 
20 nM 3-32P-radiolabeled 5′-pppRNA, 0.5 µM 8XJ105 deoxyribozyme, 1 µM helper DNA 
oligonucleotide, 70 mM HEPES, pH 7.5, 0.5 mM (-chymotrypsinogen A) or 1 mM (lysozyme) 
protein, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl at 37 °C for 30 s, 2 h, 
and 16 h. The gel image was obtained by a PhosphorImager. S = substrate (5′-pppRNA); P = 
product (protein-RNA conjugate). 
The 8XJ105 deoxyribozyme required high protein concentration for catalysis due to its 
poor interaction with the substrate (peptide apparent Km value >1 mM for its parent peptide 
substrate, AYA). This practical limitation prevented further studies and applications of 8XJ105, 
which nevertheless is an ideal model for developing methods to recruit DNA enzymes for protein 
modification reactions.  
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3.2.2 Recruiting Deoxyribozymes by DNA Aptamers 
We sought to evaluate whether a DNA aptamer can be used to recruit a deoxyribozyme to 
its substrate for DNA-catalyzed protein side chain modification reactions. A DNA aptamer can 
be easily ligated to a DNA enzyme at either end with an oligonucleotide linker of appropriate 
length. Thrombin was chosen as the model protein for this assessment because several DNA and 
RNA aptamers for thrombin have been identified with well-characterized structure information 
for the binding sites.7,8,20-23 Two previously identified thrombin-binding DNA aptamers were 
chosen as the recruiting aptamers for the DNA enzyme. The thrombin aptamer TBA, which will 
be referred to as Apt15, is a 15-mer DNA aptamer that binds to exosite I of thrombin,7,20,21 while 
HD22-29, which will be referred to as Apt29, is a 29-mer DNA aptamer that binds to exosite II 
of thrombin.8,22 The crystal structures for the complexes of thrombin-Apt15 and thrombin-Apt27 
(where Apt27 is Apt29 without the first and last nucleotides) are shown in Figure 3.4A.  
 
Figure 3.4. Relative position of the four surface-exposed Tyr residues to the two thrombin-
binding aptamers. (A) Crystal structures of the thrombin-Apt15 complex (PDB entry: 4DIH) and 
the thrombin-Apt27 complex (PDB entry: 4I7Y). Apt27 is the Apt29 aptamer without the first 
and last nucleotides; therefore, these two aptamers have the same duplex-quadruplex structure 
and bind similarly to thrombin. The four Tyr residues shown on the protein are four of the many 
surface-exposed Tyr of thrombin. (B) Peptide sequence tolerance of 8XJ105. The four thrombin-
related peptide segments are located on the thrombin surface indicated in panel A. 8XJ105 is 
highly tolerant of different amino acids flanking the Tyr residue. Panel B adapted with 
permission from ref. 5. 
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Either of the two DNA aptamers were connected to the 8XJ105 deoxyribozyme at either 
the 3- or the 5-end by a long (A15) or short (A5) oligonucleotide linker. 8XJ105 was chosen 
because it is a peptide-sequence-general deoxyribozyme. Assays of 8XJ105 with four thrombin-
related Tyr-containing peptides led to similar yields relative to the parent AYA peptide (Figure 
3.4B). In addition, DNA-catalyzed peptide-RNA conjugation allows straightforward analysis by 
PAGE-shift using a 3-32P-radiolabeled 5′-pppRNA substrate. The long and short oligonucleotide 
linkers were designed to provide the DNA enzyme with different accessibilities to different Tyr 
residues on the protein surface. Assays of all eight aptamer-8XJ105 conjugates with the AYA 
peptide showed that including either one of the DNA aptamers and either one of the linkers did 
not decrease the yield of peptide-RNA conjugation (data not shown).      
Filter-binding assays were performed to determine the Kd values of the DNA aptamers as 
well as the aptamer-deoxyribozyme conjugates. A double-filter method was applied in the 
experiments by placing a nylon membrane below the conventionally used nitrocellulose 
membrane.24 A solution containing thrombin and the 5-32P-radiolabeled DNA was incubated in 
appropriate binding conditions and filtered through the two membranes. Because the protein 
binds to the nitrocellulose membrane, the protein-bound DNA will also remain on the 
nitrocellulose membrane. The rest of the unbound DNA will bind to the nylon membrane below. 
The radioactivity on the membranes was quantified by a PhosphorImager. The percentages of the 
bound DNA relative to the total DNA were calculated and plotted versus the protein 
concentrations to determine the dissociation constant. 
Filter-binding assays of Apt15 and Apt29 in their reported binding conditions resulted in 
Kd values of >1 µM and 66 nM, respectively (Figure 3.5). These values were >10 and 10
2-fold 
higher than the reported 100 nM and 0.5 nM.7,8,22 In addition, only 10% of the total 5-32P-
radiolabeled Apt15 was bound to the thrombin even at 10 µM thrombin. It is unclear why the 
reported Kd values cannot be reproduced here. Nevertheless, Apt29 exhibited substantial binding 
to thrombin at 100 nM thrombin, which can still be effective for recruiting 8XJ105 to thrombin. 
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Therefore, Apt29 and the Apt29-8XJ105 conjugates were used for further optimizations and 
evaluations. 
 
Figure 3.5. Determination of Kd values of Apt15 and Apt29 by filter-binding assays. Binding 
conditions for Apt15: 1 nM of 5-32P-radiolabeled Apt15, 2 µM of an 18-mer blocking DNA, 
0.2–10000 nM thrombin, 20 mM HEPES, pH 7.4, 2 mM CaCl2, 150 mM NaCl, and 0.1% BSA 
at 37 °C for 30 min. Binding conditions for Apt29: 1 nM of 5-32P-radiolabeled Apt15, 2 µM of 
an 18-mer blocking DNA, 0.05–10000 nM thrombin, 50 mM Tris, pH 7.5, 1 mM MgCl2, and 
100 mM NaCl at 37 °C for 30 min. 
The thrombin-binding abilities of the Apt29 aptamer and the Apt29-8XJ105 conjugates 
were tested in DNA-catalyzed reaction conditions (70 mM HEPES, pH 7.5, 40 mM Mg2+, 
20 mM Mn2+, 1 mM Zn2+, and 150 mM Na+). Under such high concentrations of divalent metal 
ions, filter-binding assays revealed high background retention of the 5-32P-radiolabeled DNA on 
the nitrocellulose membrane even without the protein (data not shown). We systematically 
reduced the metal ion concentrations and experimentally determined two sets of alternative 
conditions (70 mM Tris or HEPES, pH 7.5, 1 mM Mg2+, 5 or 1 mM Mn2+, 0.3 mM Zn2+, and 
150 mM Na+), in which the DNA enzyme was still substantially active with the AYA peptide 
substrate. Filter-binding assays in those two conditions showed reduced or no background 
retention of the 5-32P-radiolabeled DNA. However, severe nonspecific binding was observed in 
negative controls with only 8XJ105 or an arbitrarily chosen 18-mer DNA oligonucleotide 
(Figure 3.6). Nonspecific binding was also observed for 8XJ105 in the control conditions at 
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1 µM thrombin without Mn2+ and Zn2+. Higher concentration of Na+ (1 M) or adding a long 
blocking DNA oligonucleotide [(AAC)20] did not prevent nonspecific binding to thrombin. The 
binding of the Apt29-8XJ105 conjugates to thrombin was not verified due to nonspecific binding, 
which may be caused by Mn2+ and Zn2+, or the 8XJ105 portion of the conjugates. Furthermore, 
no conjugation product was observed in SDS-PAGE for assays of Apt29-8XJ105 conjugates 
with thrombin (data not shown). In conclusion, for the case evaluated here (one deoxyribozyme 
with one protein substrate), joining a DNA aptamer unit to a deoxyribozyme did not lead to 
DNA-catalyzed modification of a protein substrate.  
 
Figure 3.6. Thrombin binding of Apt29 and the Apt29-8XJ105 conjugates in control conditions 
and the two alternative conditions where the Apt29-8XJ105 conjugates are catalytically active. 
The 5-32P-radiolabeled DNA was incubated with 0, 30, 300, or 1000 nM thrombin in conditions 
as described in the figure at 37 °C for 30 min. For the Apt25-A15-8XJ105 conjugate, the DNA 
aptamer was connected to the 5-end of the 8XJ105 deoxyribozyme with a A15 linker. For 
8XJ105-A15-Apt29, the DNA aptamer was connected to the 3-end of the 8XJ105 
deoxyribozyme with a A15 linker. Nonspecific binding was observed for 8XJ105 and an 18-mer 
DNA oligonucleotide.  
Many difficulties were met during the development of the aptamer recruiting strategy. 
The conditions for aptamer binding and the DNA-catalyzed reaction are very different. Therefore, 
it is difficult to determine suitable conditions in which both the recruiting unit and the catalytic 
unit function well. Attachment of a deoxyribozyme (a long and structured DNA oligonucleotide) 
may also perturb the binding behavior of a DNA aptamer. Furthermore, the use of a DNA 
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aptamer as the recruiting unit for DNA-catalyzed protein modification may not be ideal because 
one needs to first develop a suitable DNA aptamer for every target protein before utilizing this 
recruiting approach. These concerns stymied our pursuit for aptamer-directed DNA catalysis for 
existing DNA enzymes. However, the designed approach here, which is to attach a DNA 
aptamer to an existing deoxyribozyme, is different from an independent approach used by other 
lab members to incorporate a DNA aptamer into selection experiments. The latter involves first 
identifying a suitable DNA aptamer for the DNA enzyme selection conditions and then selecting 
for the catalytic DNA sequences that function well with the protein substrate in the presence of 
the DNA aptamer. These other experiments are currently underway.   
3.2.3 Recruiting Deoxyribozymes by Histidine Tags 
The histidine recruiting approach was evaluated experimentally for directing a DNA 
enzyme to its substrate.25 Analogous to the approach used in Rosen et al. (Figure 3.7A), we used 
a tris(NTA)-modified DNA anchor oligonucleotide. The DNA anchor forms Watson-Crick base 
pairs with the fixed-sequence binding arm of the deoxyribozyme. Therefore, recruiting the DNA 
anchor to the peptide or protein substrate also recruits the DNA enzyme (Figure 3.7B). However, 
unlike the non-enzymatic, strictly proximity-driven approach of Figure 3.7A, the tris(NTA)-
modified DNA anchor in Figure 3.7B only recruits the DNA enzyme. The subsequent 
modification reaction still requires enzymatic catalysis by the deoxyribozyme. Two peptide-
sequence-general deoxyribozymes, 8XJ105 and 6CF134, were used in this study. 8XJ105 is a 
peptide–RNA-conjugating deoxyribozyme, and 6CF134 is a Tyr kinase deoxyribozyme.5,26  
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Figure 3.7. The recruiting strategy using a histidine tag, divalent metal ions (M2+ ions), and a 
tris(NTA)-modified DNA oligonucleotide. (A) The reported strategy of recruiting a 
functionalized DNA oligonucleotide to His6-tagged proteins or natively metal-binding proteins 
for non-enzymatic, DNA-templated reaction of protein side chains.15 (B) As evaluated here, the 
potential strategy of recruiting a DNA enzyme to its peptide or protein substrate for DNA-
catalyzed modification of peptide or protein side chains. X = the amino acid side chain; Y-Z = 
the reaction partner for the protein. Figure reprinted with permission from ref. 25. 
A tris(NTA)-modified DNA anchor oligonucleotide was synthesized with the tris(NTA) 
moiety at either the 3-end or 5-end. The 3-tris(NTA) moiety was connected to the DNA by a 
hexa(ethylene glycol) spacer, whereas the 5-tris(NTA) moiety was connected to the DNA via a 
T15 oligonucleotide linker. The synthetic procedure was adapted from Goodman et al.
27 A 3- or 
5-tris(amino)-modified DNA oligonucleotide was treated with SPDP [N-succinimidyl 3-(2-
pyridyldithio)propionate] to incorporate the three 2-pyridyldithio groups, which were 
subsequently reduced to the thiol groups. The three NTA groups were attached to the DNA 
oligonucleotide by conjugation of a maleimido-C3-NTA to each of the thiol groups on the DNA 
oligonucleotide (structure shown in Figure 3.8A). MALDI mass spectrometry confirmed the 
identity of the tris(NTA)-modified DNA anchor oligonucleotides (Figure 3.8B). 
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Figure 3.8. Identity of the tris(NTA)-modified DNA oligonucleotide. (A) The structure of the 
tris(NTA) moiety. The two linkages marked with dashes were created during the multistep 
synthesis of the tris(NTA)-modified oligonucleotides. (B) Mass spectra of the 3- and 5-
tris(NTA)-modified DNA anchor used in peptide-RNA conjugation reaction. The spectrum of 
the 3-tris(NTA)-modified DNA anchor used in Tyr phosphorylation reaction is not shown here. 
Nevertheless, the identity of that DNA anchor was also confirmed by mass spectrometry: 
[M+H]+ calcd. 7343.7, found 7343.3 (Δ = –0.005%). Figure adapted with permission from ref. 
25. 
3.2.3.1 Recruiting 8XJ105 for Peptide-RNA Conjugation 
The 8XJ105 deoxyribozyme catalyzes the conjugation of a discrete, unanchored Tyr-
containing peptide to a RNA oligonucleotide, but 8XJ105 requires high peptide concentration for 
catalysis. We sought to use a histidine tag to recruit 8XJ105 for DNA-catalyzed peptide-RNA 
conjugation. A N-terminal His6-tagged peptide was used as the substrate. The intention is that the 
His6 tag and the tris(NTA) group on the DNA anchor will bind to the metal ions (M
2+) at the 
same time, thereby recruiting 8XJ105 to the peptide substrate (Figure 3.9). This recruiting effect 
is expected to reduce the required peptide concentration and increase the reaction yield of 
peptide-RNA conjugation.  
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Figure 3.9. Design of the histidine recruiting strategy in the context of DNA-catalyzed peptide-
RNA conjugation. An N-terminal His6-tagged peptide was used as the substrate for 8XJ105, a 
peptide–RNA-conjugating deoxyribozyme. The His6 tag interacts with the tris(NTA) moiety in 
the presence of divalent metal ions (Co2+, Ni2+, Cu2+, or Zn2+). The tris(NTA) group is connected 
to the 3-end of the DNA anchor by a HEG [hexa(ethylene glycol)] tether or to the 5-end by a 
T15 oligonucleotide linker. The tris(NTA)-modified DNA anchor is Watson-Crick base-paired to 
the fixed-sequence binding arm of 8XJ105. Figure adapted with permission from ref. 25. 
Three His6-tagged peptides of different lengths, which are 11-mer, 18-mer, and 24-mer, 
were first tested with 8XJ105 in control experiments without the His6/M
2+/tris(NTA) interaction. 
These experiments are important to establish the conditions and substrates with which the 
recruiting effect will be evaluated. 8XJ105 requires 1 mM Zn2+ (as well as 40 mM Mg2+ and 
20 mM Mn2+) for catalysis. Therefore, a DNA anchor oligonucleotide lacking the tris(NTA) 
group was used in control experiments to remove the recruiting interaction. Severe inhibition of 
peptide-RNA conjugation yield was observed when 8XJ105 was tested with the 11-mer peptide 
substrate (2% yield in 16 h at 10 or 30 µM peptide and <0.5% yield at >100 µM peptide). The 
Zn2+ present in the solution led to peptide aggregation by interaction with the His6 tag, which 
constitutes more than half of the 11-mer peptide. This aggregation was visible by eye as a white 
precipitate at 1 mM peptide. Reduced inhibition was observed when the two longer 18-mer and 
24-mer peptides were used. 8XJ105 had 7% and 11% yield in 16 h, respectively, with the 18-mer 
and 24-mer at 100 µM peptide, although inhibition was still observed at higher concentrations 
(>100 µM peptide). Nevertheless, the 11% yield of the His6 24-mer at 100 µM peptide can be 
compared with the 5% yield observed with a non-His6 24-mer peptide at the same concentration 
(Figure 3.10), indicating that the Zn2+-His6 tag interaction did not affect the conjugation yield at 
100 µM peptide for the His6-tagged 24-mer. Since the non-His6 24-mer peptide does not bear a 
polyhistidine segment, the inhibition of 8XJ105 activity was observed only at very high peptide 
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concentrations (>2 mM). The two 24-mers were used in further experiments to evaluate the 
histidine recruiting strategy for DNA enzymes. 
  
Figure 3.10. Control experiments using a DNA anchor oligonucleotide without the tris(NTA) 
moiety. Conditions: 20 nM 3-32P-radiolabeled 5-pppRNA, 0.5 µM 8XJ105 deoxyribozyme, 
2 µM DNA anchor oligonucleotide, 1–5000 µM peptide, 70 mM HEPES, pH 7.5, 40 mM 
MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl at room temperature for 16 h. Data for 
the His6 24-mer are shown as mean ± SD (N = 4); for the data with the other peptides, N = 1. 
Figure adapted with permission from ref. 25. 
Because Zn2+ is a required metal ion cofactor for 8XJ105, the Zn2+-mediated interaction 
between the His6 24-mer peptide and the tris(NTA)-modified DNA anchor will always be 
present in the experiments. We additionally tested the recruiting effect of three other third-row 
divalent metal ions, Co2+, Ni2+, and Cu2+, as they have been commonly used (as well as Zn2+) in 
Immobilized-Metal Affinity Chromatography (IMAC) for applications such as protein 
purification.11-13 10 µM of one of the three metal ions (Co2+, Ni2+, and Cu2+) was included in the 
reaction solution containing 8XJ105, 3-32P-radiolabeled 5-pppRNA, the DNA anchor, the His6 
24-mer peptide, and the other metal ion cofactors (Mg2+, Mn2+, and Zn2+). Inclusion of the 3-
tris(NTA) moiety but with no extra M2+ (Co2+, Ni2+, or Cu2+) added led to a 2.1-fold yield 
increase in 16 h (from 11% to 23%) relative to the non-tris(NTA) control at 100 µM peptide 
(Figure 3.11A). No additional effect was observed for the addition of 10 µM Co2+ and Ni2+. In 
contrast, the extra 10 µM Cu2+ led to 6.4-fold increase in yield (6.9% to 44%) relative to the 
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control at 30 µM peptide. A yield of 31% was observed for the non-His6 24-mer peptide, albeit 
only at 30-fold higher peptide concentration. For the 5-tris(NTA)-modified DNA anchor, the 
recruiting effect resulted in a 2.8-fold yield increase (from 11% to 30%) relative to the non-
tris(NTA) control at 100 µM peptide, but no additional benefit arose by including any of Co2+, 
Ni2+, or Cu2+ (Figure 3.11B). The results showed that the interaction of His6 tag/M
2+/tris(NTA) 
group successfully recruited 8XJ105 to the peptide substrate and enhanced the catalytic activity 
of 8XJ105 at low peptide concentrations. For the experiments using 3-tris(NTA)-modified DNA 
anchor, Cu2+ was most effective among the evaluated metal ions, consistent with its tightest 
binding in metal complexes.28 
 
Figure 3.11. Evaluation of histidine tag recruiting for 8XJ105. Conditions: 20 nM 3-32P-
radiolabeled 5-pppRNA, 0.5 µM 8XJ105 deoxyribozyme, 2 µM DNA anchor oligonucleotide, 
1–5000 µM peptide, 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, one 
of 10 µM CoCl2, NiCl2, or Cu(NO3)2, and 150 mM NaCl at room temperature. CuCl2 gave 
equivalent outcome. (A) The recruiting effect of the 3-tris(NTA)-modified DNA anchor. Data 
for 10 µM Cu2+ are shown as mean ± SD (N = 3–5). Data for the control using the His6 24-mer 
are shown as mean ± SD (N = 4). The PAGE image represents the peptide-RNA conjugation of 
8XJ105 at 30 µM peptide with 10 µM Cu2+. S = substrate; P = product. (B) The recruiting effect 
of the 5-tris(NTA)-modified DNA anchor. Figure adapted with permission from ref. 25. 
When the concentration of the 3-tris(NTA)-modified DNA anchor was 2 µM, such that 
the metal-binding capacity is 6 µM, the Cu2+ concentration was optimal at 10 µM for 8XJ105 to 
achieve high yield at low peptide concentrations (Figure3.12A). As an important control 
experiment, 10 µM Cu2+ did not increase the conjugation yield in the absence of the 3-tris(NTA) 
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moiety, indicating that all three components [the His6 tag, Cu
2+, and the tris(NTA) group] are 
required for the enhancement of the catalytic activity. The substantial recruiting effect with Cu2+ 
was also confirmed by assessing the rate of DNA-catalyzed peptide-RNA conjugation (Figure 
3.12B). The kobs values observed using the His6 24-mer peptide substrate with and without the 3-
tris(NTA) group were obtained from initial-rate kinetics. Although generic inhibition of activity 
at >100 µM peptide was observed, the result again showed a strong recruiting effect, with a 
peptide Km value of 14 µM. Comparing the data for the His6-tagged 24-mer and the untagged 
non-His6 24-mer indicates >70-fold decrease in Km value due to recruiting. 
 
Figure 3.12. Evaluating histidine tag recruiting for 8XJ105 using Cu2+ as the recruiting metal 
ion. The assay conditions were the same as in Figure 3.11 (A) Optimization of Cu2+ 
concentration. (B) Determination of peptide Km values using initial-rate kinetics. For the 3-
tris(NTA) anchor with Cu2+, the fitted peptide Km value was 14 ± 1 µM. For the control 
experiment with the His6 24-mer, Km = 82 ± 75 µM (this value is not necessarily interpretable 
due to the large error; Km is likely to be >>80 µM). For the control using the non-His6 24-mer, 
Km = 579 ± 57 µM (the 5 mM data point was omitted from the fit; Km is likely to be >1 mM). 
Data for the initial-rate kinetics with 10 µM Cu2+ and the control experiment with the His6 24-
mer are shown as mean ± SD (N = 3); in the latter case, the error bars are smaller than the data 
points. For the control using non-His6 24-mer, N = 1. Figure reprinted with permission from ref. 
25. 
Protein substrates were also tested with 8XJ105 using the histidine recruiting approach to 
determine whether this noncovalent interaction can enable DNA-catalyzed protein-RNA 
conjugation at low protein concentrations. Two His6-tagged proteins (human lysozyme and 
human plasminogen activator inhibitor 1 [PAI-1]) and one natively metal-binding protein 
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(porcine carboxypeptidase B) were chosen as the substrates. The 8XJ105 deoxyribozyme was 
incubated with the 3-32P-radiolabeled 5-pppRNA, either the 3- or 5-tris(NTA)-modified DNA 
anchor, the protein substrate, Cu2+, and the required metal ion cofactors (Mg2+, Mn2+, and Zn2+). 
Unfortunately, no protein-RNA conjugation product was observed in all cases by SDS-PAGE 
(Figure 3.13).  
 
Figure 3.13. SDS-PAGE assays of 8XJ105 with protein substrates to assess the histidine 
recruiting strategy. The three protein substrates were His6-tagged human lysozyme (lysozyme, 
15.2 kDa), His6-tagged human plasminogen activator inhibitor 1 (PAI-1, 45 kDa) and porcine 
carboxypeptidase B (carboxypeptidase, 34.5 kDa). std = 5-pppRNA. The location of the 
tris(NTA) moiety is shown. The concentrations of the protein substrate and Cu2+ are shown in 
µM. For the required metal ion cofactors (M2+), either high (40 mM Mg2+, 20 mM Mn2+, and 
1 mM Zn2+) or low (1 mM Mg2+, 5 mM Mn2+, and 0.5 mM Zn2+) metal ion concentrations were 
used. The incubation conditions were labeled as follows: 1 = room temperature, 30 s; 2 = room 
temperature, 16 h; 3 = 4 °C, 16 h. On each gel, a non-radiolabeled protein ladder is not shown. 
This ladder was loaded to calibrate our expectation of the position of the product band. Figure 
reprinted with permission from ref. 25.  
The enhanced catalytic activity of 8XJ105 by the recruiting approach did not transfer 
well to the three protein substrates tested here. Although histidine tag recruiting can direct the 
deoxyribozyme to its substrate, access by the DNA enzyme to the amino acid residues on a 
structured protein surface may still be restricted regardless of the histidine tag recruiting. The 
result with protein substrates may be due to the limitations of the individual deoxyribozyme or 
the structures of the chosen proteins.    
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3.2.3.2 Recruiting 6CF134 for Tyr Phosphorylation 
The histidine recruiting strategy was also evaluated for DNA-catalyzed Tyr 
phosphorylation (kinase activity). The peptide-sequence-general 6CF134 kinase deoxyribozyme 
was identified by Shannon Walsh using 5-pppRNA as the phosphoryl donor.26 6CF134 catalyzes 
the phosphorylation of a short Tyr-containing hexapeptide that is covalently tethered to a DNA 
anchor (~50% yield in 16 h at room temperature; figure 3.14A). However, the DNA enzyme is 
not catalytically active with a discrete, unanchored peptide. We sought to replace the covalent 
tether between the peptide substrate and the DNA anchor with the noncovalent interaction 
among the histidine tag, Cu2+, and tris(NTA), thereby enabling DNA-catalyzed Tyr 
phosphorylation of an unanchored peptide substrate.  
The peptide substrates (the same His6 and non-His6 24-mer peptides used in the 8XJ105-
catalyzed peptide-RNA conjugation reaction) were the limiting reagents in the experiments using 
the 6CF134 deoxyribozyme for Tyr phosphorylation. The materials were at much higher 
concentrations than those used in assays with 8XJ105 to enable peptide product characterization 
by MALDI mass spectrometry. The inclusion of the 3-tris(NTA) group on the DNA anchor led 
to 88% conversion of the phosphorylated peptide with 100 µM Cu2+ at 30 µM peptide (Figure 
3.14B). Negative controls omitting one of 3-tris(NTA), Cu2+, or the 5-pppRNA phosphoryl 
donor, or when the non-His6 24-mer peptide was used, led to little or no phosphorylation. 
Therefore, the noncovalent interaction among the His6 tag, Cu
2+, and tris(NTA) successfully 
recruited the 6CF134 deoxyribozyme to the peptide substrate and enabled, for the first time, 
DNA-catalyzed Tyr phosphorylation of an untethered peptide substrate. 
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Figure 3.14. The 6CF134 Tyr kinase deoxyribozyme and the histidine recruiting strategy for 
DNA-catalyzed Tyr phosphorylation. (A) DNA-catalyzed Tyr phosphorylation of a DNA-
anchored peptide by 6CF134. Assay conditions: 20 nM 5-32P-radiolabeled DNA-anchored 
CAAYAA peptide, 0.5 μM 6CF134 deoxyribozyme, 5 μM 5-pppRNA, 70 mM HEPES, pH 7.5, 
40 mM MgCl2, 20 mM MnCl2, 0.5 mM ZnCl2, and 150 mM NaCl at room temperature (t = 30 s, 
30 min, 2 h, 5 h, and 16 h; Y = substrate, YP = product). (B) MALDI mass spectrometry analysis 
of the histidine recruiting effect for 6CF134. Conditions: 30 µM peptide, 30 µM DNA anchor 
oligonucleotide, 35 µM 6CF134 deoxyribozyme, 40 µM 5-pppRNA, 70 mM HEPES, pH 7.5, 40 
mM MgCl2, 20 mM MnCl2, 2 mM ZnCl2, 150 mM NaCl, and 100 µM Cu(NO3)2 at room 
temperature for 20 h. A negative control omitting the 3-tris(NTA) is shown with 0.9% 
conversion of the product. Not shown are negative controls omitting one of Cu2+ (0.3% 
conversion) or the 5-pppRNA phosphoryl donor (<0.05% conversion), or when the non-His6 24-
mer peptide was used (0.09% conversion). Figure reprinted with permission from ref. 25. 
The 6CF134 deoxyribozyme was also tested with the two His6-tagged proteins in the 
presence of Cu2+ and the 3-tris(NTA)-modified DNA anchor. 10 or 30 µM protein was used in 
these experiments with 50 or 100 µM Cu2+. After incubation, the sample was denatured, reduced, 
and digested with trypsin. No phosphorylation product was observed in each of the MALDI mass 
spectra of the tryptic fragments (Figure 3.15). Even though 6CF134 was capable of catalyzing 
the phosphorylation of an untethered peptide with the assistance of the histidine recruiting 
strategy, the experiment with His6-tagged protein substrates was unsuccessful. The results with 
8XJ105 and 6CF134 showed that the recruiting strategy cannot lead to DNA-catalyzed covalent 
modification of the three (or two for 6CF134) protein substrates examined here. As mentioned 
previously, if the DNA enzyme cannot physically access the amino acid side chain or if the 
peptide segment on a folded protein cannot adopt the conformation suitable for catalysis, then 
merely recruiting the DNA enzyme to the substrate may not overcome the problem.  
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Figure 3.15. Representative trypsin/MALDI mass spectrometry assays of 6CF134 with the two 
protein substrates, His6 human lysozyme (15.2 kDa) and His6 human plasminogen activator 
inhibitor 1 (PAI-1; 45 kDa). Tryptic fragments were assigned with confidence in 5 of 6 instances 
for lysozyme and 2 of 5 instances for PAI-1. In each of these cases, no phosphorylation product 
peak was observed. Figure reprinted with permission from ref. 25. 
3.3 Summary  
One of the major challenges for DNA-catalyzed covalent modification of peptide and 
protein substrates is to achieve catalysis at low substrate concentrations. The selection approach 
using unanchored peptide substrates allows imposition of concentration pressure during in vitro 
selection, thereby leading to a deoxyribozyme with peptide Km of ~100 µM. However, that 
approach is not applicable to all DNA-catalyzed reactions. Here, we sought to develop an 
alternative strategy that recruits deoxyribozymes to their substrates for DNA-catalyzed 
modification of peptides or proteins. We evaluated the use of either DNA aptamers or histidine 
tags to recruit DNA enzymes.  
The 8XJ105 deoxyribozyme was connected to either of the two thrombin-binding DNA 
aptamers. The intention was to utilize the DNA aptamer’s affinity to thrombin to recruit 8XJ105 
for DNA-catalyzed protein-RNA conjugation. However, the binding of the aptamer-8XJ105 
conjugates to thrombin could not be verified by filter-binding assays due to nonspecific binding, 
likely caused by the presence of Mn2+ and Zn2+. In addition, no conjugation product was 
observed in SDS-PAGE of assays with aptamer-8XJ105 conjugates and thrombin. The metal 
ions required for catalysis as well as the addition of a large, structured DNA enzyme may affect 
the binding of the DNA aptamer to its target protein. Furthermore, this recruiting strategy 
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requires the identification of a suitable DNA aptamer (if none has yet been found) for every 
protein target before any application. Therefore, attaching a DNA aptamer to an existing DNA 
enzyme as the recruiting unit may not be an ideal approach.  
The use of a His6 tag successfully recruited 8XJ105 for DNA-catalyzed peptide-RNA 
conjugation. The interaction among the His6 tag, metal ions, and the tris(NTA) moiety led to 
enhanced conjugation yields and rates at low peptide concentrations. Among the tested metal 
ions, Cu2+ was most effective. The recruiting effect was reflected in the improved peptide Km 
value of 8XJ105. In addition, the His6/Cu
2+/tris(NTA) interaction successfully recruited 6CF134 
and enabled, for the first time, DNA-catalyzed Tyr phosphorylation of a discrete, untethered 
peptide substrate. However, where tested, DNA-catalyzed protein modification using the 
histidine recruiting strategy was not observed. Achieving DNA-catalyzed modification of 
proteins faces additional challenges, even with the benefit of histidine tag recruiting. 
Nevertheless, for DNA enzymes that do function well with protein substrates, the histidine 
recruiting strategy should enhance their catalytic activity at lower protein concentrations. The 
recruiting may also allow site-selective modification of particular surface-exposed residues, 
based on the geometric relationship among the tris(NTA) recruiting site, the recruited 
deoxyribozyme, and the side chains themselves. The experiments performed here provide a 
promising framework for future pursuit of DNA-catalyzed covalent modification of protein 
substrates.  
3.4 Materials and Methods 
3.4.1 Synthesis of Peptide Substrates 
Short peptides (fewer than seven amino acids) were synthesized as described in Chapter 
2. Long peptides (11-, 18-, and 24-mer) were prepared using Fmoc Rink amide MBHA resin on 
a Liberty Automated Microwave Peptide Synthesizer (CEM Corporation) using the instrument’s 
standard wash procedures. Each synthesis was performed at 0.1 mmol scale. For each Fmoc 
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deprotection step, 20% piperidine in DMF with 0.1 M HOBt was used at 30 W of microwave 
power and 75 °C for 3 min. Each coupling used 5 equivalents (2.5 mL of 0.2 M in DMF, 0.5 
mmol) of Fmoc-amino acid, 5 equivalents (1 mL of 0.5 M in DMF, 0.5 mmol) of HCTU 
(N,N,N′,N′-tetramethyl-O-(1H-6-chlorobenzotriazol-1-yl)uronium hexafluorophosphate), and 10 
equivalents (0.5 mL of 2 M in N-methylpyrrolidone, 1 mmol) of DIPEA (N,N-
diisopropylethylamine). All amino acid monomers except Arg and His were coupled twice at 20 
W and 75 °C for 5 min. For Arg, to reduce -lactam formation, the first coupling was performed 
without microwave power at room temperature for 25 min, followed by 25 W at 75 °C for 5 min; 
the second coupling was performed at 20 W and 75 °C for 5 min. For His, to reduce 
racemization, both couplings were performed without microwave power at room temperature for 
2 min followed by 25 W at 50 °C for 4 min. After each coupling step as well as the final Fmoc 
deprotection step, capping was performed using 7 mL of 0.5 M acetic anhydride and 0.125 M 
DIPEA in DMF at 40 W and 65 °C for 2 min. The peptide was cleaved from the solid support by 
stirring the resin in a separate vial with a solution containing 5 mL of trifluoroacetic acid (TFA), 
125 μL of water, and 50 μL of triisopropylsilane for 90 min. The liquid solution was separated 
from the resin by filtration. This solution was dried on a rotary evaporator, providing an oily 
solid. To this material was added 20 mL of cold diethyl ether, and the peptide was obtained as a 
white solid that was filtered and purified by HPLC.  
3.4.2 Synthesis of Oligonucleotides and Oligonucleotide-tris(NTA) Conjugates 
DNA oligonucleotides, 5′-triphosphorylated RNA oligonucleotides (5′-pppRNA) and 3-
32P-radiolabeled 5′-pppRNA were prepared as described in Chapter 2.  
Procedure for synthesis of tris(NTA)-modified DNA anchor. DNA oligonucleotides with 
three primary amino groups at the 3′-end or 5′-end were synthesized using the Uni-Link Amino 
Modifier (Clontech). The procedure for incorporating tris(NTA) was adapted from Goodman et 
al.27 A 50 μL sample containing 10 nmol of tris(amino)-modified DNA oligonucleotide in 100 
mM sodium phosphate buffer, pH 7.5, 100 mM NaCl, and 25 mM SPDP [N-succinimidyl 3-(2-
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pyridylthio)propionate, Fisher cat no. P121857] was incubated at room temperature for 1 h. The 
SPDP was added from a freshly prepared 100 mM stock in DMF. A Micro Bio-Spin P-6 
desalting column was washed with 100 mM sodium phosphate buffer, pH 7.5, and used to 
remove excess SPDP from the sample. The eluted sample was treated with 6.3 μL of 100 mM 
TCEP [tris(carboxyethyl)phosphine hydrochloride, Chem-Impex] and incubated at room 
temperature for 30 min. Excess TCEP was removed with another desalting column. The eluted 
sample was treated with 7 μL of 100 mM maleimido-C3-NTA (Dojindo cat. no. M035-10), 1 μL 
of 1 M sodium phosphate buffer, pH 7.5, and 2.5 μL of 3 M NaCl, and the sample was incubated 
at room temperature for 1 h. The sample was purified by 20% PAGE. The product was extracted 
from the gel in 10 mM Tris, pH 8.0, and 300 mM NaCl (no EDTA) and precipitated with 
ethanol. Typical yield after gel extraction and precipitation was 20–30%. The product was 
analyzed by mass spectrometry on a Bruker UltrafleXtreme MALDI-TOF mass spectrometer 
with matrix 3-hydroxypicolinic acid in positive ion mode.  
3.4.3 Oligonucleotide Sequences 
Sequences of oligonucleotides used in assay procedures are listed in Table 3.1. All 
sequences are written 5 to 3 and are DNA unless indicated explicitly as RNA (the two 5-
pppRNA substrates). The helper DNA oligonucleotide binds to the fixed-sequence binding arm 
of 8XJ105, as described in Chapter 2. For the 8XJ105 and 6CF134 deoxyribozymes, the 
underlined nucleotides are the initially random regions (N40 for 8XJ105 and N30 for 6CF134); the 
non-underlined nucleotides are the binding arms. For the decoy DNA for assays of 8XJ105, the 
underlined nucleotides are complementary to the initially random (N40) region of 8XJ105; the 
non-underlined nucleotides are complementary to the flanking sequences of the binding arms. 
HEG is the hexa(ethylene glycol) spacer provided as Spacer 18 (Glen Research). X is the Uni-
Link Amino Modifier (Clontech). 
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Table 3.1. Oligonucleotide sequences. 
oligonucleotide purpose oligonucleotide sequence 
 
DNA aptamer recruiting approach 
Apt15 DNA aptamer GGTTGGTGTGGTTGG 
Apt29 DNA aptamer AGTCCGTGGTAGGGCAGGTTGGGGTGACT 
blocking oligo used in binding assays CGAAGTCGCCATCTCTTC 
helper DNA for 8XJ105 (AAC)7GGACTACCTTTATGCGTAT 
 
histidine recruiting approach for DNA-catalyzed peptide-nucleic acid conjugation 
8XJ105 deoxyribozyme CCCGAAAGCCTCCTTCGGGAGATGTCTCTCAGACGGAAACTTTCAGTACGGAATGG 
ATACGCATAAAGGTAG 
3-tris(NTA) anchor DNA CTACCTTTATGCGTAT-HEG-XXX 
5-tris(NTA) anchor DNA XXXTTTTTTTTTTTTTTTCTACCTTTATGCGTAT 
control anchor DNA AACAACAACAACAACAACAACGGACTACCTTTATGCGTAT 
5-pppRNA substrate GGAAGGAGGCUUUCGGG 
decoy DNA for assays of 8XJ105 TTATGCGTATCCATTCCGTACTGAAAGTTTCCGTCTGAGAGACATCTCCCGAAGGAGGCT 
 
histidine recruiting approach for DNA-catalyzed Tyr phosphorylation 
6CF134 deoxyribozyme GAAGCGCTAGAACATGGGGACAGGCAGCTCCACCGATGGGCACCGATAGTGAGTCGTATT 
3-tris(NTA) anchor DNA TAATACGACTCACTAT-HEG-XXX 
control anchor DNA GGATAATACGACTCACTAT 
5-pppRNA substrate GAUGUUCUAGCGCUUCG 
  
3.4.4 Filter Binding Assay Procedure 
Binding conditions A: 20 mM HEPES, pH 7.4, 2 mM CaCl2, 150 mM NaCl, and 0.1% BSA 
Binding conditions B: 50 mM Tris, pH 7.5, 1 mM MgCl2, and 100 mM NaCl 
Binding conditions C: 70 mM Tris, pH 7.5, 1 mM MgCl2, 5 mM MnCl2, 0.3 mM ZnCl2, and 
150 mM NaCl 
Binding conditions D: 70 mM HEPES, pH 7.5, 1 mM MgCl2, 1 mM MnCl2, 0.3 mM ZnCl2, and 
150 mM NaCl 
Human -thrombin was obtained from Haematologic Technologies Inc. (cat. no. HCT-
0020, 36.7 kDa). A serial dilution of thrombin from a 50 µM stock solution was performed to 
freshly prepare the 5 thrombin solutions. A 50 µL sample containing 1 nM of the 5-32P-
radiolabeled aptamer or one of the aptamer-8XJ105 conjugates, 2 µM of an 18-mer blocking 
DNA oligonucleotide, and 0–10 µM thrombin (added from the 5 solutions) was incubated in 
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one of the binding conditions described above. The sample was incubated at 37 °C for 30 min. 
The 0.45 m nitrocellulose (Amersham Protran Premium, GE Healthcare) and 0.45 µm nylon 
(Nytran SuPerCharge, GE Healthcare) membranes were first soaked for 30 min in the same 
binding conditions as the samples. The membranes were assembled in a spot-blot apparatus 
(Manifold I spot-blot system, GE Healthcare), containing from top to bottom, wet blotting paper, 
the nitrocellulose membrane, the nylon membrane, and wet blotting paper. Each sample was 
applied to a spot on the apparatus and filtered through the membranes by a vacuum pump. After 
the sample was passed through, the membranes were washed with 3 µL of the binding 
buffer. The membranes were air-dried, and the radioactivity was quantified by a 
PhosphorImager.  
3.4.5 Single-Turnover Assay Procedures 
3.4.5.1 General Assay Procedure  
The general single-turnover assay procedure was followed in assays of 8XJ105 or 
aptamer-8XJ105 conjugates with the peptide or protein substrates. Chicken egg white lysozyme 
and bovine -chymotrypsinogen A were obtained from Sigma-Aldrich (cat. no. L6876 and 
C4879, 14.3 and 25.7 kDa). A 10 µL sample containing 0.4 pmol of 3-32P-radiolabeled 5-
pppRNA substrate, 10 pmol of 8XJ105 or one of the aptamer-8XJ105 conjugates, and 20 pmol 
of the helper DNA oligonucleotide was annealed in 5 mM HEPES or Tris, pH 7.5, 15 mM NaCl 
by heating at 95 °C for 1 min and cooling on ice for 5 min. The peptide or protein conjugation 
reaction was initiated by bringing the sample to 20 µL total volume of 70 mM HEPES or Tris, 
pH 7.5, one of 1 mM peptide, 0.5 mM protein, or 1 mM protein, MgCl2/MnCl2/ZnCl2 as 
appropriate, and 150 mM NaCl. The sample was incubated at 37 °C, and aliquots were quenched 
at appropriate times. 10 pmol of a decoy oligonucleotide was added to each aliquot before PAGE, 
to displace the deoxyribozyme from the substrate and product. Samples were separated by 20% 
PAGE (for peptide substrates) or SDS-PAGE (for protein substrates, 12–18% depending on the 
protein size) and quantified with a PhosphorImager.  
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3.4.5.2 Assay Procedures with Histidine Tag Recruiting 
Peptide-nucleic acid conjugation by 8XJ105. A 5 μL sample containing 20 pmol of DNA 
anchor oligonucleotide [with or without 3-tris(NTA) as appropriate], one of 100 pmol of Co2+, 
100 pmol of Ni2+, or 60–5000 pmol of Cu2+ if applicable, and the peptide substrate was 
incubated in 50 mM HEPES, pH 7.5, and 150 mM NaCl at room temperature for 1 h (this 
preincubation step was later determined to be dispensable). The reaction was initiated by 
bringing the sample to 10 μL total volume containing 20 nM 3-32P-radiolabeled 5-pppRNA, 0.5 
μM 8XJ105 deoxyribozyme, 2 μM DNA anchor oligonucleotide, 1–5000 μM peptide, 70 mM 
HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl. For Co
2+ or 
Ni2+ as the recruiting metal ion, the final concentration was 10 μM; for Cu2+, 6–500 μM. The 
sample was incubated at room temperature, and aliquots were quenched at appropriate times. To 
each aliquot before PAGE was added 10 pmol of a decoy oligonucleotide to displace the 
deoxyribozyme from the substrate and product. Samples were separated by 20% PAGE and 
quantified with a PhosphorImager. 
Tyr phosphorylation by 6CF134. The assay of Figure 3.14A was performed as 
described.26 The assays of Figure 3.14B were performed as follows. A 5 μL sample containing 
300 pmol of DNA anchor oligonucleotide [with or without 3-tris(NTA) as appropriate], 1 nmol 
of Cu(NO3)2, and 300 pmol of the His6-tagged 24-mer peptide substrate was incubated in 50 mM 
HEPES, pH 7.5, and 150 mM NaCl at room temperature for 1 h (this preincubation step was later 
determined to be dispensable). The reaction was initiated by bringing the sample to 10 μL total 
volume containing 30 μM His6-tagged 24-mer peptide, 30 μM DNA anchor oligonucleotide, 
35 μM 6CF134 deoxyribozyme, 40 μM unradiolabeled 5-pppRNA, 70 mM HEPES, pH 7.5, 
40 mM MgCl2, 20 mM MnCl2, 2 mM ZnCl2, 150 mM NaCl, and 100 μM Cu(NO3)2. The sample 
was incubated at room temperature for 20 h, immediately desalted by Millipore C18 ZipTip, and 
analyzed by MALDI mass spectrometry. Data were acquired on a Bruker UltrafleXtreme 
MALDI-TOF mass spectrometer with matrix 2,5-dihydroxybenzoic acid in positive ion mode. 
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Assays of 8XJ105 with protein substrates. His6-lysozyme was from US Biological (cat. 
no. 155733, 15.2 kDa). His6-plasminogen activator inhibitor 1 (PAI-1) was from US Biological 
(cat. no. 170035, 45 kDa). Carboxypeptidase B, which natively binds metal ions, was from 
Worthington Biochemical Corporation (cat. no. LS005305, 34.5 kDa). A 5 µL sample containing 
20 pmol of 3- or 5-tris(NTA) DNA anchor oligonucleotide, 100–3000 pmol of Cu(NO3)2, and 
100–1000 pmol of protein substrate was incubated in 50 mM HEPES, pH 7.5, 150 mM NaCl, 
and 0.04% (v/v) Tween-20 at room temperature for 1 h. The reaction was initiated by bringing 
the sample to 10 µL total volume containing 20 nM 3-32P-radiolabeled 5-pppRNA, 0.5 µM 
8XJ105 deoxyribozyme, 2 µM 3- or 5-tris(NTA) DNA anchor oligonucleotide, 10–100 µM 
protein, 70 mM HEPES, pH 7.5, 1 or 40 mM MgCl2, 5 or 20 mM MnCl2, 0.5 or 1 mM ZnCl2, 
150 mM NaCl, 10–300 µM Cu(NO3)2, and 0.02% (v/v) Tween-20. The sample was incubated at 
room temperature for 16 h. In all three cases, 16% Tris-Tricine SDS-PAGE revealed no 
detectable product formation (<0.5%). 
Assays of 6CF134 with protein substrates. The 6CF134 deoxyribozyme was assayed with 
each of lysozyme and PAI-1 as potential substrates. A 5 µL sample containing 150 or 300 pmol 
of 3-tris(NTA) DNA anchor oligonucleotide, 500 or 1000 pmol of Cu(NO3)2, and 100 or 
300 pmol of protein substrate was incubated in 50 mM HEPES, pH 7.5, and 150 mM NaCl at 
room temperature for 1 h. The reaction was initiated by bringing the sample to 10 µL total 
volume containing 10 or 30 µM protein, 15 or 30 µM 3-tris(NTA) DNA anchor oligonucleotide, 
20 or 35 µM 6CF134 deoxyribozyme, 25 or 40 µM unradiolabeled 5-pppRNA, 70 mM HEPES, 
pH 7.5, 40 mM MgCl2, 0 or 20 mM MnCl2, 0.5 or 2 mM ZnCl2, 150 mM NaCl, and 50 or 100 
µM Cu(NO3)2. The sample was incubated at room temperature for 20 or 48 h. Trypsin digestion 
was performed to prepare the sample for mass spectrometry. The sample was reduced and 
denatured by adding 10 µL of 6 M urea in 100 mM Tris-HCl, pH 8.0, and 1 µL of 250 mM DTT 
and incubating the sample at 37 °C for 1 h. To block cysteine residues, 1 µL of 350 mM 
iodoacetamide was added, and the sample was incubated at room temperature in the dark for 30 
min. The trypsin digestion reaction was initiated by adding 60 µL of 50 mM Tris-HCl, pH 8.0, 
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and 1 µL of 100 ng/µL sequencing-grade trypsin (Promega, cat. no. V511). The sample was 
incubated at 37 °C for 16 h, immediately desalted by Millipore C18 ZipTip, and analyzed by 
MALDI mass spectrometry. Data were acquired on a Bruker UltrafleXtreme MALDI-TOF mass 
spectrometer with matrix 2,5-dihydroxybenzoic acid in positive ion mode. Peptide fragments 
were calculated using ExPASy. No phosphorylation products peaks were observed for all 
identifiable Tyr-containing peptide fragments (Figure 3.15). 
3.4.6 Data Analysis of Km Plots 
Initial-rate kinetics data for Figure 3.12 were obtained by fitting the initial linear portion 
of plots (yield versus time up to 2 h) to a straight line. The peptide Km values were determined by 
fitting the data to kobs = kmax•[C
n/(Km
n+Cn)]•[1Cm/(Kim+Cm)], where C is the peptide 
concentration, kmax is the kobs at saturating peptide concentration, Km is the Km value for 
productive peptide binding, Ki is the inhibition constant for unproductive peptide binding, and 
n and m are Hill coefficients for productive and unproductive peptide binding, respectively. The 
Km value for the non-His6 24-mer was determined by fitting the data to kobs = kmax•[C
n/(Km
n+Cn)]. 
Curve fit values were as follows. For the 3-tris(NTA) anchor with Cu2+, Km = 14 ± 1 µM, 
Ki = 124 ± 8 µM, n = 2.6 ± 0.4, and m = 3.2 ± 0.5. For the control experiment with the His6 24-
mer, Km = 82 ± 75 µM, Ki = 218 ± 68 µM, n = 1.6 ± 0.6, and m = 3.3 ± 1.0 (these values are not 
necessarily interpretable due to the large errors; Km is likely to be >>80 µM). For the control 
using non-His6 24-mer, Km = 579 ± 57 µM and n = 1.5 ± 0.2 (the 5 mM data point was omitted 
from the fit; Km is likely to be >1 mM). 
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Chapter 4: Efforts Toward DNA-Catalyzed Lysine Methylation† 
4.1 Introduction 
4.1.1 DNA-Catalyzed Lysine Side Chain Modification 
Deoxyribozymes have been identified for several modification reactions of tyrosine (Tyr) 
or serine (Ser) side chains.1-5 In contrast, the identification of DNA enzymes capable of 
modifying Lys side chains has been a challenge. The unprotonated amino group on the lysine 
(Lys) side chain is comparable in nucleophilicity to the deprotonated hydroxyl group of the Tyr 
side chain and many orders of magnitude more nucleophilic than the nondeprotonated hydroxyl 
group of the Ser side chain; both of these considerations suggest that Lys should be rather 
reactive. However, in vitro selection experiments with Lys-containing substrates in a 
preorganized three-helix-junction architecture using 5′-pppRNA as the electrophile did not lead 
to DNA-catalyzed Lys modification, but instead led to deoxyribozymes that catalyze the 
formation of an unusual pyrophosphoramidate linkage.6 This result along with other studies in 
our lab established the relative unreactivity of Lys as a substrate for DNA enzymes.  
Nevertheless, DNA-catalyzed covalent modification of a Lys side chain was achieved by 
Ben Brandsen using a DNA-anchored Lys-containing peptide substrate and a 5′-Imp electrophile, 
which is more reactive than 5′-ppp (Figure 4.1A).7 This study provided important fundamental 
information for the pursuit of DNA enzymes that catalyze biologically relevant modification 
reactions of Lys residues, such as methylation and acylation. These modification reactions 
involve the nucleophilic attack of a Lys amino group on an electrophilic methyl or acyl donor 
(Figure 4.1B).  
                                                            
†  University of Illinois graduate student Cong Zhou synthesized ImdUTP and University of 
Illinois graduate student Shannon M. Walsh synthesized TrpdUTP and BndUTP. 
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Figure 4.1. (A) DNA-catalyzed Lys side chain modification. A DNA-anchored CKA peptide 
and 5′-ImpDNA were used, respectively, as the nucleophile and electrophile in the selection 
experiments.7 (B) Lys methylation and acylation. Lys methylation is a nucleophilic reaction of a 
Lys amino group on the carbon atom of the methyl group on S-adenosyl-L-methionine (SAM). 
Lys acylation is a nucleophilic reaction of a Lys amino group on the carbonyl group of an acyl-
CoA.  
4.1.2 DNA Enzymes for Lysine Methylation  
Lys methylation is an important protein post-translational modification and is well known 
in histone modification for regulating gene expression.8-12 Each methylation site can be either 
mono-, di-, or trimethylated, further extending the complexity of this modification. Lys 
methylation is also found in non-histone proteins.13,14 Methylation near the C-terminus of the p53 
protein regulates protein stability, protein-protein interactions, and transactivation activity.13 In 
nature, Lys methylation is catalyzed by Lys methyltransferases to transfer a methyl group from 
the S-adenosyl-L-methionine (SAM) cofactor to the amino group on a Lys side chain.  
Approaches to site-specifically methylate Lys in proteins are important for understanding 
the biological processes regulated by such a modification. Proteins containing a methyllysine 
residue can be prepared by semisynthesis,15 amber codon suppression,16 and the dehydroalanine 
alkylation method.17 However, each method has its own limitations which are mentioned in 
Chapter 1. Peptide-sequence-selective deoxyribozymes have been identified for various peptide 
side chain modification reactions.5,18 DNA enzymes that are capable of methylating a Lys 
residue on a protein substrate with high sequence selectivity will be very useful for biochemical 
research. 
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4.1.3 Synthetic SAM Analogs for Methyltransferases  
When the methyl group of the SAM cofactor is replaced by an ethyl or propyl group, the 
catalytic rate of transferring the extended group by a methyltransferase is greatly reduced due to 
the steric hindrance of the transition state caused by the -carbon. Nevertheless, when the 
extended group has a double or triple bond at the -carbon, the catalytic activity of alkyl transfer 
is restored by hyperconjugative stabilization of the transition state by the unsaturated -carbon.19 
SAM analogs of this kind with various functional groups on the extended chains (Figure 4.2A) 
are very useful for applications such as methyltransferase substrate profiling and labeling.20-23 
For example, a SAM analog with a pent-2-en-4-ynyl group was used to label the histone H3 
protein (Figure 4.2B).21 The terminal alkyne was conjugated via CuAAC reaction with an azide-
containing reporter group for protein labeling.  
 
Figure 4.2. (A) Structures of synthetic SAM analogs used by methyltransferases. (B) A two-step 
labeling method to label the histone H3 protein by synthetic SAM analogs and a 
methyltransferase.21 Image in panel B reprinted with permission from ref. 21.  
4.1.4 In Vitro Selection Strategy for DNA-Catalyzed Lysine Methylation 
We sought to use synthetic SAM analogs in selection experiments for identifying Lys-
methylating deoxyribozymes. Two SAM analogs with alkyne-containing chains, EnYn-SAM 
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and Yn-SAM, were chosen as the alkyl donors (Figure 4.3). DNA-anchored amines, for example, 
a DNA-anchored Lys-containing peptide, were used as the nucleophilic substrates. A DNA-
anchored substrate is ligated to the DNA pool. During the selection step, the alkyl group is 
transferred to the DNA-anchored substrate by the catalytically active sequences, which can then 
be separated by the subsequent CuAAC capture step using an azido-modified capture DNA. The 
intention is that the identified Lys-alkylating deoxyribozymes will also catalyze the methylation 
of a Lys side chain using the unmodified SAM. EnYn-SAM is more reactive than Yn-SAM due 
to the additional activation of the -carbon by the unsaturated -carbon. However, 
deoxyribozymes that utilize the more reactive EnYn-SAM may not be catalytically active with 
the unmodified SAM for methyl transfer, whereas the DNA enzymes identified from the 
selection experiments using the less reactive Yn-SAM are more likely to transfer a methyl group 
using SAM. Therefore, both SAM analogs were investigated in the selection experiments.   
 
Figure 4.3. In vitro selection strategy using synthetic SAM analogs for DNA-catalyzed Lys 
methylation. Two SAM analogs, EnYn-SAM and Yn-SAM, were used in the selection design. 
The terminal alkyne was used for the CuAAC reaction after selection step to capture the 
catalytically active DNA sequences by attaching a capture DNA oligonucleotide.  
Another potential application for the deoxyribozymes identified from this selection 
strategy is site-specific protein conjugation. Current chemical approaches for protein conjugation 
reactions at Lys residues generally lack site specificity.24 Peptide-sequence-selective Lys-
alkylating DNA enzymes will be able to introduce an alkyne-containing chain at a specific Lys 
residue, thereby allowing further conjugation via CuAAC chemistry to attach potentially any 
molecule (such as a dye, drug, or biomolecule). 
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4.2 Results and Discussion 
4.2.1 Synthesis of EnYn-SAM and Yn-SAM 
A general approach for synthesizing SAM analogs is by chemoselective S-alkylation of 
adenosyl-L-homocysteine (AdoHcy) with activated alcohols, such as mesylates or triflates, under 
mildly acidic conditions. Since other potential nucleophiles are protonated under such conditions, 
alkylation occurs selectively at the sulfur atom. The reaction yields a mixture of (S)- and (R)-
epimers, which can be separated by HPLC with extensive effort.25  
The syntheses of EnYn-SAM and Yn-SAM were performed using the approach describe 
above. However, HPLC purification after synthesis was performed merely to separate the 
products (as a mixture of both epimers) from the reactants. Further separation of the (S)- and (R)-
epimers was not necessary at this stage because DNA enzymes should be able to use either one 
as the alkyl donor in selection experiments, although individual deoxyribozymes are likely to 
prefer one over the other epimer. The synthesis of EnYn-SAM started by activating the hydroxyl 
group of (E)-pent-2-en-4-yn-1-ol with methanesulfonyl chloride (MsCl) to form an allylic 
mesylate, which was then added to a mildly acidic solution of AdoHcy to form EnYn-SAM 
(Figure 4.4A). For the synthesis of Yn-SAM, pent-4-yn-1-ol was activated by 
trifluoromethanesulfonic anhydride (Tf2O) to form an alkyl triflate, which was added to a mildly 
acidic solution of AdoHcy to form Yn-SAM (Figure 4.4B). The yields were 60% and 20% for 
EnYn-SAM and Yn-SAM, respectively. ESI mass spectrometry confirmed the identity of both 
EnYn-SAM and Yn-SAM.  
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Figure 4.4. Synthesis of SAM analogs for Lys methylation selection experiments. (A) Synthesis 
of EnYn-SAM. (E)-pent-2-en-4-yn-1-ol was first activated by MsCl under basic conditions in 
CH2Cl2. The resulting allylic mesylate was added to a solution containing AdoHcy in a 1:1 
mixture of formic and acetic acid and stirred at room temperature overnight. The yield of EnYn-
SAM was 60% as a ~1:1 mixture of both epimers. (B) Synthesis of Yn-SAM. The alcohol was 
first activated by Tf2O under basic conditions in CH2Cl2. The alkyl triflate was added to a 
solution containing AdoHcy in a 1:1 mixture of formic and acetic acid and stirred at room 
temperature for 2 h. The yield of Yn-SAM was 20% as a ~1:1 mixture of both epimers. 
4.2.2 Stability Assessment of EnYn-SAM and Yn-SAM 
The stability of the two SAM analogs was assessed in different divalent metal ion 
combinations, pH values, and incubation temperatures. These experiments were important to 
determine the suitable incubation conditions in which the selection experiments will be 
performed. Three carbons, each  to the sulfur atom, are activated by the positive charge and 
thus are susceptible to hydrolysis and nucleophilic reactions. For EnYn-SAM, the -carbon on 
the extended chain is even more reactive relative to the other two -carbons due to further 
activation by the neighboring double bond. To evaluate stability, solutions containing 100 µM of 
either EnYn-SAM or Yn-SAM were incubated in various conditions and analyzed by HPLC. 
Assays with various combinations of 40 mM Mg2+, 20 mM Mn2+, and 1 mM Zn2+ at 
50mM HEPES, pH 7.5 for 1 h showed that neither of the divalent metal ions decreased the 
stability of EnYn-SAM (Figure 4.5A). The effect of metal ions on Yn-SAM’s stability was not 
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tested; however, since EnYn-SAM is the more reactive SAM analog, a similar conclusion can be 
inferred. Both SAM analogs were less stable at higher pH as well as higher incubation 
temperature. At room temperature, EnYn-SAM had half-life of ~16 h, 1–2 h, and <1 h at pH 6.0, 
7.5, and 9.0, respectively (Figure 4.5B). At 37 °C, half-life of EnYn-SAM decreased at all three 
pH values. In contrast, Yn-SAM was much more stable than EnYn-SAM. At room temperature, 
Yn-SAM had half-life of ≥16 h at pH 7.5 and 9.0. At 37 °C, the half-life of Yn-SAM decreased 
to 2–16 h and ~2 h at pH 7.5 and 9.0, respectively. In summary, divalent metal ions such as 
Mg2+, Mn2+, and Zn2+ can be included in selection experiments without compromising the 
stability of the two SAM analogs. However, pH values and temperatures for selection 
experiments must be considered carefully to maintain sufficient stability of the chosen SAM 
analog. While determining the pH values for selection experiments, the reactivity of the amine 
nucleophile at those pH values should also be considered. In opposition to the stability of SAM 
analogs, the reactivity of an amine nucleophile is higher at higher pH values. For an initial set of 
selection experiments, three pH values (6.0, 7.5, and 9.0) were investigated in experiments using 
EnYn-SAM and two pH values (7.5 and 9.0) in experiments using Yn-SAM. All selection 
experiments were performed at room temperature. All three divalent metal ions (Mg2+, Mn2+, and 
Zn2+) were included in selection experiments performed at pH 6.0 and 7.5. For experiments at 
pH 9.0, Mn2+ and Zn2+ were not included due to oxidation or precipitation, respectively.  
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Figure 4.5. Evaluating the stability of the two SAM analogs. (A) Evaluating EnYn-SAM 
stability in various divalent metal ion combinations. Conditions: 50 mM (− Zn2+) or 70 mM 
(+ Zn2+) HEPES, pH 7.5, 100 µM EnYn-SAM, any combination of 40 mM MgCl2, 20 mM 
MnCl2, and 1 mM ZnCl2 as appropriate at room temperature or 37 °C for 1 h. (B) Evaluating 
EnYn-SAM or Yn-SAM stability in different pH values and temperatures. Conditions: 70 mM 
MES (pH 6.0), 70 mM HEPES (pH 7.50), or 50 mM CHES (pH 9.0), 100 µM EnYn-SAM or 
Yn-SAM, 40 mM MgCl2, 20 mM MnCl2, and 1 mM ZnCl2 at room temperature or 37 °C for 1, 
2, or 16 h. Timepoints not tested are marked as daggers. 
4.2.3 In Vitro Selection Experiments for DNA-Catalyzed Lysine Methylation 
In vitro selection experiments were designed to identify DNA enzymes that catalyze Lys 
methylation. An amine substrate (e.g., a CAAKAA hexapeptide) was presented to the DNA pool 
tethered to a DNA anchor oligonucleotide, which was Watson-Crick base-paired to one of the 
fixed-sequence binding arms of the DNA pool (Figure 4.6). First, the DNA-anchored peptide 
was ligated to the random N40 DNA pool. The selection step was performed by incubating the 
ligation product with a SAM analog and divalent metal ions. To separate the catalytically active 
DNA sequences that were modified with an alkyne group after the selection step, the CuAAC 
capture reaction was performed using a 5′-azido-modified capture DNA oligonucleotide to add 
extra mass, thereby enabling PAGE separation of the catalytically active sequences. In some of 
the selection rounds, the capture product was treated with DTT to cleave the disulfide bond 
connecting the anchor DNA oligonucleotide and the peptide. If the alkyne-containing chain is 
transferred not to the hexapeptide but instead to any other potential nucleophile on the DNA 
molecule, then the DTT treatment will only lead to a small PAGE shift due to loss of the 
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hexapeptide. In contrast, if the alkyne-containing chain is transferred to the hexapeptide, then the 
DTT treatment will cleave the hexapeptide, which is connected to the capture DNA 
oligonucleotide, resulting in a much greater PAGE shift. This additional DTT/PAGE operation 
will remove any catalytic DNA sequence that transfers the akyne-containing group to an 
undesired nucleophile. Finally, PCR was performed to amplify the surviving DNA sequences. 
The entire process was iterated, each round enriching the population of catalytically active DNA 
sequences until they dominated the population. 
 
Figure 4.6. In vitro selection procedure for identifying Lys-alkylating deoxyribozymes. A Lys-
containing peptide is depicted here as the nucleophilic amine substrate. A DNA-anchored 
CAAKAA peptide was ligated to the initially random DNA pool. The ligation product was 
incubated with the SAM analog (depicted here with EnYn-SAM). CuAAC capture was 
performed to add mass to the alkylated peptide connected to the catalytically active DNA 
sequences. DTT treatment of the capture sample was performed at some selection rounds to 
cleave the disulfide linkage between the capture DNA-peptide conjugate and the DNA anchor. 
The surviving DNA sequences were PCR-amplified. PAGE purification was performed between 
each step except not between the selection and capture step, where ethanol precipitation was 
performed instead. The selection process was iterated until the catalytically active DNA 
sequence dominated the population. 
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A capture standard was synthesized to mimic the selection product, which has a pent-2-
en-4-ynyl or pent-4-ynyl side chain on the Lys residue (Figure 4.7A). Propargylglycine (Pag) 
was used to mimic the alkyne-modified Lys. A CAAPagAA peptide was synthesized and 
conjugated to an anchor DNA oligonucleotide. CuAAC capture reactions using the DNA-
anchored CAA-Pag-AA capture standard at 37 °C for 2 h led to 52% yield with a short (16-mer) 
5′-azido-modified capture DNA and 44% yield with a long (52-mer) 5′-azido-modified capture 
DNA (Figure 4.7B). No capture product was observed for a negative control experiment using 
the DNA-anchored CAAKAA peptide substrate. This result verified that the CuAAC reaction 
can selectively capture the alkyne-modified peptide substrate and therefore is suitable for the 
selection experiments.  
 
Figure 4.7. Verification of the CuAAC capture reaction with a capture standard. (A) Structures 
of the selection products and a capture standard. (B) CuAAC capture with DNA-anchored 
CAAPagAA and DNA-anchored CAAKAA. Conditions: 0.2 µM 5′-32P-radiolabeled DNA pool 
containing a DNA-anchored CAAPagAA or CAAKAA, 1.25 µM DNA splint, 2.5 µM 5′-azido-
modified capture DNA, 50 mM HEPES, pH 7.5, 150 mM NaCl, 2.8 mM THPTA, 0.8 mM 
sodium ascorbate, and 0.4 mM CuSO4 at room temperature or 37 °C. 
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Nine selection experiments were designed as an initial set for the identification of Lys-
alkylating deoxyribozymes (Figure 4.8). All selection experiments used an initially random N40 
region and were incubated at room temperature during the selection step. The selection 
experiments investigated the two SAM analogs (EnYn-SAM and Yn-SAM), two amine 
nucleophiles with different tether lengths, and three different pH values. In addition to a DNA-
anchored CAAKAA peptide substrate, a DNA-anchored cysteamine substrate was also used in 
some of the selection experiments as an amine-containing small-molecule substrate instead of a 
peptide substrate. The CAAKAA peptide was loosely tethered to the anchor DNA by a HEG 
[hexa(ethylene glycol)] linker, whereas cysteamine was tightly connected to the anchor DNA by 
a short C3 linker. Each of the four combinations of two SAM analogs and two amine 
nucleophiles was incubated in either of the two incubation conditions, which are pH 7.5 with 
Mg2+/Mn2+/Zn2+ and pH 9.0 with Mg2+, leading to eight distinct selection experiments. For the 
ninth selection experiment, EnYn-SAM and the DNA-anchored cysteamine substrate were 
incubated at pH 6.0 with Mg2+/Mn2+/Zn2+.  
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Figure 4.8. In vitro selection design for Lys-alkylating deoxyribozymes (YA1–YJ1). All 
selection steps were incubated at room temperature. EnYn-SAM or Yn-SAM was used as the 
alkyl donor. A C3-tethered cysteamine or a HEG-tethered CAAKAA hexapeptide was used as 
the nucleophile. For YA1 and YF1–YJ1, the incubation time was 14 h; for YB1–YE1, the 
incubation time was 2 h. Neither Mn2+ nor Zn2+ was included in selection experiments at pH 9.0 
due to oxidation or precipitation, respectively. 
No activity was observed for all selection experiments after 14 rounds. Several factors 
could contribute to the unsuccessful outcome of these selection experiments. For example, 
despite the high reactivity of EnYn-SAM, its instability at pH 7.5 and 9.0 may be detrimental to 
the selection experiments. At pH 6.0, where EnYn-SAM was sufficiently stable, the amine 
nucleophile may not be reactive enough for the nucleophilic reaction. Furthermore, unlike 5′-
ImpDNA, which was bound to the binding arm of the deoxyribozyme by preprogramed Watson-
Crick base pairing interactions, SAM analogs must be bound by the catalytically active DNA 
sequences for catalysis, providing another challenge for achieving DNA-catalyzed Lys 
methylation. Therefore, a second set of selection experiments was designed, incorporating 
modified nucleotides with protein-like functional groups to assist catalysis and the binding to the 
SAM analogs. 
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4.2.4 Incorporating Modified Nucleotides in Selection Experiments for Lysine Methylation 
Modified nucleotides with protein-like functional groups have been incorporated into 
deoxyribozymes to expand the scope of DNA-catalyzed reactions. Other lab members, Cong 
Zhou et al., showed that incorporating either modified AmdU, COOHdU, or HOdU in place of 
unmodified dT in selection experiments led to DNA enzymes capable of hydrolyzing an aliphatic 
amide bond (Figure 4.9).26 In addition, modified nucleotides with hydrophobic moieties such as 
TrpdU and BndU have been included in DNA aptamers for enhanced affinity to their protein 
substrates.27 Therefore, we included modified nucleotides in the selection experiments for DNA-
catalyzed Lys methylation. Other than the five modified dU mentioned above, ImdU was also 
included, given that the imidazole modification resembling the histidine residue may also be 
useful to the DNA enzymes.   
 
Figure 4.9. Structures of modified nucleotides used in the selection experiments for DNA-
catalyzed Lys methylation.  
To initiate selection experiments, DNA pools containing modified nucleotides were 
synthesized either by solid-phase synthesis or enzymatic primer extension as appropriate. If the 
phosphoramidite of a modified dU is commercially available, then solid-phase synthesis is 
preferred because primer extension still requires the synthesis of a reverse-complement pool. For 
AmdU-, HOdU-, and COOHdU-modified pools, where modified dU phosphoramidites are 
commercially available, the DNA pools were synthesized via solid-phase syntheses. For ImdU-, 
TrpdU-, and BndU-modified pools, where the corresponding phosphoramidites are not 
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commercially available, modified dUTPs were synthesized and used in primer extension of the 
reverse-complement pools to generate the modified DNA pools. The synthesis of ImdUTP was 
performed by Cong Zhou, and the syntheses of TrpdUTP and BndUTP were performed by 
Shannon Walsh. Each DNA pool was ligated with a DNA-anchored peptide substrate, and the 
selection experiment was initiated by incubating the ligation product with a SAM analog and 
divalent metal ions. The in vitro selection procedure was modified to enable the use of modified 
nucleotides (Figure 4.10). After the capture step (or for some selection rounds, DTT treatment 
following the capture step), the surviving DNA sequences were PCR-amplified with natural 
dNTPs using KOD XL polymerase, which tolerates the modified nucleotides. The PCR sample 
was PAGE-separated, and the reverse-complement single strand was used in primer extension 
with natural dATP, dGTP, dCTP, and one of the modified dUTPs to generate the modified DNA 
pool, which was used in the subsequent selection round.  
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Figure 4.10. In vitro selection procedure with modified nucleotides. The ligation, selection, 
capture, and DTT treatment steps were the same as previously described in Figure 4.6. After the 
capture or DTT treatment step, the surviving DNA sequences, which contained modified 
nucleotides, were PCR-amplified. KOX XL polymerase, which tolerates modified nucleotides, 
was used with natural dNTPs to amplify the surviving DNA sequences. The reverse-complement 
single strand was PAGE-separated and used in the subsequent primer extension step with natural 
dATP, dGTP, dCTP, and one of the modified dUTPs to synthesize the modified DNA pool.  
Twelve selection experiments were designed using either EnYn-SAM or Yn-SAM as the 
alkyl donor, each including one of the six modified nucleotides (Figure 4.11). For all modified 
nucleotides except for TrpdU, the random N40 DNA pool contained 25% of each nucleotide (dA, 
dG, dC and one of the modified dU). Previous experiments performed by Shannon Walsh 
suggested that a pool containing 25% TrpdU had too many modified nucleotides to survive the 
amplification step. Therefore, the percentage of Trp modification in the initially random DNA 
pool was reduced to 15%. A DNA-anchored CAAKAA hexapeptide with a short C3 tether was 
used in all selection experiments. The samples were incubated at pH 7.5 with Mg2+, Mn2+, and 
Zn2+ in the selection step. For selection experiments using EnYn-SAM, the incubation was at 
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room temperature for 2 h; for selection experiments using Yn-SAM, the incubation was at 37 °C 
for 14 h.  
 
Figure 4.11. Selection experiments for DNA-catalyzed Lys methylation with modified 
nucleotides. In all selection experiments, the CAAKAA peptide was connected to the DNA 
anchor by a C3 tether. EnYn-SAM was used in the YT1–YZ1 selection experiments and Yn-
SAM was used in the ZR1–ZX1 selection experiments. The initially random DNA pool 
contained either 15% of TrpdU or 25% of one of the other modified nucleotides. All experiments 
were performed in 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 
150 mM NaCl. For YT1–YZ1 selection experiments, the samples were incubated at room 
temperature for 2 h in the selection step; for ZR1–ZX1 selection experiments, the samples were 
incubation at 37 °C for 14 h in the selection step.  
These selection experiments are currently underway. If activity is observed, individual 
deoxyribozymes will be identified and further characterized. One important characteristic of an 
individual DNA enzyme is its stereoselectivity for the SAM analog, i.e., whether the 
deoxyribozyme is selective for one of the two epimers. In addition, the identified DNA enzymes 
will be tested with the unmodified SAM to see if DNA-catalyzed Lys methylation is achieved. If 
no activity is observed, new selection experiments will be designed considering other factors, 
such as random region length or incorporating two modified nucleotides in each selection 
experiment.  
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4.3 Summary and Future Directions 
Lys methylation is an important post-translational modification involved in numerous 
biological processes. Developing DNA enzymes as tools to site-specifically methylate Lys side 
chains on protein surfaces is valuable for biochemical studies to further understand the biological 
pathways regulated by Lys methylation. In vitro selection strategy for DNA-catalyzed Lys 
methylation utilized synthetic SAM analogs with terminal alkyne-containing chains as the alkyl 
donors. The terminal alkyne enables CuAAC reaction with a 5′-azido-modified DNA to capture 
the catalytically active DNA sequences after each selection step. The identified Lys-alkylating 
deoxyribozymes are intended also to be catalytic active with the SAM itself for DNA-catalyzed 
Lys methylation. In addition, these Lys-alkylating DNA enzymes can potentially be used to site-
specifically introduce an alkyne moiety onto a protein for bioconjugation reactions.  
Two SAM analogs, EnYn-SAM and Yn-SAM, were synthesized and evaluated with 
regard to their stabilities in various incubation conditions. Inclusion of divalent metal ions did 
not affect the stability of the SAM analogs. However, both analogs were unstable at high pH and 
temperature. The more reactive EnYn-SAM was very unstable at pH 7.5 and pH 9.0, thereby 
limiting the incubation conditions in selection experiments using that analog. In contrast, Yn-
SAM was sufficiently stable for selection experiments in all tested conditions.  
An initial set of selection experiments for DNA-catalyzed Lys methylation investigated 
the two SAM analogs (EnYn-SAM and Yn-SAM), the two amine nucleophiles (a HEG-tethered 
CAAKAA peptide and a C3-tethered cysteamine), and three pH values (pH 6.0, 7.5, and 9.0). 
Unfortunately, no activity was observed for all selection experiments. It is likely that the 
selection conditions tested here did not allow DNA catalysis due to the instability of EnYn-SAM 
or the unreactivity of the amine nucleophiles. In other words, the SAM analog may be too 
unstable under conditions where the amine nucleophile was reactive enough, whereas when the 
SAM analog is sufficiently stable, the amine nucleophile may not be reactive. In addition, unlike 
the previous DNA-catalyzed Lys modification approach where the reaction partner was an 
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activated DNA oligonucleotide that was bound to the binding arm of the DNA enzyme, the SAM 
analog is a small molecule without preprogramed binding interactions with the deoxyribozyme. 
Therefore, utilizing the SAM analog as the reaction partner for DNA-catalyzed Lys modification 
may be more challenging than the oligonucleotide reaction partner for DNA enzymes.  
Ongoing efforts toward DNA-catalyzed Lys methylation use modified nucleotides that 
have protein-like functional groups, with the intention to assist catalysis as well as SAM analog 
binding. The selection experiments are currently underway using each of AmdU, ImdU, COOHdU, 
HOdU, TrpdU, and BndU modified nucleotides.  
4.4 Materials and Methods 
4.4.1 Synthesis of SAM-Analogs 
 
EnYn-SAM. The synthesis of EnYn-SAM followed the procedure in Peters et al.21 480 mg 
(12 mmol) of NaOH was suspended in 12 mL of dichloromethane (DCM). The mixture was 
cooled to 0 °C followed by the addition of 0.85 mL (d = 1.48 g/mL, 11 mmol) of 
methanesulfonyl chloride and 820 mg (10 mmol) of (E)-pent-2-en-4-yn-1-ol. The mixture was 
stirred at room temperature for 17 h and washed with saturated NaHCO3 until the aqueous layer 
was basic. The organic layer was collected and dried on a rotary evaporator to yield a yellow oil, 
which was then dissolved in a 1 mL mixture of 1:1 (v/v) formic acid and acetic acid. To the 
solution was added 10 mg (26 µmol) of S-adenosyl-L-homocysteine, and the solution was stirred 
at room temperature for 18 h. The solution was diluted with 30 mL of water and extracted with 3 
60 mL of diethylether. The aqueous solution was lyophilized and the sample was redissolved 
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in 5 mL of water. Purification of EnYn-SAM was performed by HPLC [Shimdazu Prominence 
instrument; Phenomenex Jupiter Proteo column, 4 µm, 10  250 mm; gradient of 2% acetonitrile 
and 98% aqueous trifluoroacetic acid (0.1% v/v) at 0 min to 7% acetonitrile and 93% aqueous 
trifluoroacetic acid (0.1% v/v) at 20 min, and to 70% acetonitrile and 30% aqueous 
trifluoroacetic acid (0.1% v/v) at 50 min, with flow rate of 2 mL/min]. The identity of the 
product was confirmed by ESI-MS: [M]+ calcd. 449.5, found 449.4, Δ = −0.02%. The product 
was quantified by NanoDrop (260 = 15400 M−1 cm−1).  
 
Yn-SAM. The procedure for synthesizing Yn-SAM was similar to the procedure in 
Dalhoff et al.25 Oven-dried glassware was used for the synthesis of pent-4-
ynyltrifluoromethanesulfonate. 1.26 g (12 mmol of pyridine residues) of poly(4-vinylpyridine) 
was suspended in 7.5 mL of dry DCM. The mixture was cooled to 0 °C in an ice bath followed 
by the addition of 1.85 mL (d = 1.68 g/mL, 11 mmol) of trifluoromethanesulfonic anhydride 
under argon. 0.75 mL (d = 0.904 g/mL, 8.1 mmol) of pent-4-yn-1-ol was dissolved in 5 mL of 
dry DCM and added dropwise to the stirring mixture over 20 min. The mixture was removed 
from the ice bath, stirred for another 10 min, filtered, and washed with saturated NaHCO3 until 
the aqueous layer was basic. The organic layer was collected, dried over magnesium sulfate, and 
filtered. The organic solvent was removed on a rotary evaporator. 10 mg (26 µmol) of S-
adenosyl-L-homocysteine was dissolved in a 1 mL mixture of 1:1 (v/v) formic acid and acetic 
acid and cooled to 0 °C. The 1 mL solution was transferred to the flask containing pent-4-
ynyltrifluoromethanesulfonate and stirred at room temperature for 2 h. The solution was diluted 
with 20 mL of water and extracted with 3 20 mL of diethylether. The aqueous solution was 
lyophilized and the sample was redissolved in 5 mL of water. Purification of Yn-SAM was 
134 
performed by HPLC [Shimdazu Prominence instrument; Phenomenex Jupiter Proteo column, 4 
µm, 10  250 mm; gradient of 2% acetonitrile and 98% aqueous trifluoroacetic acid (0.1% v/v) 
at 0 min to 7% acetonitrile and 93% aqueous trifluoroacetic acid (0.1% v/v) at 20 min, and to 
70% acetonitrile and 30% aqueous trifluoroacetic acid (0.1% v/v) at 50 min, with flow rate of 2 
mL/min]. The identity of the product was confirmed by ESI-MS: [M]+ calcd. 451.2, found 451.2. 
The product was quantified by NanoDrop (260 = 15400 M−1 cm−1). 
4.4.2 Synthesis of Peptide and Oligonucleotides 
Peptide substrate. The CAAKAA hexapeptide was prepared as described in Chapter 2.  
DNA-anchored substrates. DNA-anchored peptide and cysteamine conjugates were 
prepared following the procedure in Walsh et al.2 The CAAKAA peptide or cysteamine was 
connected to the anchor DNA oligonucleotide by disulfide formation between a DNA-tethered 
3′-thiol and the N-terminal cysteine side chain of CAAKAA or cysteamine. The 3′-thiol-
modified DNA oligonucleotides were synthesized as 5′-DNA-HEG-p-C3-S-S-C3-OH-3′ or 5′-
DNA-p-C3-S-S-C3-OH-3′. A 50 µL sample containing 5 nmol of 3′-disulfide-modified DNA 
anchor oligonucleotide in 100 mM HEPES, pH 7.5, and 50 mM DTT was incubated at 37 °C for 
2 h. The reduced product was precipitated to remove DTT by addition of 50 µL of water, 10 µL 
of 3 M NaCl, and 300 µL of ethanol. The precipitated product was dissolved in 35 µL of water 
and 10 µL of 100 mM triethylammonium acetate, pH 7.0. Activation as the pyridyl disulfide was 
achieved by adding 5 µL of 100 mM 2,2′-dipyridyl disulfide in DMF and incubating at 37 °C for 
2 h. The product was precipitated by addition of 50 µL of water, 10 µL of 3 M NaCl and 300 µL 
of ethanol and dissolved in 35 µL of water. Conjugation to the peptide or cysteamine was 
performed by adding 10 µL of 100 mM triethylammonium acetate, pH 7.0, 5 µL of 20 mM 
peptide or 1 µL of 100 mM cysteamine (100 nmol, 20 equivalents). The sample was incubated at 
37 °C for 12 h and purified by 20% PAGE. 
5′-Azido-modified capture DNA oligonucleotides. The 5′-azido-modified capture DNA 
oligonucleotides were synthesized from 5′-amino-C6-DNA oligonucleotides, which were 
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prepared by solid-phase synthesis. A sample containing 6 µL of 100 mM 6-azidohexanoic acid 
(the procedure for synthesizing this compound was described in Chapter 2) in DMF, 6 µL of 
100 mM N-hydroxysuccinimide (NHS) in DMF, and 10 µL of 500 mM 1-ethyl 3-(3-
dimethylaminopropyl) carbodiimide (EDC) in water was activated at room temperature for 
40 min. The conjugation reaction was initiated by bringing the sample to 100 µL total volume 
containing 50 µM 5′-amino-C6-DNA oligonucleotide, 100 mM MES, pH 6.0, 6 mM 6-
azidohexanoic acid, 6 mM NHS, and 50 mM EDC. The sample was incubated at 37 °C for 12 h, 
ethanol-precipitated, and purified by HPLC. 
4.4.3 Stability Evaluation of the Two SAM Analogs 
The stability of the two SAM analogs was evaluated by HPLC. A 100 µL solution 
containing one of 70 mM MES (pH 6.0), 70 mM HEPES (pH 7.5), or 50 mM CHES (pH 9.0), 
100 µM of EnYn-SAM or Yn-SAM, any combination of 40 mM MgCl2, 20 mM MnCl2, 
1 mM ZnCl2 as appropriate, and 150 mM NaCl at room temperature or 37 °C for 1 h, 2 h, or 
16 h. The solution was diluted to 500 µL total volume and analyzed by HPLC [Shimdazu 
Prominence instrument; Phenomenex Jupiter Proteo column, 4 µm, 10  250 mm; gradient of 
2% acetonitrile and 98% aqueous trifluoroacetic acid (0.1% v/v) at 0 min to 7% acetonitrile and 
93% aqueous trifluoroacetic acid (0.1% v/v) at 20 min, and to 70% acetonitrile and 30% aqueous 
trifluoroacetic acid (0.1% v/v) at 50 min, with flow rate of 2 mL/min]. The percentage of SAM 
analog remaining in a sample was calculated by the equation: % SAM analog remaining = 
Asample/Acontrol)100%, where Asample is the peak area of the SAM analog in the sample, and 
Acontrol is the peak area of SAM analog in a control sample without incubation.  
4.4.4 In Vitro Selection Procedures 
4.4.4.1 Selections with Unmodified Nucleotides 
Procedure for ligation step in round 1. A 35 µL sample containing 1 nmol of DNA pool, 
800 pmol of DNA splint, and 600 pmol of 5′-phosphorylated DNA-anchored peptide or 
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cysteamine substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by 
heating at 95 °C for 3 min and cooling on ice for 5 min. To this solution was added 4 µL of 10× 
T4 DNA ligase buffer (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) and 1 µL of 5 
U/µL T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h and separated by 
8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5-10 pmol), 25 pmol of DNA splint, and 50 pmol of DNA-anchored 
peptide or cysteamine substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this solution was added 2 
µL of 10× T4 DNA ligase buffer and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). The sample 
was incubated at 37 °C for 12 h and separated by 8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 16 µL sample containing 200 pmol of ligated pool was annealed in 
one of the annealing conditions by heating at 95 °C for 3 min and cooling on ice for 5 min. The 
selection reaction was initiated by bringing the sample to 40 µL total volume containing 100 µM 
SAM analog, buffer, and metal ions in one of the selection conditions. The Mn2+ was added from 
a 10× stock solution containing 200 mM MnCl2. The Zn
2+ was added from a 10× stock solution 
containing 10 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES, pH 7.5; this stock solution was 
freshly prepared from a 100× stock of 100 mM ZnCl2 in 200 mM HNO3. The metal ions were 
added last to the final sample. The sample was incubated at room temperature for 2 or 14 h and 
separated by 8% PAGE. 
Annealing conditions A: 5 mM MES, pH 6.0, 15 mM NaCl, and 0.1 mM EDTA 
Selection conditions A: 70 mM MES, pH 6.0, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 
150 mM NaCl 
Annealing conditions B: 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA 
Selection conditions B: 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, 
and 150 mM NaCl 
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Annealing conditions C: 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA 
Selection conditions C: 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool was annealed in one of the annealing conditions by heating at 95 °C for 3 min and cooling 
on ice for 5 min. The selection reaction was initiated by bringing the sample to 20 µL total 
volume containing 100 µM SAM analog, buffer, and metal ions in one of the selection 
conditions. The sample was incubated at room temperature for 2 or 14 h and separated by 8% 
PAGE. 
Procedure for CuAAC capture step in round 1. The precipitated selection sample was 
brought to 20 µL total volume containing 300 pmol of DNA splint for capture, 400 pmol of 16 nt 
5-azido capture oligonucleotide, 50 mM HEPES, pH 7.5, 150 mM NaCl, 2.8 mM tris(3-
hydroxypropyltriazolylmethyl)amine (THPTA), 0.8 mM sodium ascorbate, and 0.4 mM CuSO4. 
The three reagents were added from 28 mM (10), freshly prepared 20 mM (25), and 4 mM 
(10) stock solutions, respectively. The sample was incubated at 37 °C for 2 h and separated by 
8% PAGE. 
Procedure for CuAAC capture step in subsequent rounds. The precipitated selection 
sample was brought to 20 µL total volume containing 25 pmol of DNA splint for capture, 
50 pmol of 52 nt (even rounds) or 16 nt (odd rounds) 5-azido capture oligonucleotide, 50 mM 
HEPES, pH 7.5, 150 mM NaCl, 2.8 mM THPTA, 0.8 mM sodium ascorbate, and 0.4 mM CuSO4. 
The sample was incubated at 37 °C for 2 h and separated by 8% PAGE. 
Procedure for DTT treatment. At each of rounds 1–3, 6, 9, and 12, the sample from the 
capture step was brought to 20 µL total volume containing 100 mM HEPES, pH 7.5, and 50 mM 
DTT. The sample was incubated at 37 °C for 2 h and separated by 8% PAGE. 
Procedure for PCR. In each selection round, two PCR reactions were performed, 10-
cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared containing the 
PAGE-separated capture product, 200 pmol of forward primer, 50 pmol of reverse primer, 
20 nmol of each dNTP, 10 µL of 10 Taq polymerase buffer [1 = 20 mM Tris-HCl, pH 8.8, 
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10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100], and 1 µL of Taq 
polymerase. This sample was cycled 10 times according to the following PCR program: 94 °C 
for 2 min, 10 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Taq polymerase 
was removed by phenol/chloroform extraction. Second, a 50 µL sample was prepared containing 
1 µL of the 10-cycle PCR product, 100 pmol of forward primer, 25 pmol of reverse primer, 
10 nmol of each dNTP, 20 µCi of -32P-dCTP (800 Ci/mmol), 5 µL of 10 Taq polymerase 
buffer, and 0.5 µL of Taq polymerase. This sample was cycled 30 times according to the 
following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 
72 °C for 5 min. The sample was separated by 8% PAGE. 
4.4.4.2 Selections with Modified Nucleotides 
Procedures for ligation, selection, capture were the same as the procedures in selections 
with unmodified nucleotides. Any changes to incorporate modified nucleotides are described 
below. These changes were developed largely by graduate student Cong Zhou, as reported.26 
ImdUTP was synthesized by Cong, while TrpdUTP and BndUTP was synthesized by graduate 
student Shannon Walsh.28 KOD XL polymerase used in primer extension and PCR is a 40:1 
mixture of the KOD exonuclease minus (exo−) mutant polymerase and the wild-type KOD 
polymerase. The KOD exo− polymerase has a single point mutation N210D from the wild-type 
KOD polymerase.29 The two plasmids were created by Shannon, and the polymerases were also 
prepared by Shannon.28 
Procedure for synthesis of modified pools for round 1. For AmdU, COOHdU, and HOdU-
modified nucleotides, the modified DNA pools for round 1 were synthesized by solid-phase 
synthesis using commercially available phosphoramidites. For ImdU, TrpdU, and BndU-modified 
nucleotides, the modified DNA pools for round 1 were prepared by primer extension, as follows. 
A reverse-complement of the DNA pool containing either 25% ImdU, 15% TrpdU, or 25% BndU 
was synthesized and ligated to a 3-tail to enable separation from the product by PAGE after 
primer extension. A 50 µL sample containing 250 pmol of reverse-complement template, 
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500 pmol of forward primer, 15 nmol each of dATP, dGTP, dCTP, and one of the modified 
dUTPs, 5 µL of 10KOD XL polymerase buffer [1.2 M Tris-HCl, pH 8.0, 60 mM (NH4)2SO4, 
100 mM KCl, 1% Triton X-100, 0.01% BSA], and 2 µL of KOD XL polymerase was incubated 
in a PCR thermocycler with the following primer extension program: 94 °C for 2 min, 47 °C for 
2 min, 4 (72 °C for 1 h). Eight reactions were performed for each modified nucleotide to 
generate the initial DNA pool. The samples were ethanol-precipitated and separated by 8% 
PAGE. 
Procedure for primer extension to generate modified pools for subsequent rounds. A 
25 µL sample containing the reverse-complement single strand (obtained from the PCR step), 
50 pmol of forward primer, 7.5 nmol each of dATP, dGTP, dCTP, and one of the modified 
dUTPs, 20 µCi of -32P-dCTP (800 Ci/mmol), 2.5 µL of 10KOD XL polymerase buffer 
(1.2 M Tris-HCl, pH 8.0, 60 mM (NH4)2SO4, 100 mM KCl, 1% Triton X-100, 0.01% BSA), and 
0.5 µL of KOD XL polymerase was incubated in a PCR thermocycler with the following primer 
extension program: 94 °C for 2 min, 47 °C for 2 min, 172 °C for 1 h). The sample was 
separated by 8% PAGE.  
Procedure for PCR of modified pools. In each selection round, two PCR reactions were 
performed, 10-cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared 
containing the PAGE-separated capture product, 200 pmol of forward primer, 50 pmol of reverse 
primer, 20 nmol of each dNTP, 10 µL of 10 KOD XL polymerase buffer [1.2 M Tris-HCl, 
pH 8.0, 60 mM (NH4)2SO4, 100 mM KCl, 1% Triton X-100, 0.01% BSA], and 1 µL of KOD XL 
polymerase. This sample was incubated in a PCR thermocycler with the following PCR program: 
94 °C for 2 min, 47 °C for 2 min, 72 °C for 30 min; then 94 °C for 2 min, 10 (94 °C for 1 min, 
47 °C for 1 min, 72 °C for 1 min), 72 °C for 5 min. KOD XL polymerase was removed by 
phenol/chloroform extraction. Second, a 50 µL sample was prepared containing 1 µL of the 10-
cycle PCR product, 25 pmol of forward primer, 100 pmol of reverse primer, 10 nmol of each 
dNTP, 10 µCi of -32P-dCTP (800 Ci/mmol), 5 µL of 10 Taq polymerase buffer, and 0.5 µL of 
Taq polymerase. This sample was incubated in a PCR thermocycler with the following PCR 
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program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. 
The sample was separated by 8% PAGE, and the reverse-complement single strand was used for 
the subsequent primer extension. 
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